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Journeying is hard. 
There confront many turnings, 
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Hanging cloud sail, 
I mount the wind and cleave the waves, 
bridging my sea someday.-Bai Li 
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The natural product complanadine A has shown promise in regenerative science, 
promoting neuronal outgrowth by inducing the secretion of growth factors from glial 
cells. Through the use of tandem, cobalt-mediated [2+2+2] cycloaddition reactions two 
synthetic routes have been developed with different sequences for the formation of the 
unsymmetric bipyridyl core. The regioselective formation of each of the pyridines was 
achieved based on the inherent selectivity of the molecules or by reversing this inate 
regioselectivity through the addition of Lewis bases. This strategy has been successfully 
employed to provide laboratory access to complanadine A as well as structurally related 
compounds possessing the lycodine core. 
Phthaloyl peroxide derivatives have the potential to function as organocatalysts 
for the dihydroxylation of alkenes. The development of an organocatalytic system for the 
syn-dihydroxylation of alkenes, using hydrogen peroxide as the stoichiometric oxidant, 
 ix
could minimize the waste and cost associated with the current industrial process. With 
new access to phthaloyl peroxide derivatives, this dihydroxylation method was improved 
with stoichiometric dichlorophthaloyl peroxide for the dihydroxylation of alkenes. 
Substituted phenols are broadly useful compounds, functioning as starting 
materials and end products in all areas of chemical industry. Since the initial discovery of 
phenol from coal tar advances have been made in the synthetic preparations of this class 
of compounds which possess a hydroxyl group appended to an aromatic hydrocarbon 
core. Ideally the synthesis of phenols is achieved through the direct installation of oxygen 
into an aromatic precursor, which is typically more abundant. In this thesis it is discussed 
how phthaloyl peroxide, in the absence of other reagents, enables the conversion of 
aromatic hydrocarbons to phenols even when the precursors possess functionality that is 
incompatible with strongly oxidizing conditions. The reaction is shown to proceed 
through a "reverse rebound" mechanism as opposed to the classical rebound mechanism, 
providing insight into the unique aryl selectivity of the chemical transformation. 
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CHAPTER 1 Background for (–)-Complanadine A and (+)-Lycodine 
  2
1.1 Isolation and Structural Characterization of Complanadine A 
 
Lycopodium alkaloids are natural products with unique annulated ring systems and they 
have attracted scientific inquiry based on their biogenesis, biology, and as targets for chemical 
synthesis.1 In 1958 lycodine was isolated by Anet and Eves from Lycopodium annotinum L., 
Lycopodiaceae.2 Later, in 1960, Ayer and coworkers identified the structure of lycodine 1.1 as 
possessing a transannular skeleton fused with a pyridyl ring and it was given the IUPAC name 
[4aR-(4aa,5a,10ba,12R’)]-2,3,4,4a,5,6-hexahydro-12-methyl-1H-5,10b-propano-1,7-
phenanthroline (Figure 1.1).3 Subsequently, related Lycopodium alkaloids were isolated and their 
structures elucidated. In 2000 Kobayashi and coworkers examined the club moss 
Lycopodiumserratum var. serratum and isolated a dimeric alkaloid with a pseudo-symmetrical 
lycodine skeleton that was later named as complanadine A (Figure 1.2).4  
  
 
Figure 1.1. Lycodine (1.1) and complanadine A (1.2). 
 
 
  3
 
Figure 1.2. NOE analysis of complanadine A (1.2). 
Kobayashi and coworkers subsequently isolated complanadines B (1.3), C (1.4), D (1.5) 
and E (1.6) (Figure 1.3).5 Interstingly, the structures of complanadine B to E possessed diffrent 
oxidation states with complanadine C possessing a rearranged skeleton (complanadine C 1.4). 
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Figure 1.3. Complanadines B through E.
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1.2 Biological Activity of Complanadine A 
Gene therapy-based approaches to increasing the production of neurotrophic factors, 
while promising, have not overcome the limitations of short-lived effects, undesirable immune 
responses, intracranial delivery, and challenges involving the use of viral vectors. Our group has 
an interest in using small molecules to provide an alternative approach, relative to biologics, to 
promote regeneration.6 Able to mimic neurotrophic factors, or to induce neurotrophic factor 
biosynthesis, small molecules possess a pharmacological advantage.  Along these lines it was 
discovered that the natural product complanadine A (1.2) and complanadine B (1.3), induced the 
secretion of neurotrophic factors from 1321N1 cells (human glial cells derived from brain 
astrocytoma), promoting the differentiation of PC-12 cells.7 The enhanced expression of NGF 
mRNA by 1321N1 cells treated with complanadine B was determined by semiquantitative RT-
PCR.8 
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1.3 Proposed Biosynthetic Pathway  
 
Defined by A. W. Ayer,1b the lycopodium alkaloids can be separated into four classes: 
lycodine, lycopodine, fawcettimine, and miscelaneous derivatives (Figure 1.4). The biosynthesis 
of these compounds has been based on Conroy’s biogenetic hypothesis.8 Based on these 
observation one can us the different oxidation states to differentiate the four major classes of 
lycopodium natural products.  
In Figure 1.5 the biosynthesis is outlined. Starting from L-lysine 1.10, cadaverine 1.11 is 
formed following a decaboxylation. An oxidase transforms cadaverine 1.11 to 5-aminopentanal 
1.12 in equilibrium with piperideine 1.13. Malonyl-CoA 1.14 dimerizes to give 1.15 which goes 
on to react with 1.13 to access 1.16. At this stage 1.19 will be formed after decarboxylation and 
dimerization. The alkaloids originate from two pelleterine 1.18 units that form the bonds 
between C-4 and C-13 to give the lycodane skeleton. Under oxidation, the pyridine-based 
lycodine 1.1 provide the second class. After further oxidation of the pyridine and detaching C-1 
from Nα and reattaching Nβ, the pyridone skeleton provides the lycopodine class 1.8. Migration of 
C-4 from C-13 to C-12 gives the fawcettimine skeleton 1.9.  
  6
 
Figure 1.4. Four major lycopodium alkaloids with different oxidation states. 
 
 
Figure 1.5. Proposed biosynthetic pathway to pelletierine and precursors of the lycopodium 
alkaloids.
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1.4 Previous Syntheses of Lycodine 
 
Lycopodium alkaloids have been extensively studied by synthetic scientists.9 Relevant to 
our work these include lycodine, complanadine A15 and complanadine B. 
The synthesis of lycodine was achieved in racemic form twice, once by Heathcock10 and 
coworkers and subsequently by Tsukano11, Hirama and coworkers. Heathcock’s synthesis 
(Scheme 1.1) was a landmark achievement for the time. The overall yield of lycodine 1.1 was 
16% over 11 synthetic steps. The synthesis started with cyanodione 1.20 which was treated with 
oxalyl chloride to give a chlorocyclohexenone intermediate that was treated with a zinc-copper 
couple in methanol, to provide enone 1.21 on the gram scale. Conjugate addition of the anion of 
a hydrazone led to the diketone product 1.22. Masking the diketone as a diacetal intermediate 
and reduction of the nitrile provided the corresponding amine 1.23. Under acid deprotection 
1.23, in situ, imine formation and a tandem Mannich reaction occurred to generate ketone 1.24. 
The pyridine heterocycle was then formed in four steps providing lycodine 1.1.   
  8
Scheme 1.1 Heathcock's synthesis of (±)-lycodine. 
 
 
In 2010, Tsukano and Hirama finished the second synthesis of lycodine (Scheme 1.2).11 
Key features included an intermolecular Diels-Alder cycloaddition and an intramolecular Heck 
reaction. The step count for the synthesis is 16 and an overall yield of 1.8%. The synthesis 
started from the 3-hydroxyl pyridyl ester 1.25 which was subjected to a TIPS protection to give 
TIPS ether 1.26. Reaction of ester 1.26 generated phosphate 1.27. The product 1.27 underwent a 
HWE reaction to provide the unsaturated ester 1.28 which was desilylated to form the hydroxyl 
pyridine 1.29 that was subjected to Diels-Alder reaction with 1.30. The reaction afforded the 
desired compound 1.31 with additional undesired isomers. After triflation, the compound 1.32 
underwent a Heck reaction to give the transannulated product 1.33. The ester 1.34 was 
saponified and subjected to a Schmidt reaction and, after hydrolysis, pyridyl ketone 1.35 was 
formed. Lastly, methylation and reduction of the ketone through a thioacetal formed lycodine.  
 
  9
 
 
Scheme 1.2 Tsukano and Hirama's synthesis of (±)-lycodine. 
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1.5 Additional Syntheses of Complanadine A and Complanadine B 
 
The Tsukano and Hirama group (Scheme 1.3) followed their synthesis of lycodine 
with syntheses of complanadines A and B (1.2 and 1.3) in 201311,12. After screening they 
seperated the enantiomers of 1.36 by amylose chiral column to provide (+)-1.36 and (-)-
1.36. Oxidation of 1.36 to the pyridine N-oxide 1.37 and borylation of 1.36 under 
Hartwig’s borolative conditions followed by conversion of boron to bromine the resulting 
bromide 1.38 was formed. In the key transformation a dehydrogenerative coupling 
reaction of 1.37 and 1.38 was achieved using palladium catalysis based on the work of 
Fagnou and Buchwald.14 Complanadine A 1.2 was then formed by reduction of 1.39. For 
complanadine B 1.3, N-oxide intermediate 1.39 was treated with acetic anhydride to 
transfer the oxidation at nitrogen to the benzylic position to 1.40. Three additional 
deprotection and oxidation reactions then provided complanadine B 1.3.    
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Scheme 1.3 Tsukano and Hirama's synthesis of complanadine A and complanadine B. 
 
Sarpong’s synthesis13 (Scheme 1.4), which coincided with ours, started with the 
amino ketal 1.42, generated in a seven-step procedure from pulegone 1.41. A tandem 
cyclizations using enamide 1.43 and the amino ketal 1.42 formed N-desmethyl α-
obscurine 1.44 in 70% yield on the gram scale. The Boc-protected lycodine 1.45 could be 
made in four steps. At this stage the application of an iridium catalyzed borylation of 1.48 
genetaed borate ester 1.49. Suzuki cross-coupling of boronic ester 1.48 and triflate 1.47 
provided protected complanadine A that was deprotected by removal of the Boc 
protecting groups with acid to give complanadine A 1.2 in 42% yield over two steps. In 
the Sarpong group’s synthesis of complanadine B the intermediate 1.48 was oxidized to 
  12
provide ketone 1.50 that was chlorinated at the 2-position of the pyridine and coupled to 
the boronate 1.49.  
Scheme 1.4: Sarpong's synthesis of complanadine A and complanadine B. 
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1.6 Conclusion 
 
The background science of complanadine A and lycodine including the isolation 
of complanadine A 1.2 and lycodine 1.1, biological activity of complanadine A 1.2, the 
proposed biosynthesis of the lycopodium alkaloids, and the syntheses of lycodine, 
complanadine A 1.2 and complanadine B 1.3 were described.  
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CHAPTER 2 Synthesis of Complanadine A and Lycodine - First and 
Second Generation Syntheses of Complanadine A 
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2.1 Retrosynthetic Analysis of Complanadine A and Lycodine 
 
The synthesis of complanadine A1, 2 was envisioned through the application of sequential 
[2+2+2] metal controlled cycloaddition reactions between a disubstituted-butadiyne 2.4 and two 
molecules of alkyne-nitrile 2.1 (Figure 2.1).  Two potential sequences for the ordered, 
regioselective formation of the pyridine rings were possible, both generating complanadine A. 
 
Figure 2.1. Retrosynthetic analysis of the complanadine A. 
A variety of metals have been employed for pyridine synthesis using the 2+2+2 
cycloaddition using one unit of a nitrile and two alkynes. The metals used for these reactions 
include; ruthenium3, rhodium4, titanium5, tantalum6, nickel7, iron8, and cobalt9. Cobalt 
represented the most promising metal as it has shown the greatest tolerance for functionality. As 
shown in Figure 2.2 the catalytic cycle proceedes through four steps.10 Although the sequence 
appears promising there are challenges; first, as the reaction forms intermediate metallacycle 
such as 2.21 regioselectivity will be an issue and secondly, alkyne trimerization leading to the 
formation of substituted benzenes is possible.11 
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Figure 2.2. Mechanism of the cobalt-mediated [2+2+2] reaction to form pyridines. 
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2.2 Synthesis of Alkynyl Nitriles Bicyclic Compound  
 
We chose natural (+)-pulegone 2.27 as the starting material for the synthesis due to its 
cost and availability with the correct sterochemical configuration (Figure 2.3). This chiral center 
was envisioned to allow all of the other stereocenters to form, in a diastereoselective manner, 
based on this initial stereocenter. Additionally the compound can be readily transformed into a 
number of useful compounds including thioether 2.26.  
 
CN
N
R
H
Me N
CN
Me
N
H
CN
Me
or
O
Me
CN
NRR'
O
Me
SPh
R'RN X
O
Me
Me
Me
(+)-pulegone (2.27)
2.22
2.23
2.1 2.24
2.25
2.26
 
Figure 2.3. Second general retrosynthetic route to bicyclic compound 2.1. 
Following from literature precedence thioether 2.26 was synthesized on batches of more 
than 100g.12 Alkylation of thioether 2.26 using sodium hydride and a phthamidyl iodide afforded 
exclusively the O-alkylation product (Scheme 2.1). Use of 3-chloro-1-iodo-propane, however, 
provided the C-alkylation product 2.30 in acceptable yield. The solvent for this reaction proved 
critical as THF was less efficient DMF. In the next step, a Finkelstein reaction using sodium 
iodide and sodium azide provided the alkyl azide compound 2.32 in 90% yield. 
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Scheme 2.1. Synthesis of enone azide 2.32. 
 
 
The use of the anion of TMSCH2CN, generated by deprotonation using LDA, in a 
Michael addition generated the desired adduct 2.33 (Scheme 2.2). This reaction had a competing 
Peterson olefination. To minimize the formation of the trans isomer ethyl salicylate was used for 
protonation13 of the resulting enolate, delivering the proton on the opposite face of the TMS 
acetonitrile group to afford 2.34 or 2.35 in 48% yield after a cesium fluoride desilylation. 
 
Scheme 2.2. Michael additions condition optimization. 
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We planned to synthesize the quaternary center of 2.1 through an intramolecular 
displacement as shown in Figure 2.4.  
 
Figure 2.4. Retrosynthetic approach to the bicyclic compound 2.1. 
The azido ketone 2.34 was reacted with ethynyl Grignard reagents to generate the 
corresponding propargyl alcohol (Scheme 2.3). To a solution of the resulting propargyl alcohol 
2.39 the hydroxyl group was converted to an acetate using catalytic magnesium perchlorate in 
neat acetic anhydride. A Staudinger reaction was then used to reduce 2.40 to the amine which 
was protected with Cbz group to form 2.41 in moderate yield. Cyclization through a copper 
catalyzed amide addition to the propargyl acetate failed.14 Therefore, we attempted an 
intermolecular displacement using benzyl amines.  
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Scheme 2.3. Failed attempts to synthesize alkyne-nitrile bicyclic compound. 
 
 
Followed our existing route the propargyl acetate 2.48 was prepared for the 
intermolecular amination reaction. Following careful degassing of the solution the copper 
catalyzed reaction successfully generated the desired propargyl amine (Scheme 2.4). Use of a 
methanolic solution of the potassium carbonate was used to deprotect the acetate, forming amino 
alcohol 2.49. This compound was cyclized using triphenylphosphine and carbontetrachloride to 
give the desired bicyclic compound 2.55.15 Under the same conditions the PMB and DMB 
derivatives were similarly prepared.  
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Scheme 2.4. Successful route to the bicylic compounds 2.55, 2.56 and 2.57. 
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Scheme 2.5. The crystal structure of 2.58 verifying the structure. 
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MeOH, 71%
OAc
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Figure 2.5. X-ray structure of the bicyclic compound 2.55 
The synthesis of the key alkyne-nitrile was achieved in an overall yield of 9 percent and 
provided the bicyclic compounds in three grams batches (Figure 2.6). 
 
 
Figure 2.6. Summary of the synthesis of bicyclic compound 2.55. 
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2.3 Synthesis of Lycodine and First Generation of Synthesis of Complanadine 
A 
 
After minor optimization bis(trimethylsilyl)acetylene reacted with the alkyne nitrile 2.55 
to generate lycodine in protected form. This compound was deprotected by TBAF desilylation of 
the pyridyl TMS followed by hydrogenation to remove the benzyl ether. This provided the third 
synthesis of lycodine to date (Scheme 2.6). 
Scheme 2.6. CpCo(CO)2 mediated [2+2+2] cyclcoaddition with bis(trimethyl)acetylene and the 
bicyclic compound and synthesis of lycodine. 
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After a number of experiments with butadiynes we used a modification of the cobalt 
catalyzed reaction developed by Schreiber and coworkers using THF at elevated temperature, 
with 2.55 and 2.4 to form the desired pyridine alkyne adduct in 82% yield (Scheme 2.15).17 It 
was worth noting that the THF conditions were carried out on the gram scale affording, in 
addition to the major isomer, the minor regioisomer 2.63 on the milligram scale. In Figure 2.7 
two proposals are presented for the formation of the metallocycle, one following from a steric 
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model put forth by Wakatsuki9a and another following an electronic model described by Saá and 
Vollhardt.10b The CpCo(CO)2 after loss of carbon monoxide possesses a free coordination site for 
bistrimethylsilylbutdiyne to form complex 2.70 or 2.71. After losing another molecule of CO and 
complexation bicyclic compound 2.55 with formation of mettalocycles 2.74 and 2.75 (Figure 
2.8).  
Scheme 2.7. THF 140 °C condition to construct pyridyl alkyne compound 2.63 and 2.64. 
 
 
 
Figure. 2.7. Electronic origin for the regioselectivity of cobalt catalyzed [2+2+2] cycloaddition. 
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Figure 2.8. Proposed mechanism for the regioselectivity in the first [2+2+2] pyridine formation. 
Unfortunately the second 2+2+2 cycloaddition could not be achieved directly after the 
first. The inability of pyridyl-alkyne 2.78 to undergo a second [2+2+2] cycloaddition was 
thought to be due to the steric impediment caused by the aryl-trimethylsilyl group adjacent to the 
alkyne.  Removal of both trimethylsilyl groups with TBAF in THF generated alkyne 2.77 which 
was silylated using LDA and TMSCl to generate silyl-alkyne 2.88. In addition, a series of other 
pyridyl-alkynes 2.64-2.89 were similarly prepared via deprotonation of 2.64 with LDA and 
reaction of the resulting acetylide anion with the appropriate electrophile (Scheme 2.8).  These 
disubstituted alkynes allowed the examination of their propensity to undergo the second [2+2+2] 
cycloaddition.  
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Scheme 2.8. Utilizing THF 140 °C condition for the second [2+2+2] pyridine formation. 
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It was found that all of the reactions generated symmetric compounds such as 2.90 and 
2.91 and when the aryl silicon groups were removed the simplified spectrum of symmetric 
compound 2.92 made it readily evident (Scheme 2.9). Furthermore removal of the benzyl group 
to form 2.93 additionally confirmed the assignment, supporting the conclusion that we had 
formed an isomer of complanadine A. However, when subjected to the same reaction conditions 
the minor regioisomer 2.63 did provide the desired product (Scheme 2.10). However, the low 
yileds associated with accessing the minor regioisomer 2.63 limited the usefulness of this 
approach. 
Scheme 2.9. Synthesis of the undesired symmetric dimeric compound 2.93. 
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Scheme 2.10. Synthesis of complanadine A through the minor regioisomer. 
 
An alternative synthesis of alkyne 2.95 was achieved as outlined in Scheme 2.11. Using 
the [2+2+2] cycloaddition adduct 2.98 to access the propargyl ether (Scheme 2.12). The silyl 
ether 2.98 was transformed using standard chemistry to the desired pyridyl alkyne 2.63. With 
scalable access to 2.63 the second cobalt mediated [2+2+2] reaction was achieved and 
complanadine A was accessed again. However, this route suffered from low yields and an 
increased number of steps. 
Scheme 2.11. Preparation of the pyridine 2.98. 
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Scheme 2.12. Improved first generation of synthesis for complanadine A. 
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2.4 Second Generation of Synthesis of Complanadine A 
As the first [2+2+2] provided the 2-alkynylpyridine 2.64 in good yield efforts were made 
to utilize this compound by changing the regioselectivity of the second [2+2+2] cycloaddition. 
Examination of a number of alkynyl arenes revealed a strong regioselectivity preference for the 
reaction (Scheme 2.13). 
Scheme 2.13. Cycloadditions with aryl alkynes and bicyclic compound 2.55. 
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With ample quantities of the key bicyclic compound 2.55 the benzyl group was changed 
in an attempted to change the regioselectivity of the second [2+2+2] cycloaddition reaction. The 
use of CAN to cleavage the PMB group of 2.56 or DMB on 2.57 succeeded, generating the 
secondary amine 2.119 on the gram scale allowing the syntheses of a variety of alkyne-nitriles 
with different carbonyl groups (Scheme 2.14).  
Scheme 2.14. Synthesis of bicyclic compound derivatives. 
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Using 2.120 and 2.122 under the standard THF 140 °C cobalt mediated conditions the 
desired isomers were formed, albeit as minor constituents (Figure 2.15). Additionally, the use of 
Lewis basic ligands was also found to be beneficial (Table 2.1). Additional testing of solvent, 
temperature, and concentration gave us an approximate set of conditions to form the desired 
bipyridyl 2.128 as the major product. 
Scheme 2.15. The effects of the nitrogen bound functionality on the regioselectivity. 
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Table 2.1. The effects of additives on the second [2+2+2] cycloaddition. 
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Table 2.2. Screen of solvent, temperature and concentrations for the second [2+2+2] 
cycloaddition. 
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The final conditions were a diluted solution of the two components and cobalt reagent in 
dioxane with PPh3 heated to 140 °C to give the bipyridyl product 2.130 in 42% yield (Table 2.2). 
Deprotection of all of the formyl, benzyl, and silyl groups preceded over three steps to yield 
complanadine A (Scheme 2.16). The reversal of the regioselectivity through the use of 
triphenylphosphine is rationalized in Figure 2.9, due to both the sterics of triphenylphosphine 
and the removal of a coordination site that the pyridine could complex.  
Scheme 2.16. Second generation of synthesis of complanadine A. 
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Figure 2.9. Proposed mechanism for the cobalt mediated [2+2+2] cycloaddition with PPh3. 
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2.5 Conclusion 
The successful syntheses of lycodine (1.1) and complanadine A (1.2), which was achieved 
through two separate routes, have been achieved. Both routes to complanadine A were developed 
utilizing cobalt-mediated [2+2+2] cycloaddition reactions. In addition, related lycodine 
derivatives can be rapidly accessed through similar cycloadditions using disubstituted alkynes. 
The controlled formation of the 2, 3’-bipyridyl core was achieved through either modifying the 
partners in the reaction sequence or through the use of Lewis-basic additives.  
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2.7 Experimental Section 
 
 
 
To a solution of thioether 2.26 (5.0 g, 22.7 mmol, 1.0 equiv.) in DMF (120 mL) at 0 °C solid 
NaH (1.04 g, 60% oil dispersion, 26.0 mmol, 1.2 equiv.) was added in portions over five minutes 
with extensive gas evolution. After 60 min the 1-chloro-3-iodopropane (5.10 g, 25.0 mmol, 1.1 
equiv.) was added dropwise over 10 minutes and the cooling bath was removed and the solution 
was stirred for 1 hour. The reaction mixture was diluted with aqueous saturated NH4Cl solution 
(500 mL) and EtOAc (250 mL). The organic phase was separated and the aqueous phase was 
extracted with EtOAc (4 × 100 mL). The combined organic extracts were washed with brine 
(100 mL), dried over Na2SO4, filtered, and concentrated. The crude material was purified by 
silica gel chromatography (5/1 → 2/1 hexanes/Et2O) to afford yellow paste 2.30 (3.54 g, 53%). 
 
2.30: Rf = 0.45 (silica gel, Hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3 , 2.30-major: 
2.30-minor = 0.77 : 0.23 Mixture of Diastereomers): δ 0.96 (d, J = 6.4 Hz, 3H**), 1.08 (d, J = 
6.4 Hz, 3H*), 1.42-1.72 (m, 3H), 1.72-2.02 (m, 4H), 2.04-2.15 (m, 2H), 2.28-2.34 (m, 1H), 3.12 
(t, J = 13.2 Hz, 1H*), 3.30 (dd, J = 5.2 and 14.0 Hz, 1H**), 3.44-3.54 (m, 2H), 7.27-7.50 (m, 
5H); 13C NMR (100 MHz, CDCl3): δ 19.6, 21.9, 22.2, 27.0, 27.1, 27.8, 29.6, 31.86, 31.91, 32.2, 
33.5, 34.5, 35.7, 45.0, 45.1, 45.8, 59.7, 61.4, 128.86, 128.95, 129.0, 129.3, 129.5, 135.3, 136.0, 
136.5, 207.2, 207.9; IR: v 2955, 2927, 1701, 1438 cm-1; HRMS calcd. for C16H21ClOS+ [M+]: 
296.1002. Found: 296.1005.  
H* for minor isomer 
H**for major isomer 
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To a solution of ketone 2.30 (3.67 g, 12.4 mmol, 1.0 equiv.) in CH2Cl2 (150 mL) at –78 °C a 
solution of purified mCPBA (2.24 g, 13.0 mmol, 1.1 equiv.) in CH2Cl2 (50 mL) was added over 1 
hour. The mixture was warmed to 23 °C over one hour then stirred 10 hours where upon the 
solution became homogeneous. The reaction was diluted with aqueous NaHSO3 solution (10% 
w/w, 50 mL). The mixture was extracted with EtOAc (3 × 50 mL). The combined organic 
extracts were washed with brine (50 mL), dried over Na2SO4, filtered, and concentrated. The 
crude product was purified by silica gel chromatography (10/1 → 2/1 hexanes/Et2O) to afford 
2.31 as yellow oil (1.9 g, 82%). 
 
2.31: Rf = 0.50 (silica gel, hexanes/ EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ 1.03 (d, J = 
6.0 Hz, 3H), 1.82-1.89 (m, 2H), 1.99-2.09 (m, 2H), 2.12-2.21 (m, 1H), 2.31 (t, J = 7.6 Hz, 2H), 
2.37-2.50 (m, 2H), 3.48 (t, J = 6.4 Hz, 2H), 6.72-6.74 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 
21.1, 26.9, 30.6, 31.2, 34.3, 44.5, 46.5, 137.8, 145.5, 199.4; IR (neat): v 2957, 1675, 1384 cm1; 
HRMS calcd. for C10H16ClO+ [M+H+]: 187.0890. Found: 187.0890.  
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To a solution of enone 2.31 (231 mg, 1.24 mmol, 1.0 equiv.) in DMF (10 mL) at 23 °C solid NaI 
(403 mg, 2.7 mmol, 2.2 equiv.) and NaN3 (159 mg, 2.5 mmol, 2.0 equiv.) were added. The 
reaction flask was immersed into 65 °C oil bath and stirred for 24 hours. The reaction was 
diluted with aqueous saturated NH4Cl solution (20 mL) and the mixture was extracted with 
EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated. The crude product was purified by silica gel chromatography 
(10/1 → 2/1 hexanes/EtOAc) to afford 2.32 as pale yellow oil (171 mg, 72%). 
 
2.32: Rf = 0.50 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ 1.05 (d, J = 
6.0 Hz, 3H), 1.66-2.00 (m, 2H), 2.01-2.27 (m, 5H), 2.38-2.45 (m, 1H), 2.45-2.51 (m, 1H), 3.25 
(t, J = 6.8 Hz, 2H), 6.70-6.73 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 21.2, 26.9, 27.8, 30.6, 
34.3, 46.6, 51.0, 138.2, 145.3, 199.5; IR (neat): v 2956, 2097, 1674 cm1; HRMS calcd. for 
C10H16N3O+ [M+H+]: 194.1293. Found: 194.1291.  
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To s solution of the diisopropylamine (95 µL, 0.67 mmol, 2.0 equiv) in Et2O (2 mL) n-BuLi 
solution (0.35 mL, 2.0 M, 0.67 mmol, 2.0 equiv) was added at –78 °C. After 5 minutes neat 
trimethylsilylacetonitrile (92 µL, 0.67 mmol, 2.0 equiv.) was added. After 30 min the solution 
was transferred via cannula to a second flask containing enone 2.32 (65 mg, 0.34 mmol, 1.0 
equiv.) in Et2O (5 mL) cooled to – 78 °C. After 25 minutes the resulting yellow solution was 
transferred via cannula to a third flask containing ethyl salicylate (0.15 mL, 1.0 mmol, 3.0 
equiv.) in Et2O (2 mL) cooled to – 78 °C. The reaction was allowed to slowly warm to 23 °C 
over 1 hour. The lithium phenoxide was quenched by the addition of acetic acid (60 µL, 1.0 
mmol, 3 equiv.). The reaction was filtered through a pad of celite. The solution was washed with 
aqueous saturated NaHCO3 solution (10 mL) and brine (5 mL). The organic layer was dried over 
Na2SO4, filtered and concentrated. The crude material was purified by silica gel chromatography 
(20/1 → 1/1 hexanes/Et2O) to afford yellow oil (42 mg, 72%) as a mixture of 4 diastereomers 
that was used in the next reaction (below). 
 
To a solution of the above diastereomers (42 mg, 0.14 mmol, 1.0 equiv.) in MeCN (3 mL) solid 
CsF (5.0 mg, 0.030 mmol, 0.24 equiv.) was added. The resulting mixture was stirred at 23 °C for 
6 hours then diluted with aqueous saturated NH4Cl solution (5 mL) and extracted with EtOAc (3 
× 5 mL). The organic extracts were washed with brine (10 mL), dried over Na2SO4, filtered and 
concentrated. The crude material was purified by silica gel chromatography (10/1 → 1/1 
hexanes/EtOAc) to afford ketone 2.34 (27.8 mg, 87%) as a light yellow oil.  
 
2.34: Rf = 0.65 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ 1.08 (d, J = 
6.4 Hz, 3H), 1.16-1.25 (m, 1H), 1.40-1.51 (m, 1H), 1.56-1.62 (m, 2H), 1.63-1.84 (m, 2H), 1.96-
2.17 (m, 3H), 2.31-2.44 (m, 2H), 2.56-2.61 (m, 2H), 3.24-3.35 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ 16.9, 22.0, 23.7, 27.0, 30.0, 37.3, 38.3, 50.1, 51.3, 52.2, 118.2, 210.0; IR: v 2954, 
2098, 1709 cm-1; HRMS calcd. for C12H18N4ONa+ [M + Na+]: 257.1378. Found: 257.1373.  
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To a solution of thioether 2.26 (30.0 g, 136 mmol, 1.0 equiv.) in DMF (1.25 L) at 0 °C solid NaH 
(5.99 g, 60% oil dispersion, 150 mmol, 1.1 equiv.) was added portion wise over five minutes 
with extensive gas evolution.  After 60 minutes the iodo ester (37.3 g, 163 mmol, 1.2 equiv.) was 
added neat, dropwise over 10 minutes then the cooling bath was removed and the resulting 
solution was stirred at 23 ºC for 1 hour.  The reaction was diluted with aqueous saturated NH4Cl 
solution (2 L) and EtOAc (1 L).  The organic phase was collected and the aqueous phase was 
extracted with EtOAc (4 × 500 mL).  The combined organic extracts were washed with brine 
(500 mL), dried over Na2SO4, filtered, and concentrated.  The crude material was purified by 
silica gel chromatography (5/1 → 2/1 hexanes/Et2O) to afford a diastereomeric mixture of 
ketones 2.26-int as yellow viscous oil (27.3 g, 63%). 
 
2.26-int: Rf = 0.31 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3, 7/3 Mixture 
of Diastereomers): δ 0.88 (t, J = 6.8 Hz, 0.7 H), 0.96 (d, J = 6.8 Hz, 2.1 H), 1.08 (d, J = 6.0 Hz, 
0.9 H), 1.22-1.30 (m, 0.3 H), 1.46-1.94 (m, 5 H), 1.96-2.36 (m, 7 H), 3.14 (t, J = 13.2 Hz, 0.3 H), 
3.35 (dd, J = 6.0 and 14.4 Hz, 0.7 H), 3.98-4.04 (m, 2H), 7.26-7.37 (m, 5H); 13C NMR (100 
MHz, CDCl3): δ 19.3, 20.7, 22.0, 22.5, 22.7, 27.5, 29.5, 30.2, 30.6, 31.6, 33.0, 34.3, 35.4, 44.7, 
45.6, 59.6, 60.8, 61.2, 64.2, 64.3, 128.6, 128.7, 129.1, 129.2, 129.9, 130.1, 135.8, 136.3, 170.8, 
206.9, 207.7; IR: v 1739, 1700, 1043 cm-1; HRMS calcd. for C18H24O3SNa+ [M+Na+]: 
343.13438. Found: 343.13447.  
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The diastereomeric mixture of ketones 2.26-int (27.0 g, 84 mmol, 1.0 equiv.) in CH2Cl2 (1.0 L) 
was cooled to –78 °C and a solution of purified m-CPBA (15.3 g, 88 mmol, 1.05 equiv.) in 
CH2Cl2 (600 mL) was added over 1 hour.  The cooling bath was removed and the solution was 
stirred for 10 hours at 23 ºC where upon the solution became homogeneous.  The reaction was 
then diluted with aqueous NaHSO3 (10% w/w, 200 mL).  The mixture was extracted with EtOAc 
(3 × 400 mL).  The organic extracts were washed with brine (200 mL), dried over Na2SO4, 
filtered, and concentrated.  The crude product was purified by silica gel chromatography (10/1 → 
2/1 hexanes/Et2O) to afford enone 2.45 as yellow oil (13.6 g, 77%). 
 
2.45: Rf = 0.39 (silica gel, Hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ 1.05 (d, J = 
6.4 Hz, 3H), 1.58-1.77 (m, 2H), 2.04-2.09 (m, 4H), 2.09-2.13 (m, 1H), 2.13-2.19 (m, 1H), 2.25 
(t, J = 8.0 Hz, 2H), 2.41 (dt, J = 5.0 and 18.0 Hz, 1H), 2.47-2.52 (m, 1H), 4.04 (t, J = 6.4 Hz, 
2H), 6.68-6.70 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 21.0, 21.2, 26.0, 27.3, 30.6, 34.3, 46.6, 
64.0, 138.3, 144.9, 171.2, 199.5; IR (neat): v 1734, 1717 cm1; HRMS calcd. for C12H18O3Na+ 
[M+Na+]: 233.11536. Found: 233.11490.  
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To a solution of trimethylsilyl acetonitrile (0.28 mL, 2.1 mmol, 1.3 equiv.) in Et2O (30 mL) at 
−78 °C was added a solution of n-butyllithium (1.8 M Hexanes, 1.1 mL, 2.0 mmol, 1.2 equiv.) 
over one minute.  After stirring for 40 minutes at −78 °C the pale yellow solution was transferred 
over 3 minutes via cannula to a stirred solution of the enone 2.45 (350 mg, 1.7 mmol, 1.0 equiv.) 
in Et2O (30 mL) at −78 °C.  After 30 minutes, the bright yellow solution was added over 3 
minutes via cannula to a stirred solution of ethyl salicylate (0.97 mL, 6.6 mmol, 4.0 equiv.) at 
−78 °C in Et2O (30 mL).  After 5 minutes the cooling bath was removed and the reaction was 
allowed to warm to 23 ºC over 20 minutes and acetic acid (0.10 mL, 1.7 mmol, 1.1 equiv.) was 
added in one portion.  The solution was washed with aqueous saturated sodium bicarbonate 
solution (50 mL).  The organic extract was washed with brine (50 mL), dried over Na2SO4, 
filtered, and concentrated.  The crude material was purified by silica gel chromatography (20/1 
→ 5/1 hexanes/EtOAc) to afford a mixture of diastereomers as light yellow oil (300 mg, 56%) 
  
To a solution of the above diastereomers (4.50 g, 13.9 mmol, 1.0 equiv.) in MeCN (110 mL) at 
23 °C was added solid CsF (0.20 g, 1.3 mmol, 0.10 equiv.). The resulting mixture was stirred at 
23 ºC for six hours.  The reaction was diluted with aqueous saturated NH4Cl solution (100 mL) 
and extracted with EtOAc (2 × 200 mL).  The organic extracts were washed with brine (100 
mL), dried over Na2SO4, filtered, and concentrated.  The crude material was purified by silica gel 
chromatography (10/1 → 1/1 hexanes/Et2O) to afford ketone 2.46 (2.80 g, 80%) as yellow oil. 
The two steps yield is 45%. 
 
2.46: Rf = 0.45 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ 1.07 (d, J = 
6.0 Hz, 3H), 1.15-1.23 (m, 1H), 1.48-1.84 (m, 4H), 1.95-2.17 (m, 7H), 2.31-2.44 (m, 2H), 2.56-
2.63 (m, 2H), 3.99-4.09 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 16.8, 20.9, 22.0, 22.8, 26.5, 
30.0, 37.2, 38.1, 50.1, 52.0, 64.0, 118.2, 171.1, 210.1; IR: 1735, 1710, 1048 cm-1; HRMS calcd. 
for C14H21NO3Na+ [M+Na+]: 274.14191. Found: 274.14169.  
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To a solution of ketone 2.46 (11.5 g, 45.8 mmol, 1.0 equiv.) in THF (350 mL) at 23 °C a solution 
of the ethynyl magnesium chloride (114 mL, 0.60 M in toluene/THF, 69 mmol, 1.5 equiv.) was 
added dropwise over five minutes.  After 30 minutes the resulting alkoxide was quenched by the 
addition of aqueous saturated NH4Cl solution (100 mL) and the mixture was extracted with 
EtOAc (3 × 200 mL).  The organic extracts were washed with brine (50 mL), dried over Na2SO4, 
filtered, and concentrated. The crude alcohol was purified by silica gel chromatography (5/1 → 
2/1 hexanes/EtOAc) to afford alcohol 2.47 (12.3 g, 97%) as a yellow oil. 
 
2.47: Rf = 0.41 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ 0.95 (d, J = 
6.8 Hz, 3H), 1.18-1.25 (m, 1H), 1.41-1.66 (m, 3H), 1.70-1.79 (m, 2H), 1.83-1.93 (m, 1H), 1.93-
2.04 (m, 2H). 2.06 (s, 3H), 2.20-2.26 (m, 1H), 2.45-2.51 (m, 2H), 2.80 (dd, J = 8.8 and 17.6 Hz, 
1H), 2.92 (dd, J = 0.4 and 14.8 Hz, 1H), 4.04-4.16 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 
16.9, 21.0, 21.4, 21.5, 23.2, 25.9, 32.2, 37.6, 45.5, 49.3, 64.2, 70.9, 72.2, 87.5, 120.4, 171.1; IR: 
v 3462, 1738, 1457, 1024 cm-1; HRMS calcd. for C16H23NO3Na+ [M+Na+]: 300.15756. Found: 
300.15724.  
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To a solution of alcohol 2.47 (9.0 g, 32 mmol, 1.0 equiv.) in acetic anhydride (27.6 mL, 92 
mmol, 2.8 equiv.) at 23 °C solid magnesium perchlorate (0.70 g, 3.1 mmol, 0.1 equiv.) was 
added in one portion.  After 30 minutes the mixture was diluted with aqueous saturated NaHCO3 
solution (200 mL) and solid NaHCO3 was added to adjust the pH to 8.  The mixture was 
extracted with EtOAc (3 × 100 mL).  The organic extracts were washed with brine (100 mL), 
dried over Na2SO4, filtered, and concentrated.  The crude acetate was purified by silica gel 
chromatography (5/1 → 2/1 hexanes/EtOAc) to yield diacetate 2.48 (10.1 g, 97%) as a yellow 
oil. 
 
2.48: Rf = 0.45 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ 0.94 (d, J = 
6.4 Hz, 3H), 1.24-1.33 (m, 2H), 1.44-1.64 (m, 4H), 1.69-1.78 (m, 2H), 2.04 (s, 3H), 2.06 (s, 3H), 
2.08-2.14 (m, 2H), 2.31-2.34 (m, 1H), 2.52-2.54 (m, 1H), 2.59 (s, 1H), 2.97 (td, J = 2.8 and 14.8 
Hz, 1H), 4.05-4.16 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 17.0, 21.0, 21.3, 21.6, 22.0, 23.0, 
25.9, 32.1, 37.3, 43.1, 46.8, 64.0, 74.5, 77.5, 82.7, 119.8, 168.2, 171.1; IR: v 1737, 1727 cm-1; 
HRMS calcd. for C18H25NO4Na+ [M+Na+]: 342.16813. Found: 342.16774.  
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To a solution of acetate 2.47 (100 mg, 0.36 mmol, 1.0 equiv.) in methanol (5 mL) and water (0.1 
mL) solid potassium carbonate (248 mg, 1.80 mmol, 5.0 equiv.) was added. The mixture was 
stirred for 12 hours then diluted with aqueous saturated NH4Cl solution (20 mL) and extracted 
with EtOAc (3 × 10 mL). The organic extracts were washed with brine (20 mL), dried over 
Na2SO4, filtered, and concentrated to provide 2.58 as colorless crystals (59.9 mg, 71%, m.p. 89.0 
- 92.1 °C). 
 
2.58: Rf = 0.15 (silica gel, EtOAc); 1H NMR (400 MHz, CDCl3): δ 0.95 (d, J = 6.4 Hz, 3H), 
1.20-1.26 (m, 1H), 1.41-1.48 (m, 1H), 1.51-1.73 (m, 7H), 1.82-1.92 (m, 1H), 2.02-2.08 (m, 2H), 
2.22-2.24 (m, 1H), 2.48 (s, 1H), 2.50-2.55 (m, 1H), 2.77 (dd, J = 11.6 and 17.6 Hz, 1H), 3.64-
3.75 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 16.9, 21.4, 21.5, 23.1, 29.9, 32.2, 37.8, 45.7, 49.3, 
62.8, 71.1, 72.2, 87.6, 120.6; IR: v 3299, 2918, 2248 cm-1; HRMS calcd. for C14H22NO2+ [M 
+H+]: 236.1651. Found: 236.1645. 
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A flask containing neat benzyl amine (1.2 mL, 11 mmol, 3.5 equiv.) and diacetate 2.48 (1.0 g, 
3.1 mmol, 1 equiv.) was evacuated and backfilled with N2 three times. By syringe THF (24 mL) 
was added and the mixture was degassed via iterative freeze-pump-thaw sequences (3 cycles).  
Solid CuCl (105 mg, 1.1 mmol, 0.34 equiv.) was added in one portion with a back flow of N2.  
The reaction flask was placed in an 80 °C oil bath for 30 minutes, then cooled to 23 °C, and 
diluted with pentane (100 mL).  The mixture was filtered through silica gel (EtOAc/hexanes = 
1/1) and concentrated to provide amine 2.49 (1.05 g, 92%) as yellow oil. 
 
2.49: Rf = 0.35 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ 1.01(d, J = 6.4 
Hz, 3H), 1.10 (t, J = 12.0 Hz, 1H), 1.20-1.27 (m, 1H), 1.43-1.65 (m, 4H), 1.72-1.91 (m, 2H), 
2.01 (s, 3H), 2.02-2.06 (m, 1H), 2.22 (m, 1H), 2.30-2.35 (m, 1H), 2.46 (s, 1H), 2.56 (dd, J = 2.4 
and 17.2 Hz, 1H), 3.00 (dd, J = 12.4 and 17.2 Hz, 1H), 3.80 (dd, J = 12.0 and 49.6 Hz, 2H), 
4.04-4.07 (m, 2H), 7.25-7.33 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 16.5, 20.8, 21.8, 22.7, 
23.8, 25.9, 33.0, 37.7, 46.2, 46.4, 47.0, 55.7, 64.0, 74.7, 86.6, 120.0, 127.0, 128.3, 128.4, 140.3, 
171.0; IR: v 2953, 1737 cm-1; HRMS calcd. for C23H31N2O2+ [M+H+]: 367.23855. Found: 
367.23794.  
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A flask containing p-methoxylbenzylamine (2.0 mL, 15.3 mmol, 4.1 equiv.) and acetate 2.48 
(1.20 g, 3.8 mmol, 1.0 equiv.) was evacuated and backfilled with N2 three times.  By syringe 
THF (28 mL) was added and the mixture was degassed via iterative freeze-pump-thaw sequences 
(3 cycles).  To the degassed solution solid CuCl (110 mg, 1.08 mmol, 0.29 equiv.) was added in 
one portion with a back flow of N2.  The flask was immersed into an 80 °C oil bath for 30 
minutes, cooled to 23 °C, and diluted with pentane (100 mL).  The mixture was filtered through 
silica gel (hexanes/EtOAc = 1/1) and concentrated to provide 2.50 (1.20 g, 81%) as pale yellow 
oil. 
 
2.50: [α]24D -38.2° (c 0.19, CH2Cl2); Rf = 0.30 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 
MHz, CDCl3): δ 1.01 (d, J = 6.4 Hz, 3H), 1.09 (t, J = 12.4 Hz, 1H), 1.19-1.27 (m, 2H), 1.44-1.64 
(m, 3H), 1.72-1.77 (m, 2H), 1.83-1.89 (m, 1H), 2.01-2.06 (m, 4H), 2.17-2.23 (m, 1H), 2.31-2.35 
(m, 1H), 2.46 (s, 1H), 2.53-2.58 (m, 1H), 3.0 (dd, J = 9.0 and 16.8 Hz, 1H), 3.66 (d, J = 11.2 Hz, 
1H), 3.78-3.81 (m, 4H), 4.03-4.07 (m, 2H), 6.84-6.88 (m, 2H), 7.23-7.25 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δ 16.5, 20.9, 21.9, 22.8, 23.8, 26.0, 33.0, 37.7, 46.2, 46.5, 46.5, 55.3, 55.7, 
64.1, 74.7, 86.8, 113.9, 120.1, 129.6, 132.4, 158.8, 171.1; IR: v 3287, 1735 cm-1; HRMS calcd. 
for C24H33N2O3+ [M+H+]: 397.24912. Found: 397.24867.  
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A flask containing 3,4-dimethoxylbenzylamine (0.22 mL, 1.5 mmol, 2.5 equiv.) and diacetate 
2.48 (185 mg, 0.58 mmol, 1.0 equiv.) was evacuated and backfilled with N2 three times. By 
syringe THF (6 mL) was added and the mixture was degassed via iterative freeze-pump-thaw 
sequences (three times). Solid CuCl (25 mg, 0.25 mmol, 0.44 equiv.) was added in one portion 
with a back flow of N2. The reaction flask was placed in an 80 °C oil bath for 20 minutes, cooled 
to 23 °C, and diluted with pentane (50 mL). The mixture was filtered through silica gel 
(hexanes/EtOAc = 1/1) and concentrated to provide amine 2.51 (190 mg, 77%) as pale yellow 
oil. 
 
2.51: Rf = 0.30 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ  1.01 (d, J = 
6.8 Hz, 3H), 1.11 (t, J = 12.4 Hz, 1H), 1.18-1.25 (m, 1H), 1.43-1.67 (m, 3H), 1.68-1.79 (m, 4H), 
1.83-1.93 (m, 1H), 2.01-2.07 (m, 4H), 2.22 (dt, J = 2.8 and 12.8 Hz, 1H), 2.30-2.33 (m, 1H), 
2.44 (s, 1H), 2.57 (dd, J = 2.8 and 17.2 Hz, 1H), 3.01 (dd, J = 12.0 and 17.2 Hz, 1H), 3.61 (d , J 
= 12.0 Hz, 1H), 3.79 (s, 3H), 3.81-3.84 (m, 4H), 4.05-4.08 (m, 2H), 6.42-6.47 (m, 2H), 7.14-7.17 
(m, 1H); 13C NMR (100 MHz, CDCl3): δ 16.5, 20.9, 21.9, 22.7, 23.8, 25.9, 33.1, 37.8, 42.0, 
46.0, 46.2, 55.3, 55.4, 55.5, 64.3, 74.7, 86.7, 98.6, 104.1, 120.2, 120.7, 130.4, 158.5, 160.1, 
171.1; IR: v 3279, 2953, 2919, 1735 cm-1; HRMS calcd. for C25H35N2O4+ [M +H+]: 427.25968. 
Found: 427.25929. 
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To a solution of the propargylamine 2.49 (1.70 g, 4.64 mmol, 1.0 equiv.) in methanol (25 mL) 
was added solid K2CO3 (3.0 g, 21.7 mmol, 4.7 equiv) in one portion.  The heterogeneous 
solution was stirred vigorously for seven hours at 23 °C and then diluted with saturated aqueous 
NH4Cl solution (50 mL) and extracted with EtOAc (3 × 50 mL).  The organic extracts were 
washed with brine (50 mL), dried over Na2SO4, filtered, and concentrated to provide alcohol 
2.52 (1.50 g, 99%) as yellow oil. 
 
2.52: [α]24D -73.9° (c 0.70, CH2Cl2); Rf = 0.30 (silica gel, EtOAc); 1H NMR (400 MHz, CDCl3): 
δ 1.01 (d, J = 6.4 Hz, 3H), 1.10 (t, J = 12.0 Hz, 1H), 1.20-1.27 (m, 1H), 1.41-1.89 (m, 8H), 2.00-
2.06 (m, 1H), 2.19-2.25 (m, 1H), 2.31-2.38 (m, 1H), 2.46 (s, 1H), 2.59-2.64 (m, 1H), 2.98 (dd, J 
= 12.0 and 17.2 Hz, 1H), 3.63-3.68 (m, 2H), 3.73 (d, J = 11.6 Hz, 1H), 3.84 (d, J = 11.6 Hz, 1H), 
7.25-7.33 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 16.5, 21.9, 22.6, 23.8, 29.7, 33.1, 37.8, 46.1, 
46.5, 47.2, 55.9, 62.4, 74.8, 86.7, 120.3, 127.1, 128.48, 128.52, 140.2; IR: v 3344, 3063, 2924, 
2867, 1454, 733 cm-1; HRMS calcd. for C42H56N4O22+ [2M 2+]: 324.22016. Found: 324.21988. 
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To a solution of the propargylamine 2.50 (1.20 g, 3.0 mmol, 1.0 equiv.) in methanol (20 mL) was 
added solid K2CO3 (2.0 g, 14.5 mmol, 4.8 equiv) in one portion.  The heterogeneous solution 
was stirred vigorously for 7 hours at 23 °C, then diluted with saturated aqueous NH4Cl solution 
(60 mL), and extracted with EtOAc (3 × 50 mL).  The organic extracts were washed with 
aqueous saturated sodium chloride solution (20 mL), dried over Na2SO4, filtered, and 
concentrated to provide the corresponding alcohol 2.53 (1.07 g, 99%) as yellow oil. 
 
2.53: [α]24D -51.8° (c 0.55, CH2Cl2); Rf = 0.21 (silica gel, EtOAc); 1H NMR (400 MHz, CDCl3): 
δ 1.01 (d, J = 6.4 Hz, 3H), 1.09 (t, J = 12.0 Hz, 1H), 1.21- 1.27 (m, 2H), 1.41-1.50 (m, 3H), 1.62-
1.75 (m, 3H), 1.81-1.90 (m, 1H), 2.01-2.04 (m, 1H), 2.18-2.22 (m, 1H), 2.31-2.34 (m, 1H), 2.47 
(s, 1H), 2.61 (dd, J = 3.6 and 17.2 Hz, 1H), 2.97 (dd, J = 12.0 and 17.2 Hz, 1H), 3.58-3.67 (m, 
3H), 3.78-3.81 (m, 4H), 6.84-6.90 (m, 2H), 7.23-7.30 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 
16.5, 21.9, 22.6, 23.8, 29.7, 33.0, 37.8, 46.1, 46.4, 46.6, 55.3, 55.8, 62.4, 74.7, 86.8, 113.9, 120.3, 
129.6, 132.3, 158.7; IR: v 3406, 1510, 1243, 1033 cm-1; HRMS calcd. for C22H31N22O2+ 
[M+H+]: 355.23855. Found: 355.23805.  
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To a solution of 2.51 (195 mg, 0.46 mmol, 1.0 equiv.) in methanol (5.0 mL) and water (0.10 mL) 
was added solid K2CO3 (300 mg, 2.2 mmol, 4.8 equiv). The heterogeneous solution was stirred 
vigorously for 17 hours at 23 °C, then diluted with aqueous saturated NH4Cl solution (40 mL), 
and extracted with EtOAc (3 × 40 mL). The organic extracts were washed with brine (30 mL), 
dried over Na2SO4, filtered, and concentrated to provide the corresponding alcohol 2.54 (166 mg, 
94%) as yellow oil. 
 
2.54: Rf = 0.30 (silica gel, EtOAc); 1H NMR (400 MHz, CDCl3): δ 1.01 (d, J = 6.8 Hz, 3H),1.10 
(t, J = 12.4 Hz, 1H), 1.20-1.24 (m, 1H), 1.39-1.55 (m, 2H), 1.63-1.72 (m, 2H), 1.77-2.04 (m, 
5H), 2.23 (dt, J = 2.4 and 12.4 Hz, 1H), 2.30-2.34 (m, 1H), 2.44 (s, 1H), 2.62 (dd, J =2.8 ad 17.2 
Hz, 1H), 2.99 (dd, J =12.0 and 17.2 Hz, 1H) 3.60-3.67 (m, 3H), 3.79 (s, 3H), 3.81 (s, 3H), 3.84 
(d, J = 11.6 Hz, 1H), 6.42-6.45 (m, 2H), 7.15 (dd, J = 2.0 and 6.8 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 16.6, 21.9, 22.6, 23.8, 29.8, 33.2, 37.9, 42.1, 45.9, 46.2, 55.3, 55.4, 55.7, 62.4, 74.7, 
86.7, 98.7, 104.1, 120.4, 120.5, 130.5, 158.5, 160.2; IR: v 3285, 2921, 1614 cm-1; HRMS calcd. 
for C23H33N2O3+ [M +H+]: 385.24912. Found: 385.24852. 
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Alcohol 2.52 (750 mg, 2.3 mmol, 1.0 equiv.) was dissolved in CCl4 (20 mL) and PPh3 (1.21 g, 
4.6 mmol, 2.0 equiv.) and imidazole (315 mg, 4.6 mmol, 2.0 equiv.) were added sequentially as 
solids.  The reaction was placed in a heated oil bath for 15 hours then the oil bath was removed 
and the solution was diluted with saturated aqueous NH4Cl solution (50 mL) and extracted with 
EtOAc (3 × 25 mL).  The organic extracts were washed with brine (20 mL), dried over Na2SO4, 
filtered, and concentrated.  The crude material was purified by silica gel chromatography (1/0 → 
5/1 hexanes/EtOAc) to afford alkyne-nitrile 2.55 (530 mg, 75%, m.p. 138.2-138.5 °C) as pale 
yellow crystalline solid. 
 
2.55: [α]24D –152.7° (c 1.0, CH2Cl2); Rf = 0.60 (silica gel, hexenes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ 0.99 (d, J = 6.4 Hz, 3H), 1.12 (t, J = 12.4 Hz, 1H), 1.25-1.66 (m, 6H), 
1.93-2.01 (m, 2H), 2.11-2.15 (m, 1H), 2.26-2.34 (m, 2H), 2.51 (s, 1H), 2.55-2.63 (m, 2H), 2.93 
(d, J = 13.6 Hz, 1H), 3.00 (dd, J = 12.0 and 18.0 Hz, 1H), 4.06 (d, J = 13.6 Hz, 1H), 7.20-7.33 
(m, 5H); 13C NMR (100 MHz, CDCl3): δ 17.3, 22.2, 24.3, 25.9, 26.7, 37.2, 38.1, 45.9, 46.4, 
48.5, 53.4, 58.6, 76.6, 83.6, 120.6, 126.6, 128.1, 128.5, 140.3; IR: v 1454, 1068, 701 cm-1; 
HRMS calcd. for C21H27N2+ [M+H+]: 307.21742. Found: 307.21690. 
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The alcohol 2.53 (450 mg, 1.3 mmol, 1.0 equiv.) was dissolved in CCl4 (15 mL) and PPh3 (0.67 
g, 2.54 mmol, 2.0 equiv.) and imidazole (172 mg, 2.5 mmol, 2.0 equiv.) were added sequentially 
as solids to the solution.  The flask was placed in a heated oil bath for 15 hours, the oil bath was 
removed, and the solution was diluted with aqueous saturated NH4Cl solution (30 mL) and 
extracted with EtOAc (3 × 20 mL).  The organic extracts were washed with brine (20 mL), dried 
over Na2SO4, filtered, and concentrated.  The crude material was purified by silica gel 
chromatography (1/0 to 5/1 hexanes/EtOAc) to afford 2.56 (530 mg, 74%) as pale yellow oil. 
 
2.56: [α]24D –70.2° (c 0.69, CH2Cl2); Rf = 0.55 (silica gel, hexanes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ 1.00 (d, J = 6.4 Hz, 3H), 1.12 (t, J = 12.0 Hz, 1H), 1.28-1.75 (m, 6H), 
1.93-2.00 (m, 2H), 2.11-2.15 (m, 1H), 2.22-2.29 (m, 2H), 2.50 (s, 1H), 2.54-2.63 (m, 2H), 2.86 
(d, J = 13.2 Hz, 1H), 3.00 (dd, J = 12.0 and 21.2 Hz, 1H), 3.79 (s, 3H), 3.99 (d, J = 13.2 Hz, 1H), 
6.83 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ 17.1, 22.1, 
24.2, 25.7, 26.6, 37.1, 40.0, 45.8, 46.2, 48.1, 52.6, 55.1, 58.5, 76.6, 83.5, 113.4, 120.4, 129.4, 
132.1, 158.3; IR: v 1512, 1243, 830 cm-1; HRMS calcd. for C22H29N2O+ [M+H]+: 337.22799. 
Found: 337.22731. 
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The alcohol 2.54 (250 mg, 0.65 mmol, 1.0 equiv.) was dissolved in CCl4 (6 mL) then PPh3 (0.34 
g, 1.3 mmol, 2.0 equiv.) and imidazole (89 mg, 1.3 mmol, 2.0 equiv.) were added as solid to the 
solution. The flask was placed in a heated oil bath for 15 hours, the oil bath was removed, and 
the solution was diluted with aqueous saturated NH4Cl solution (20 mL) and extracted with 
EtOAc (3 × 15 mL). The organic extracts were washed with brine (20 mL), dried over Na2SO4, 
filtered, and concentrated. The crude material was purified by silica gel chromatography (1/0 → 
5/1 hexanes/EtOAc) to afford the bicyclic compound 2.57 (189 mg, 79%) as pale yellow oil. 
 
2.57: [α]23.0D -36.0° (c 0.50, CH2Cl2); Rf = 0.25 (silica gel, hexanes/EtOAc = 4/1); 1H NMR (400 
MHz, CDCl3): δ 1.00 (d, J = 6.4 Hz, 3H), 1.11 (t, J = 4.0 Hz, 1H), 1.29-1.37 (m, 1H), 1.41-1.51 
(m, 2H), 1.58-1.66 (m, 2H), 1.71-1.76 (m, 1H), 1.93-2.00 (m, 2H), 2.11-2.15 (m, 1H), 2.23-2.30 
(m, 2H), 2.50 (s, 1H), 2.55-2.63 (m, 2H), 2.87 (d, J = 17.0 Hz, 1H), 3.00 (dd, J = 12.0 and 17.2 
Hz, 1H), 3.86 (s, 3H), 3.88 (s, 3H), 4.01 (d, J = 13.6 Hz, 1H), 6.77-6.85 (m, 3H); 13C NMR (100 
MHz, CDCl3): δ 17.3, 22.2, 24.3, 25.9, 26.7, 37.2, 38.1, 45.8, 46.4, 48.3, 53.0, 55.8, 55.9, 58.6, 
76.6, 83.6, 110.8, 111.5, 120.4, 120.5, 132.8, 147.7, 148.8; IR: v 3278, 2921, 1612, 1504 cm-1; 
HRMS calcd. for C23H31N2O2+ [M +H+]:367.2386. Found: 367.2380. 
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In a pressure tube 1,4-(bistrimethylsilyl)butdiyne 2.4 (317 mg, 1.6 mmol, 2.0 equiv.) and alkyne-
nitrile 2.55 (250 mg, 0.82 mmol, 1.0 equiv.) were dissolved in freshly degassed THF (17 mL).  
Neat CpCo(CO)2 (100 L, 0.82 mmol, 1.0 equiv.) was added to the solution and the tube was 
sealed. The resulting solution was placed in a 140 °C oil bath and after 20 hours the vessel was 
cooled to 23 °C and the solvent was removed.  The crude material was purified by silica gel 
chromatography (1/0 → 5/1 hexanes/EtOAc) to afford 2.64 (320 mg, 78%) and 2.63 (12.3 mg, 
3% yield). 
 
 
2.64: [α]24D +5.0° (c 0.28, CH2Cl2); Rf = 0.60 (silica gel, hexanes/EtOAc = 10/1); 1H NMR (400 
MHz, CDCl3): δ 0.26 (s, 9H), 0.42 (s, 9H), 0.74 (d, J = 6.0 Hz, 3H), 1.13-1.32 (m, 5H), 1.44-1.46 
(m, 2H), 1.53-1.61 (m, 1H), 1.69-1.77 (m, 1H), 1.85-1.90 (m, 1H), 2.07-2.10 (m, 1H), 2.37-2.44 
(m, 1H), 2.48-2.53 (m, 1H), 2.68 (d, J = 18.8 Hz, 1H), 3.17 (dd, J = 14.8 and 18.8 Hz, 1H), 4.14 
(dd, J = 14.4 and 60.0 Hz, 2H), 7.22-7.26 (m, 1H), 7.32-7.36 (m, 2H), 7.46-7.48 (m, 2H), 8.25 (s, 
1H); 13C NMR (100 MHz, CDCl3): δ -1.4, -0.4, 21.3, 22.3, 26.4, 27.0, 33.9, 35.2, 38.8, 43.7, 
46.1, 48.1, 51.0, 60.3, 95.5, 106.0, 126.4, 127.8, 128.2, 134.9, 137.3, 140.2, 142.6, 144.1, 159.2; 
IR: v 1248, 842 cm-1; HRMS calcd. for C31H45N2Si2+ [M +H+]: 501.31213. Found: 501.31193. 
 
2.72: Rf = 0.55 (silica gel, silica gel, hexanes/EtOAc = 10/1); 1H NMR (400 MHz, CDCl3): δ 
0.29 (s, 9H), 0.75 (d, J = 6.4 Hz, 3H), 0.83-0.88 (m, 2H), 0.97 (d, J = 6.8 Hz, 1H), 1.14-1.21 (m, 
1H), 1.2-1.33 (m, 2H), 1.42-1.61 (m, 2H), 1.72-1.80 (m, 2H), 1.89-1.94 (m, 1H), 2.09-2.12 (m, 
1H), 2.4-2.52 (m, 2H), 3.19 (dd, J = 6.8 and 19.6 Hz, 1H), 4.14 (dd, J = 14.0 and 63.6 Hz, 2H), 
7.24-7.33 (m, 1H), 7.34-7.50 (m, 2H), 7.48-7.50 (m, 2H), 8.15 (d, J = 2.0 Hz, 1H), 8.46 (d, J = 
2.0 Hz, 1H); IR: v 2949, 2924, 1451, 1249, 843 cm-1; HRMS calcd. for C28H37N2Si+ [M+H]+: 
429.27260. Found: 429.27203. 
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To alkyne-nitrile 2.55 (62 mg, 0.20 mmol, 1.0 equiv.) and diyne 2.4 (50 mg, 0.26 mmol, 1.3 
equiv.) in degassed chlorobenzene (3 mL) was added a solution of CoCp(CO)2 (0.049 mL, 0.40 
mmol, 2 equiv.) in degassed chlorobenzene (2.5 mL) over 90 minutes. During the addition the 
reaction  was irradiated with a 600 W slide projector lamp placed 5 cm from the flask. After four 
hours another portion of diyne 2.72 (50 mg, 0.26 mmol, 1.3 equiv.) was added in one portion. 
Irradiation continued for four hours. The reaction was loaded on a column and purified by silica 
gel chromatography (1/0 → 5/1 hexanes/EtOAc) to afford compound 2.64 (71 mg, 70%). 
 
Compound data: see above for 2.64. 
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In a 30 mL pressure tube, 1,4-(bistrimethylsilyl)butdiyne int-1 (455 mg, 1.63 mmol, 2.0 equiv.) 
and nitrile 2.55 (250 mg, 0.82 mmol, 1 equiv.) were dissolved in freshly degassed THF (17 mL). 
Neat CpCo(CO)2 (0.2mL, 1.6 mmol, 2 equiv.) was added into the solution and the tube was 
sealed. The resulting solution was heated at 140 °C for 20h. The mixture was cooled to 23 °C 
and the solvent was evaporated. The crude material was purified by silica gel chromatography 
(0/1 to 1/5 EtOAc/Hexanes) to afford compound 2.81-pre (300 mg, 63%) as dark brown foam.  
 
2.81-pre: [α]23.0D +4.9° (c 0.23, CH2Cl2); Rf = 0.65 (silica gel, Hexanes/EtOAc = 10/1); 1H 
NMR (400 MHz, CDCl3): δ 0.20 (s, 6H), 0.43 (s, 3H), 0.45 (s, 3H), 0.55 (d, J = 3.6 Hz, 3H), 
0.80-0.99 (m, 20H), 1.12-1.30 (m, 2H), 1.36-1.45 (m, 1H), 1.51-1.75 (m, 2H), 1.86-1.89 (m, 1H), 
2.02-2.09 (m, 1H), 2.35-2.50 (m, 2H), 2.66-2.79 (m, 1H), 3.13-3.21 (m, 1H), 4.02 (d, J = 14.4 
Hz, 1H), 4.21 (d, J = 14.4 Hz, 1H), 7.20-7.25 (m, 1H), 7.32 (t, J = 7.6 Hz, 2H), 7.48 (d, J = 7.6 
Hz, 2H), 8.31 (s, 1H); 13C NMR (100 MHz, CDCl3): δ -4.5, 14.1, 16.9, 18.2, 21.1, 22.4, 26.4, 
26.9, 27.1, 34.0, 35.1, 38.5, 43.6, 46.0, 48.3, 50.9, 60.2, 86.7, 92.7, 107.9, 126.4, 127.8, 128.2, 
132.2, 136.7, 141.9, 142.5, 144.5, 159.2; IR: v 2926, 2856, 1507, 901 cm-1; HRMS calcd. for 
C31H45N2Si2+ [M +H+]: 585.4060. Found: 585.4056. 
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In a 12 mL pressure tube, 1,4-(bistrimethylsilyl)butdiyne int-2 (34.1 mg, 0.12 mmol, 2.5 equiv.) 
and nitrile 2.55 (15 mg, 0.049 mmol, 1 equiv.) were dissolved in freshly degassed THF (1.5 mL). 
Neat CpCo(CO)2 (9 µL, 0.073 mmol, 1.5 equiv.) was added into the solution and the tube was 
sealed. The resulting solution was heated at 140 °C for 36 h. The mixture was cooled to 23 °C 
and the solvent was evaporated. The crude material was purified by silica gel chromatography 
(0/1 to 1/5 EtOAc/Hexanes) to afford compound 2.82-pre (14.9 mg, 52%) as dark brown foam.  
 
2.82-pre: [α]23.0D +6.0° (c 0.33, CH2Cl2); Rf = 0.70 (silica gel, Hexanes/EtOAc = 10/1); 1H 
NMR (400 MHz, CDCl3): δ 0.43 (s, 9H), 0.75 (d, J = 6.0 Hz, 3H), 1.05-1.32 (m, 23H), 1.44-1.48 
(m, 2H), 1.50-1.56 (m, 1H), 1.69-1.80 (m, 2H), 1.84-1.90 (m, 1H), 2.06-2.11 (m, 1H), 2.37-2.52 
(m, 2H), 2.70 (d, J = 18.8 Hz, 1H), 3.17 (dd, J = 7.2 and 18.4 Hz, 1H), 4.07 (d, J = 14.4 Hz, 1H), 
4.21 (d, J = 14.4 Hz, 1H), 7.22-7.26 (m, 1H), 7.34 (t, J = 7.2 Hz, 1H), 7.47 (d, J = 7.2 Hz, 1H), 
8.24 (s, 1H); 13C NMR (100 MHz, CDCl3): δ -1.1, 11.6, 18.7, 21.3, 22.4, 26.4, 27.0, 34.0, 35.1, 
38.9, 43.7, 46.0, 48.1, 51.0, 60.3, 91.8, 108.0, 126.4, 127.8, 128.2, 134.2, 137.0, 140.2, 142.7, 
144.4, 159.3; IR: v 2944, 2865, 1493, 735 cm-1; HRMS calcd. for C37H57N2Si2+ [M +H+]: 
585.40603. Found: 585.40510. 
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In a pressure tube int-3 (18 mg, 98 μmol, 3.0 equiv.) and alkyne-nitrile 2.55 (10 mg, 33 µmmol, 
1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 (8 µL, 57 
µmmol, 1.7 equiv.) was added to the solution and the tube was sealed. The resulting solution was 
placed in a 140 °C oil bath. After 36 hours the vessel was removed from the oil bath, cooled to 
23 °C, and the solution was concentrated.  The crude material was purified by silica gel 
chromatography (20/1 → 5/1 hexanes/EtOAc) to afford 2.107 (9.9 mg, 62%) as yellow oil.  
 
 
 
 
To a solution of 2.107 (9.9 mg, 20 μmol, 1.0 equiv.) in dioxane (1.0 mL) at 23 °C was added 
TBAF solution (81 μL, 1 M in THF, 81 μmol, 4.0 equiv.) and the resulting solution was placed in 
a heated oil bath. After 8 hours the mixture was cooled to 23 °C and concentrated.  The crude 
material was purified on silica gel chromatography (1/0 to 5/1 hexanes/EtOAc) to afford int-4 
(5.9 mg, 70%) as light brown foam. 
 
Int-4: Rf = 0.31 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (600 MHz, CDCl3): δ  0.75 (d, J = 
6.0 Hz, 3H), 1.13-1.16 (m, 1H), 1.20-1.34 (m, 4H), 1.47-1.59 (m, 2H), 1.74-1.81 (m, 2H), 1.93 
(dt, J = 3.2 and 12.7 Hz, 1H), 2.11-2.14 (m, 1H), 2.44-2.60 (m, 2H), 2.74 (d, J = 18.6 Hz, 1H), 
3.23 (dd, J = 3.2 and 18.6 Hz, 1H), 4.07 (d, J = 14.1 Hz, 1H), 4.22 (d, J = 14.1 Hz, 1H), 7.22-
7.24 (m, 1H), 7.33-7.37 (m, 3H), 7.47 (d, J = 7.1 Hz, 2H), 7.88 (d, J = 3.3 Hz, 1H), 7.99 (d, J = 
8.1 Hz, 1H), 8.20 (d, J = 8.1 Hz, 1H); 13C NMR (150.8 MHz, CDCl3): δ 21.1, 22.4, 26.5, 27.1, 
34.0, 35.3, 38.5, 43.7, 45.9, 48.1, 50.9, 60.6, 117.6, 120.6, 126.5, 128.0, 128.3, 135.4, 139.8, 
142.2, 143.9, 148.5, 158.7, 170.0; IR: v 2923, 1384 cm-1; HRMS calcd. for C26H30N3S+ [M 
+H+]: 416.21550. Found: 416.21562. 
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In a pressure tube int-5 (17 mg, 98 μmol, 3.0 equiv.) and alkyne-nitrile 2.55 (10 mg, 33 µmol, 
1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 (8 µL, 57 µmol, 
1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in a 140 °C oil 
bath. After 30 hours the vessel was cooled to 23 °C and concentrated.  The crude material was 
purified by silica gel chromatography (20/1 → 5/1 hexanes/EtOAc) to afford 2.108 (7.2 mg, 
45%) as pale yellow oil. 
 
 
 
To a solution of 2.108 (6.9 mg, 14 μmol, 1.0 equiv.) in dioxane (1.0 mL) at 23 °C was added 
TBAF solution (43 μL, 1 M in THF, 43 μmol, 3.0 equiv.) and the resulting solution was placed in 
a heated oil bath. After 8 hours the mixture was cooled to 23 °C and concentrated.  The crude 
material was purified by silica gel chromatography (1/0 to 10/1 hexanes/EtOAc) to afford int-6 
(5.1 mg, 87%) as light brown foam. 
 
Int-6: Rf = 0.35 (silica gel, Hexanes/EtOAc = 5/1); 1H NMR (600 MHz, CDCl3): δ 0.74 (d, J = 
5.9 Hz, 3H), 0.82-0.88 (m, 1H), 1.12-1.16 (m, 1H), 1.23-1.29 (m, 2H), 1.30-1.38 (m, 1H), 1.44-
1.57 (m, 2H), 1.72-1.78 (m, 2H), 1.90 (dt, J = 3.2 and 12.7 Hz, 1H), 2.09-2.11 (m, 1H), 2.48-
2.50 (m, 2H), 2.72 (d, J = 18.6 Hz, 1H), 3.20 (dd, J = 7.0 and 18.6 Hz, 1H), 4.06 (d, J = 14.2 Hz, 
1H), 4.22 (d, J = 14.2 Hz, 1H), 7.07 (dd, J = 3.4 and 5.0 Hz, 1H), 7.22 (d, J = 7.3 Hz, 1H), 7.31-
7.35 (m, 3H), 7.46 (d, J = 7.3 Hz, 2H), 7.49 (d, J = 8.2 Hz, 1H), 7.54 (dd, J = 1.1 and 3.4 Hz, 
1H), 8.09 (d, J = 8.2 Hz, 1H); 13C NMR (150.8 MHz, CDCl3): δ 21.1, 22.4, 26.5, 27.1, 34.1, 
35.4, 38.6, 43.8, 45.9, 48.2, 50.9, 60.4, 117.0, 124.0, 126.5, 126.7, 127.9, 128.0, 128.2, 135.1, 
136.8, 142.4, 145.4, 149.7, 158.5; IR: v 2919, 1384 cm-1; HRMS calcd. for C27H31N2S+ [M 
+H+]: 415.2208. Found: 415.2208. 
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In a pressure tube int-7 (16.1 mg, 89 μmol, 3.0 equiv.) and alkyne-nitrile 2.55 (9.1 mg, 30 µmol, 
1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 (8 µL, 57 
µmmol, 1.8 equiv.) was added and the tube was sealed. The resulting solution was placed in a 
140 °C oil bath. After 30 hours the vessel was removed from the oil bath, cooled to 23 °C, and 
concentrated.  The crude material was purified by silica gel chromatography (20/1 → 5/1 
hexanes/EtOAc) to afford 2.109 (8.9 mg, 51%) as pale yellow oil.  
 
2.109: Rf = 0.65 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ  0.11 (s, 9H), 
0.78 (d, J = 5.6 Hz, 3H), 1.18-1.40 (m, 5H), 1.45-1.58 (m, 3H), 1.76-1.81 (m, 2H), 1.91 (dt, J = 
3.6 and 13.2 Hz, 1H), 2.10-2.12 (m, 1H), 2.53 (d, J = 6.8 Hz, 1H), 2.71 (d, J = 19.2 Hz, 1H), 
3.19 (dd, J = 6.8 and 19.2 Hz, 1H), 4.14 (d, J = 14.4 Hz, 1H), 4.25 (d, J = 14.4 Hz, 1H), 7.23-
7.26 (m, 2H), 7.30-7.34 (m, 4H), 7.50 (d, J = 7.8 Hz, 2H), 8.34 (s, 1H); 13C NMR (100 MHz, 
CDCl3): δ 0.22, 21.6, 22.5, 26.4, 27.1, 34.1, 35.3, 39.3, 43.8, 45.9, 48.1, 51.2, 60.2, 124.1, 125.0, 
126.4, 127.8, 128.2, 129.1, 130.7, 135.3, 141.5, 142.7, 144.7, 157.5, 158.2; IR: v 2923, 1428 cm-
1; HRMS calcd. for C30H39N2SSi+ [M +H+]: 487.25977. Found: 487.25969. 
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In a 10 mL pressure tube int-8 (16.2 mg, 99 μmol, 3.0 equiv.) and alkyne-nitrile 2.55 (10.1 mg, 
33 µmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 (8 µL, 
57 µmmol, 1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in a 
140 °C oil bath. After 26 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 5/1 hexanes/EtOAc) to 
afford compound 2.110 (7.9 mg, 51%) as yellow oil.  
 
2.110: Rf = 0.60 (silica gel, Hexanes/EtOAc = 2/1); 1H NMR (500 MHz, CDCl3): δ  0.30 (s, 
9H), 0.76 (d, J = 6.0 Hz, 3H), 1.17-1.37 (m, 4H), 1.44-1.80 (m, 4H), 1.86-1.92 (m, 1H), 2.11-
2.13 (m, 1H), 2.47-2.55 (m, 2H), 2.71 (d, J = 9.5 Hz, 1H), 3.19 (dd, J = 7.3 and 18.8 Hz, 1H), 
4.13 (d, J = 14.4 Hz, 1H), 4.24 (d, J = 14.4 Hz, 1H), 6.53 (dd, J = 1.7 and 3.2 Hz, 1H), 6.92 (d, J 
= 3.2 Hz, 1H), 7.24 (d, J = 7.3 Hz, 1H), 7.35 (t, J = 7.3 Hz, 2H), 7.50 (d, J = 7.3 Hz, 3H), 8.38 (s, 
1H); 13C NMR (125.6 MHz, CDCl3): δ 0.38, 21.6, 22.4, 26.4, 27.1, 34.1, 35.3, 39.3, 43.8, 46.0, 
48.1, 51.1, 60.3, 109.0, 112.1, 126.4, 127.8, 128.2, 129.0, 135.7, 141.6, 142.1, 142.7, 151.0, 
155.8, 158.5; IR: v 3393, 2918, 1384 cm-1; HRMS calcd. for C30H39N2OSi+ [M +H+]: 
471.28262. Found: 471.28291. 
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In a pressure tube int-9 (17.2 mg, 98 μmol, 3.0 equiv.) and alkyne-nitrile 2.55 (10 mg, 33 µmol, 
1.0 equiv.) were dissolved in freshly degassed THF (1.5 mL). Neat CpCo(CO)2 (8 µL, 57 µmol, 
1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in a 140 °C oil 
bath. After 24 hours the vessel was cooled to 23 °C and the reaction was concentrated.  The 
crude material was purified by silica gel chromatography (20/1 → 2/1 hexanes/EtOAc) to afford 
2.115 (8.2 mg, 52%) as yellow oil. 
 
 
 
To a solution of alkyne 2.115 (8.2 mg, 17 µmol, 1 equiv.) in dioxane (1.0 mL) at 23 °C was 
added TBAF solution (49 μL, 1 M in THF, 49 μmol, 3.0 equiv.) and the resulting solution was 
placed in a heated oil bath. After 14 hours the mixture was cooled to 23 °C and concentrated.  
The crude material was purified by silica gel chromatography (20/1 to 1/1 hexanes/EtOAc) to 
afford int-10 (6.1mg, 88%) as light brown foam. 
 
Int-10: Rf = 0.35 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (400 MHz, CDCl3): δ  0.68 (d, J = 
6.0 Hz, 3H), 0.78-0.83 (m, 1H), 1.08-1.54 (m, 6H), 1.71-1.75 (m, 2H), 1.89 (d, J = 3.6 and 8.8 
Hz, 1H), 2.07-2.09 (m, 1H), 2.45-2.47 (m, 2H), 2.72 (d, J = 18.8 Hz, 1H), 3.21 (dd, J = 7.2 and 
18.8 Hz, 1H), 4.05 (d, J = 14.0 Hz, 1H), 4.18 (d, J = 14.0 Hz, 1H), 7.16-7.22 (m, 2H), 7.30 (t, J = 
8.0 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 7.72 (dt, J = 1.6 and 7.6 Hz, 1H), 8.09 (d, J = 7.6 Hz, 1H), 
8.15 (d, J = 7.6 Hz, 1H), 8.27 (dt, J = 1.2 and 7.6 Hz, 1H), 8.60-8.63 (m, 1H); 13C NMR (125.7 
MHz, CDCl3): δ 21.3, 22.4, 26.5, 27.2, 34.2, 35.6, 38.8, 43.8, 45.9 48.2, 51.1, 60.5, 119.1, 121.0, 
123.2, 126.5, 128.0, 128.8, 135.3, 136.7, 138.6, 142.4, 149.2, 153.4, 156.8, 158.1; IR: v 2919, 
1384 cm-1; HRMS calcd. for C28H32N3+ [M +H+]: 410.25907. Found: 410.25875. 
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In a 10 mL pressure tube int-11 (21.6 mg, 96 µmol, 3.0 equiv.) and alkyne-nitrile 2.55 (9.8 mg, 
33 µmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 (8 µL, 
57 µmol, 1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in an 
140 °C oil bath. After 36 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 2/1 EtOAc/Hexanes) to 
afford compound 2.116 (4.9 mg, 28%) as yellow oil. 
 
 
 
To a solution of 2.116 (4.9 mg, 9.2 µmol, 1.0 equiv.) in dioxane (1.0 mL) at 23 °C was added 
TBAF solution (1 M in THF, 37 µL, 37 µmol, 4.0 equiv.) and the resulting solution was placed in 
a heated oil bath. After 14 hours the mixture was cooled to 23 °C and concentrated.  The crude 
material was purified by silica gel chromatography (20/1 to 1/1 hexanes/EtOAc) to afford 
compound int-12 (4.0 mg, 94%) as light brown foam. 
 
Int-12: Rf = 0.43 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (500 MHz, CDCl3): δ  0.79 (d, J = 
5.9 Hz, 3H), 0.83-0.90 (m, 1H), 1.18-1.44 (m, 4H), 1.52-1.59 (m, 2H), 1.78-1.88 (m, 2H), 1.98 
(dt, J = 3.7 and 16.1 Hz, 1H), 2.17-2.20 (m, 1H), 2.54-2.57 (m, 2H), 2.84 (d, J = 18.5 Hz, 1H), 
3.33 (dd, J = 7.1 and 18.5 Hz, 1H), 4.11 (d, J = 14.2 Hz, 1H), 4.28 (d, J = 14.2 Hz, 1H), 7.24-
7.27 (m, 1H), 7.36-7.47 (m, 2H), 7.50 (d, J = 10.0 Hz, 2H), 7.58-7.59 (m, 1H), 7.71-7.76 (m, 
2H), 7.93-7.95 (m, 1H), 8.14 (d, J = 8.5 Hz, 1H), 8.27 (d, J = 8.5 Hz, 1H), 8.78 (d, J = 2.1 Hz, 
1H), 9.55 (d, J = 2.1 Hz, 1H); 13C NMR (150.8 MHz, CDCl3): δ 21.1, 22.4, 26.6, 27.2, 34.1, 
35.6, 38.6, 43.8, 45.9, 48.2, 51.0, 60.5, 118.9, 126.5, 126.8, 128.0, 128.3, 128.5, 129.0, 129.6, 
129.7, 132.4, 133.6, 135.5, 137.8, 142.3, 148.0, 149.6, 151.8, 159.3; IR: v 2917, 1384 cm-1; 
HRMS calcd. for C32H34N3+ [M +H+]: 460.27472. Found: 460.27503. 
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In a pressure tube int-13 (23 mg, 0.13 mmol, 2.6 equiv.) and alkyne-nitrile 2.55 (15 mg, 49 
µmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.5 mL). Neat CpCo(CO)2 (10 µL, 82 
µmol, 1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in an 140 
°C oil bath. After 14 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 1/1 hexanes/EtOAc) to 
afford 2.113 (6.9 mg, 26%) and 2.114 (3.0mg, 16%).  
 
2.113: Rf = 0.31 (silica gel, Hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ  0.81 (d, J = 
5.6 Hz, 3H), 0.86-0.95 (m, 1H), 1.21-1.60 (m, 6H), 1.81-1.83 (m, 3 H), 1.96-2.00 (m, 2H), 2.17-
2.18 (m, 1H), 2.54-2.65 (m, 2H), 2.79 (d, J = 18.8 Hz, 1H), 3.30 (dd, J = 7.6 and 18.8 Hz, 1H), 
4.12 (d, J = 14.4 Hz, 1H), 4.22 (d, J = 14.4 Hz, 1H), 7.15-7.34 (m, 7H), 7.45 (d, J = 7.6 Hz, 2H), 
7.69 (dt, J = 2.0 and 7.6 Hz, 1H), 8.16 (s, 1H), 8.47 (dd, J = 2.0 and 4.8 Hz, 1H), 8.60 (d, J = 2.0 
Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 21.5, 22.4, 26.5, 27.1, 34.0, 35.3, 38.9, 43.7, 45.9, 
48.1, 51.1, 60.4, 122.7, 126.5, 127.2, 128.0, 128.2, 128.3, 128.5, 129.7, 134.4, 136.2, 136.8, 
137.2, 137.6, 139.8, 142.2, 148.3, 150.9, 158.0; IR: v 2919, 1384 cm-1; HRMS calcd. for 
C34H36N3+ [M +H+]: 486.29037. Found: 486.29099. 
 
2.114: Rf = 0.69 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ  0.82 (d, J = 
6.0 Hz, 3H), 1.21-1.46 (m, 5H), 1.46-1.62 (m, 2H), 1.81-1.84 (m, 2H), 1.97-2.01 (m, 1H), 2.18-
2.19 (m, 1H), 2.59-2.66 (m, 2H), 2.83 (d, J = 18.8 Hz, 1H), 3.32 (dd, J = 7.2 and 18.8 Hz, 1H), 
7.13 (d, J = 14.4 Hz, 1H), 4.24 (d, J = 14.4 Hz, 1H), 7.16-7.27 (m, 6H), 7.32-7.35 (m, 4H), 7.42-
7.46 (m, 2H), 8.13 (d, J = 2.0 Hz, 1H), 8.50-8.54 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 21.3, 
22.4, 26.5, 27.1, 34.1, 35.3, 38.7, 43.7, 45.9, 48.2, 51.1, 60.4, 122.9, 126.5, 127.8, 128.0, 128.1, 
128.3, 130.0, 130.2, 136.4, 136.5, 137.0, 137.0, 139.7, 142.1, 148.0, 150.2, 154.4, 158.4; IR: v 
2913, 1384 cm-1; HRMS calcd. for C34H36N3+ [M +H+]: 486.29037. Found: 486.29092. 
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In a pressure tube int-14 (8.4 mg, 48 μmol, 4.1 equiv.) and alkyne-nitrile 2.55 (3.6 mg, 12 
µmmol, 1.0 equiv.) were dissolved in freshly degassed THF (1 mL). Neat CpCo(CO)2 (3 µL, 24 
µmmol, 2.0 equiv.) was added and the tube was sealed. The resulting solution was placed in an 
140 °C oil bath. After 12 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 10/1 hexanes/EtOAc) to 
afford 2.111 (2.3 mg, 51%) as brown foam.  
 
2.111: Rf = 0.65 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ  0.06 (s, 9H), 
0.79 (d, J = 5.6 Hz, 3H), 1.19-1.41 (m, 4H), 1.45-1.54 (m, 2H), 1.75-1.79 (m, 2H), 1.90-1.93 (m, 
1H), 2.11-2.12 (m, 1H), 1.75-1.78 (m, 1H), 2.54-2.56 (m, 2H), 2.72 (d, J = 18.8 Hz, 1H), 4.12 (d, 
J = 14.4 Hz , 1H), 4.15 (d, J = 14.4 Hz, 1H), 4.26 (d, J = 14.4 Hz, 1H), 7.25-7.45 (m, 8H), 7.51 
(d, J = 8.0 Hz, 2H), 8.34 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 0.2, 21.7, 22.5, 26.4, 27.1, 
34.2, 35.4, 39.4, 43.8, 46.0, 48.2, 51.2, 60.2, 126.4, 127.7, 127.8, 127.9, 128.2, 129.1, 130.2, 
135.0, 141.6, 142.8, 143.9, 158.0, 162.3; IR: v 2918, 1384, 837 cm-1; HRMS calcd. for 
C32H41N2Si+ [M +H+]: 481.3039. Found: 481.3033. 
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In a pressure tube int-15 (25 mg, 0.14 mmol, 3.0 equiv.) and alkyne-nitrile 2.55 (14.5 mg, 47 
µmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.2 mL). Neat CpCo(CO)2 (10 µL, 82 
µmol, 1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in an 140 
°C oil bath. After 30 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 10/1 hexanes/EtOAc) to 
afford 2.112 (9.9 mg, 43%) as pale yellow foam.  
 
2.112: Rf = 0.45 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ  0.81 (d, J = 
6.0 Hz, 1H), 1.21-1.25 (m, 1H), 1.33-1.64 (m, 6H), 1.79-1.83 (m, 2H), 1.97 (dt, J = 3.2 and 12.4 
Hz, 1H), 2.15-2.17 (m, 1H), 2.53-2.68 (m, 2H), 2.80 (d, J = 18.4 Hz, 1H), 3.30 (dd, J = 7.2 and 
18.4 Hz, 1H), 4.16 (d, J = 14.4 Hz, 1H), 4.22 (d, J = 14.4 Hz, 1H), 7.21-7.38 (m, 13H), 7.46 (d, J 
= 7.2 Hz, 2H), 8.12 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 21.6, 22.5, 26.5, 27.1, 34.1, 35.3, 
39.1, 43.8, 45.9, 48.1, 51.2, 60.3, 126.4, 126.7, 127.4, 127.8, 127.8, 127.9, 128.2, 129.7, 130.0, 
133.8, 136.6, 136.6, 140.4, 140.7, 142.4, 154.0, 157.4; IR: v 2922, 1384 cm-1; HRMS calcd. for 
C35H37N2+ [M +H+]: 485.2957. Found: 485.2959. 
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In a pressure tube int-16 (23 mg, 0.13 mmol, 2.6 equiv.) and alkyne-nitrile 2.55 (15 mg, 49 
µmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.5 mL). Neat CpCo(CO)2 (10 µL, 82 
µmol, 1.7 equiv.) was added and the tube was sealed. The resulting solution was placed in an 140 
°C oil bath. After 14 hours the vessel was cooled to 23 °C and the reaction was cooled.  The 
crude material was purified by silica gel chromatography (20/1 → 1/1 hexanes/EtOAc) to afford 
2.117 (6.9 mg, 26%) as pale foam.  
 
2.117: Rf = 0.21 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (400 MHz, CDCl3): δ  0.79 (d, J = 
5.8 Hz, 3H), 1.22-1.60 (m, 6H), 1.73-1.79 (m, 3H), 1.95-1.99 (m, 1H), 2.16-2.17 (m, 1H), 2.53-
2.67 (m, 2H), 2.85 (d, J = 15.6 Hz, 1H), 3.26-3.35 (m, 1H), 4.23 (s, 2H), 7.00 (d, J = 7.6 Hz, 
1H), 7.15-7.38 (m, 9H), 7.44-7.49 (m, 3H), 8.34 (s, 1H), 8.70 (d, J = 4.0 Hz, 1H); 13C NMR (100 
MHz, CDCl3): δ 21.9, 22.4, 26.4, 27.1, 34.1, 39.6, 43.8, 46.0, 47.9, 51.3, 60.4, 77.2, 121.6, 
125.3, 126.4, 127.9, 128.0, 128.0, 128.1, 128.2, 129.9, 132.5, 135.5, 136.8, 142.4, 149.7, 152.8, 
159.8; IR: v 3423, 1918, 1384 cm-1; HRMS calcd. for C34H36N3+ [M +H+]: 486.29037. Found: 
486.29031. 
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In a pressure tube int-17 (22 mg, 0.10 mmol, 3.0 equiv.) and alkyne-nitrile 2.55 (10 mg, 33 
µmol, 1.0 equiv.) were dissolved in freshly degassed THF (1.5 mL). Neat CpCo(CO)2 (8 µL, 57 
µmol, 1.9 equiv.) was added and the tube was sealed. The resulting solution was placed in an 140 
°C oil bath. After 36 hours the vessel was cooled to 23 °C and the reaction was concentrated.  
The crude material was purified by silica gel chromatography (20/1 → 5/1 hexanes/EtOAc) to 
afford 2.118 (8.9 mg, 51%).  
 
 
 
To a solution of 2.118 (8.9 mg, 17 µmol, 1.0 equiv.) in dioxane (1 mL) at 23 °C was added TBAF 
solution (80 µL, 1 M in THF, 0.080 mmol, 4.8 equiv.) and the resulting solution was placed in a 
heated oil bath. After four hours the mixture was cooled to 23 °C and concentrated. The crude 
material was purified by silica gel chromatography (1/0 to 20/1 hexanes/EtOAc) to afford int-18 
(7.2 mg, 94%) as light brown foam. 
 
Int-18: Rf = 0.45 (silica gel, hexanes/EtOAc = 2/1); 1H NMR (400 MHz, CDCl3): δ  0.78 (d, J = 
5.8 Hz, 3H), 0.86-0.90 (m, 1H), 1.18-1.46 (m, 4H), 1.50-1.63 (m, 3H), 1.79-1.83 (m, 1H), 1.96 
(dt, J = 3.6 and 9.5 Hz, 1H), 2.16-2.18 (m, 1H), 2.55-2.59 (m, 2H), 2.82 (d, J = 18.3 Hz, 1H), 
3.33 (dd, J = 3.6 and 18.3 Hz, 1H), 4.13 (d, J = 14.1 Hz, 1H), 4.27 (d, J = 14.1 Hz, 1H), 7.25-
7.27 (m, 2H), 7.37 (t, J = 7.8 Hz, 2H), 7.47-7.52 (m, 3H), 7.73 (d, J = 8.2 Hz, 1H), 7.85-7.96 (m, 
3H), 8.16 (dd, J = 1.8 and 8.2 Hz, 1H), 8.21 (d, J = 8.2 Hz, 1H), 8.49 (s, 1H); 13C NMR (125.7 
MHz, CDCl3): δ 21.2, 22.4, 26.6, 27.2, 34.2, 35.7, 38.8, 43.9, 45.9, 48.2, 51.0, 60.4, 118.8, 
124.8, 126.0, 126.1, 126.2, 126.5, 127.6 128.0, 128.2, 128.3, 128.7, 133.4, 133.6, 135.2, 136.9, 
137.1, 142.5, 154.3, 158.7; IR: v 2920, 1384 cm-1; HRMS calcd. for C33H35N2+ [M +H+]: 
459.27948. Found: 459.27940. 
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In a pressure tube 2.55 (18 mg, 59 μmol, 1.0 equiv.) and bis TMS-alkyne 2.59 (33 mg, 0.19 
mmol, 3.3 equiv.) were dissolved in freshly degassed chlorobenzene (0.5 mL). A solution of 
CpCo(CO)2 (10 µL, 82 μmol, 1.4 equiv.) in chlorobenzene (0.5 mL) was added by syringe pump 
(0.5mL/h). The reaction was heated to reflux with a projector light for 2 hours. The mixture was 
cooled to 23 °C and the solvent was removed. The crude material was purified by silica gel 
chromatography (1/0 → 5/1 hexanes/EtOAc) to afford compound 2.60 (6.1 mg, 26%) as dark 
brown oil.  
 
2.60: [α]23.0D +20.0° (c 0.35, CH2Cl2); Rf = 0.32 (silica gel, hexanes/EtOAc = 4/1); 1H NMR 
(400 MHz, CDCl3): δ  0.32 (s, 9H), 0.76 (d, J = 6.0 Hz, 3H), 1.15-1.34 (m, 4H), 1.41-1.58 (m, 
3H), 1.74-1.78 (m, 2H), 1.90 (dt, J = 3.2 and 12.4 Hz, 1H), 2.09-2.12 (m, 1H), 2.41-2.53 (m, 
2H), 2.67 (d, J = 18.8 Hz, 1H), 3.19 (dd, J = 7.2 and 18.8 Hz, 1H), 4.12 (d, J = 14.4 Hz, 1H), 
4.22 (d, J = 14.4 Hz, 1H), 7.23-7.26 (m, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.48 (d, J = 7.6 Hz, 2H), 
8.26 (d, J = 2.0 Hz, 1H), 8.44 (d, J = 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 0.0, 22.6, 
23.6, 27.5, 28.2, 35.1, 36.4, 40.2, 44.9, 47.0, 49.3, 52.3, 61.3, 127.6, 128.9, 129.3, 133.2, 138.3, 
140.7, 143.8, 151.9, 160.0; IR: v 2919, 1360, 837 cm-1; HRMS calcd. for C26H37N2Si+ [M +H+]: 
405.2726. Found: 405.2719. 
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To a solution of 2.60 (25 mg, 62 μmol, 1.0 equiv.) in THF (2 mL) at 23 °C was added TBAF 
solution (0.19 mL, 1 M in THF, 0.19 mmol, 3.0 equiv.) and the flask was immersed in a heated 
oil bath. After 12 hours the mixture was cooled to 23 °C and diluted with saturated NH4Cl 
solution (5 mL) and extracted with EtOAc (3 × 5 mL). The organic extracts were washed with 
brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was purified by 
silica gel chromatography (5/1 → 2/1 hexanes/EtOAc) to afford 2.61 (20 mg, 97%).  
 
2.61: [α]23.0D +49.2° (c 0.63, CH2Cl2); Rf = 0.23 (silica gel, hexanes/EtOAc = 4/1); 1H NMR 
(400 MHz, CDCl3): δ  0.75 (d, J = 6.0 Hz, 3H), 1.13-1.36 (m, 5H), 1.44-1.50 (m, 1H), 1.55-1.59 
(m, 1H), 1.73-1.81 (m, 2H), 1.92 (dt, J = 7.2 and 12.8 Hz, 1H), 2.10-2.13 (m, 1H), 2.43-2.52 (m, 
2H), 2.68 (d, J = 18.8 Hz, 1H), 3.21 (dd, J = 7.2 and 18.8 Hz, 1H), 4.07 (d, J = 14.0 Hz, 1H), 
4.23 (d, J = 14.0 Hz, 1H), 7.14 (dd, J = 4.8 and 8.0 Hz, 1H), 7.24 (t, J = 7.2 Hz, 1H), 7.35 (t, J = 
7.2 Hz, 2H), 7.47 (d, J = 7.2 Hz, 2H), 8.12 (dd, J = 1.2 and 8.0 Hz, 1H), 8.38 (dd, J = 1.2 and 8.0 
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 21.1, 22.4, 26.5, 27.1, 34.0, 35.4, 38.5, 43.8, 45.5, 
48.2, 50.9, 60.3, 121.6, 126.5, 128.0, 128.2, 134.4, 138.2, 142.4, 146.8, 158.6; IR: v 2919, 1359, 
735 cm-1; HRMS calcd. for C23H29N2+ [M +H+]: 333.2331. Found: 333.2327. 
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Lycodine (1.1): Under 1 atm H2, pyridne 2.61 (4.2 mg, 0.044 mmol, 1.0 equiv.) was dissolved in 
THF (1.5 mL) and Pd/C (1 mg, 10% wt, 7%) was added at 23 °C.  After 10 hours the same 
amount of Pd/C was added. After another 10 hours, the reaction was diluted with EtOAc (10 
mL), and filtered, concentrated to afford lycodine (1.1) (2.9 mg, 95%) as white crystal (m.p. : 
95.3-96.3 °C).   
 
Lycodine (1.1): [α]23.0D -69.2° (c 0.13, MeOH); Rf = 0.22 (silica gel, CHCl3/MeOH = 100/7); 1H 
NMR (400 MHz, CDCl3): δ  0.81 (d, J = 6.4 Hz, 3H), 1.10-1.21 (m, 2H), 1.32 (m, 2H), 1.36-
1.43 (m, 1H), 1.49 (ddd, J = 2.0, 3.6 and 12.0 Hz, 1H), 1.56-1.61 (m, 2H), 1.66 (dt, J = 3.6 and 
12.8 Hz, 1H), 1.73 (dt, J = 3.6 and 12.8 Hz, 1H), 1.78-1.84 (m, 1H), 2.11-2.15 (m, 1H), 2.45 (dt, 
J = 3.6 and 12.8 Hz, 1H), 2.68 (d, J = 18.8 Hz, 1H), 2.75-2.80 (m, 1H), 3.15 (dd, J = 7.2 Hz, 
1H), 7.29 (dd, J = 4.8 and 8.0 Hz, 1H), 7.89 (dd, J = 1.6 and 8.0 Hz, 1H), 8.31 (dd, J = 1.6 and 
4.8 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 22.3, 27.0, 27.1, 27.4, 34.7, 35.7, 42.0, 44.5, 44.7, 
51.5, 58.0, 123.3, 135.3, 137.3, 147.6, 159.6; IR: v 3438, 1635 cm-1; HRMS calcd. for 
C16H23N2+ [M +H+]: 243.1861. Found: 243.1856. 
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To a solution of 2.64 (700 mg, 1.3 mmol, 1.0 equiv.) in THF (15 mL) at 23 °C was added TBAF 
solution (6.0 mL, 1 M in THF, 6.0 mmol, 4.5 equiv.) and the flask was immersed in a heated oil 
bath. After 13 hours the mixture was cooled to 23 °C, diluted with saturated NH4Cl solution (20 
mL), and extracted with EtOAc (3 × 30 mL).  The organic extracts were washed with brine (10 
mL), dried over Na2SO4, filtered, and concentrated.  The crude material was purified by silica gel 
chromatography (1/0 to 5/1 hexanes/EtOAc) to afford 2.77 (431 mg, 85%) as light brown foam. 
 
2.77: [α]24D +19.1° (c 0.29, CH2Cl2); Rf = 0.43 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 
MHz, CDCl3): δ 0.75 (d, J = 6.0 Hz, 3H), 1.11-1.32 (m, 4H), 1.47-1.58 (m, 3H), 1.74-1.80 (m, 
2H), 1.91-1.94 (m, 1H), 2.05-2.12 (m, 1H), 2.37-2.53 (m, 2H), 2.70 (d, J = 18.8 Hz, 1H), 3.10 (s, 
1H), 3.22 (dd, J = 7.2 and 18.8 Hz, 1H), 4.04 (d, J = 14.0 Hz, 1H), 4.21 (d, J = 14.0 Hz, 1H), 
7.25-7.47 (m, 6H), 8.11 (d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 20.8, 22.4, 26.4, 
27.1, 33.9, 35.3, 38.2, 43.7, 45.8, 48.1, 50.8, 60.4, 76.1, 83.2, 125.4, 126.5, 128.0, 128.2, 134.6, 
138.9, 139.0, 142.1, 159.3; IR: v 1559, 1451, 734 cm-1; HRMS calcd. for C25H29N2+ [M+H]+: 
357.23307. Found: 357.23225. 
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To a solution of 2.72 (50 mg, 0.10 mmol, 1.0 equiv.) in THF (5 mL) at 23 °C was added TBAF 
solution (0.15 mL, 1.0 M in THF, 0.15 mmol, 1.5 equiv.). After 10 minutes the mixture was 
diluted with aqueous saturated NH4Cl solution (10 mL) and extracted with EtOAc (3 × 10 mL). 
The combined organic extracts were washed with brine (10 mL), dried over Na2SO4, filtered, and 
concentrated. The crude material was purified by silica gel chromatography (1/0 → 10/1 
hexanes/EtOAc) to afford compound 2.83 (39 mg, 91%) as light yellow foam. 
 
2.83: Rf = 0.55 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 MHz, CDCl3): δ  0.42 (s, 9H), 
0.75 (d, J = 6.4 Hz, 3H), 0.83-0.92 (m, 1H), 1.11-1.32 (m, 4H), 1.46 (s, 1H), 1.52-1.58 (m, 1H), 
1.70-1.77 (m, 2H), 1.89 (dt, J = 3.6 and 12.8 Hz, 1H), 2.08-2.12 (m, 1H), 2.37-2.54 (m, 2H), 
2.69 (d, J = 18.8 Hz, 1H), 3.14-3.20 (m, 2H), 4.07 (d, J = 14.4 Hz, 1H), 4.22 (d, J = 14.4 Hz, 
1H), 7.24 (t, J = 7.2 Hz, 1H), 7.33-7.36 (m, 2H), 7.46-7.48 (m, 2H), 8.27 (s, 1H); 13C NMR (100 
MHz, CDCl3): δ -1.34, 21.3, 22.4, 26.3, 27.0, 33.9, 35.2, 38.8, 43.7, 46.0, 48.1, 51.0, 60.3, 78.1, 
84.8, 126.5, 127.8, 128.2, 134.8, 137.6, 140.3, 142.5, 143.3, 159.3; IR: v 2921, 1247, 841 cm-1; 
HRMS calcd. for C28H37N2Si+ [M +H+]: 429.2726. Found: 429.2722. 
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To a solution of 2.77 (600 mg, 1.7 mmol, 1.0 equiv.) in THF (15 mL) at 0 °C was added a 
solution of LiHMDS (2.0 mL, 1.0 M in THF, 2.0 mmol, 1.2 equiv.) dropwise over two minutes.  
After 10 minutes neat TMSCl (0.30 mL, 2.4 mmol, 1.4 equiv.) was added.  The resulting solution 
was stirred for one hour, diluted with aqueous saturated NH4Cl solution (20 mL), and extracted 
with EtOAc (3 × 30 mL).  The organic extracts were washed with brine (30 mL), dried over 
Na2SO4, filtered, and concentrated. The crude material was purified by silica gel chromatography 
(1/0 → 5/1 hexanes/EtOAc) to afford alkyne 2.80 (650 mg, 90%) as light brown foam. 
 
2.80: [α]24D +73.9° (c 1.9, CH2Cl2); Rf = 0.65 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (400 
MHz, CDCl3): δ 0.26 (s, 9H), 0.73 (d, J = 6.4 Hz, 3H), 1.11-1.32 (m, 4H), 1.43-1.61 (m, 3H), 
1.72-1.82 (m, 2H), 1.91 (dt, J = 3.6 and 12.4 Hz, 1H), 2.09-2.11 (m, 1H), 2.36-2.53 (m, 2H), 
2.70 (d, J =18.8 Hz, 1H), 3.18 (dd, J = 7.2 and 18.8 Hz, 1H), 4.3 (d, J = 14.0 Hz, 1H), 4.21 (d, J 
= 14.0 Hz, 1Hc  c), 7.23-7.46 (m, 6H), 8.07 (d, J = 1.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 
-0.2, 20.8, 22.3, 26.4, 27.1, 33.9, 35.4, 38.2, 43.7, 45.7, 48.1, 50.8, 60.4, 93.5, 104.2, 125.5, 
126.5, 128.0, 128.2, 134.5, 138.5, 139.9, 142.2, 159.2; IR: v 1434, 1249, 843 cm-1; HRMS 
calcd. for C28H37N2Si+ [M+H]+: 429.27260. Found: 429.27143. 
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To a solution of 2.77 (9.0 mg, 25 µmol, 1.0 equiv.) in THF (1.0 mL) at 0 °C was added LiHMDS 
solution (80 µL, 1.0 M in THF/toluene, 0.080 mmol, 3.2 equiv.) followed by solid TBSCl (6.6 
mg, 44 µmol, 1.7 equiv.). After three hours the reaction was diluted with saturated NH4Cl 
solution (10 mL) and extracted with EtOAc (3 × 5 mL). The combined organic extracts were 
washed with brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was 
purified by silica gel chromatography (1/0 → 10/1 hexanes/EtOAc) to afford 2.81 (10.1 mg, 
85%) as clear oil. 
 
2.81: [α]23.0D +43.3° (c 0.30, CH2Cl2); Rf = 0.75 (silica gel, hexanes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ  0.20 (s, 6H), 0.74 (d, J = 3.0 Hz, 3H), 1.01 (s, 9H), 1.11-1.32 (m, 4H), 
1.43-1.49 (m, 1H), 1.54-1.59 (m, 2H), 1.64 (brs, 1H), 1.72-1.80 (m, 2H), 1.91 (dt, J = 3.6 and 
12.8 Hz, 1H), 2.09-2.11 (m, 1H), 2.37-2.53 (m, 2H), 2.70 (d, J = 18.8 Hz, 1H), 3.19 (dd, J = 7.2 
and 18.8 Hz, 1H), 4.02 (d, J = 19.2 Hz, 1H), 4.20 (d, J = 19.2 Hz, 1H), 7.22-7.25 (m, 1H), 7.32-
7.40 (m, 2H), 7.44-7.47 (m, 2H), 8.08 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ -4.68, 
16.7, 20.9, 22.3, 26.2, 26.5, 27.1, 33.9, 35.3, 38.2, 43.7, 45.7, 48.1, 50.8, 60.4, 92.0, 105.0, 125.8, 
126.5, 128.0, 128.2, 134.4, 138.4, 140.0, 142.2, 159.1; IR: v 2925, 1449, 1384 cm-1; HRMS 
calcd. for C31H43N2Si+ [M +H+]: 471.3196. Found: 471.3191. 
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To a solution of 2.77 (14.5 mg, 41 µmol, 1.0 equiv.) in THF (1 mL) at –78 °C was added 
LiHMDS solution (61 µL, 1.0 M in THF/toluene, 61 µmol, 1.5 equiv.) and neat TIPSOTf (12 
µL, 45 µmol, 1.1 equiv.). After one hour the reaction was diluted with saturated NH4Cl solution 
(10 mL) and extracted with EtOAc (3 × 5 mL). The combined organic extracts were washed with 
brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was purified by 
silica gel chromatography (1/0 → 10/1 hexanes/EtOAc) to afford 2.77 (4.2 mg, 20%) as clear oil 
and 2.82 (4.9 mg, 33%). 
 
2.82: [α]23.0D +37.5° (c 0.40, CH2Cl2); Rf = 0.72 (silica gel, hexanes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ  0.74 (d, J = 6.0 Hz, 3H), 0.92 (t, J = 7.2 Hz, 1H), 1.15 (s, 17H), 1.18-1.33 
(m, 7H), 1.43-1.49 (m, 1H), 1.52-1.61 (m, 2H), 1.72-1.79 (m, 2H), 1.91 (dt, J = 3.6 and 12.4 Hz, 
1H), 2.09-2.12 (m, 1H), 2.39-2.53 (m, 2H), 2.71 (d, J = 18.8 Hz, 1H), 2.19 (dd, J = 7.2 and 18.8 
Hz, 1H), 4.04 (d, J = 15.0 Hz, 1H), 4.22 (d, J = 15.0 Hz, 1H), 7.24 (t, J = 6.8 Hz, 1H), 7.33-7.37 
(m, 3H), 7.45 (d, J = 6.8 Hz, 2H), 8.09 (d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 11.3, 
18.7, 20.9, 22.3, 26.5, 27.1, 34.0, 35.3, 38.2, 43.7, 45.8, 48.1, 50.8, 60.4, 90.4, 106.6, 126.3, 
126.5, 128.0, 128.2, 134.4, 138.3, 140.3, 142.2, 159.0; IR: v 2918, 1384 cm-1; HRMS calcd. for 
C34H49N2Si+ [M +H+]: 513.36595. Found: 513.36587. 
 
 90 
 
 
 
To a solution of 2.77 (10 mg, 28 µmol, 1.0 equiv.) in THF (1 mL) at 0 °C was added LiHMDS 
solution (0.15 mL, 1.0 M in THF/toluene, 150 µmol, 5.4 equiv.) and neat ethyl chloroformate 
(20 µL, 0.26 mmol, 9.2 equiv.). After 2 hours the reaction was diluted with saturated NH4Cl 
solution (10 mL) and extracted with EtOAc (3 × 5 mL). The combined organic extracts were 
washed with brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was 
purified by silica gel chromatography (1/0 → 2/1 hexanes/EtOAc) to afford 2.86 (8.8 mg, 76%) 
as clear oil. 
 
2.86: [α]23.0D +12.0° (c 0.25, CH2Cl2); Rf = 0.68 (silica gel, hexanes/EtOAc = 5/1); 1H NMR 
(400 MHz, CDCl3): δ  0.76 (d, J = 6.0 Hz, 3H), 0.88-0.94 (m, 1H), 1.14-1.36 (m, 5H), 1.40-1.52 
(m, 2H), 1.55-1.61 (m, 1H), 1.74-1.80 (m, 2H), 1.92-1.96 (m, 1H), 2.11-2.14 (m, 1H), 2.36-2.42 
(m, 1H), 2.51-2.55 (m, 1H), 2.72 (m, d, J = 18.8 Hz, 1H), 3.20 (dd, J = 6.8 and 18.8 Hz, 1H), 
4.03 (d, J = 14.0 Hz, 1H), 4.23 (d, J = 14.0 Hz, 1H), 4.12 (dd, J = 14.0 and 80.0 Hz, 2H), 4.29 (q, 
J = 7.2 Hz, 2H), 7.23-7.27 (m, 1H), 7.35 (t, J = 8.0 Hz, 2H), 7.46 (d, J = 8.0 Hz, 2H), 8.18 (d, J = 
8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 14.0, 20.8, 22.3, 26.5, 27.1, 33.8, 35.3, 38.1, 43.6, 
45.9, 48.2, 50.8, 60.6, 62.2, 78.5, 84.7, 126.6, 126.7, 128.0, 128.3, 134.8, 137.2, 140.7, 142.0, 
153.7, 160.1; IR: v 2923, 1710, 1219 cm-1; HRMS calcd. for C28H33N2O2+ [M +H+]: 429.2542. 
Found: 429.2543. 
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To a solution of 2.94 (10 mg, 28 µmol, 1.0 equiv.) in THF (1 mL) at 0 °C was added LiHMDS 
solution (0.15 mL, 1.0 M in THF/toluene, 0.15 mmol, 5.4 equiv.) and after 20 minutes neat 
acetone (20 µL, 0.27 mmol, 9.7 equiv.) was added. After 10 minutes the reaction was diluted 
with saturated NH4Cl solution (10 mL), and extracted with EtOAc (3 × 5 mL). The organic 
extracts were washed with brine (5 mL), dried over Na2SO4, filtered, and concentrated. The 
crude material was purified by silica gel chromatography (1/0 →2/1 hexanes/EtOAc) to afford 
2.129 (7.9 mg, 68%) as clear oil. 
 
2.129: [α]23.0D +41.0° (c 0.56, CH2Cl2); Rf = 0.30 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ  0.74 (d, J = 6.4 Hz, 3H), 0.94 (t, J = 7.2 Hz, 2H), 1.12-1.31 (m, 4H), 1.37-
1.49 (m, 1H), 1.52-1.66 (m, 6H), 1.72-1.79 (m, 3H), 1.91 (dt, J = 3.6 and 12.8 Hz, 1H), 2.10-
2.11 (m, 1H), 2.21-2.23 (m, 1H), 2.36-2.52 (m, 2H), 2.70 (d, J = 18.8 Hz, 1H), 3.19 (dd, J = 7.2 
and 18.8 Hz, 1H), 4.03 (d, J =14.0 Hz, 1H), 4.11 (d, J = 14.0 Hz, 1H), 7.25-7.30 (m, 1H), 7.35 (t, 
J = 7.2 Hz, 2H), 7.45 (d, J = 7.2 Hz, 2H), 8.10 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): 
δ 20.8, 22.3, 26.5, 27.0, 31.2, 33.9, 35.3, 38.1, 43.6, 45.7, 48.1, 50.7, 60.4, 65.5, 81.9, 92.8, 
125.3, 126.5, 128.0, 128.2, 134.7, 138.4, 139.6, 142.1, 159.1; IR: v 3500, 1459 cm-1; HRMS 
calcd. for C28H35N2O+ [M +H+]: 415.2749. Found: 415.2749. 
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To a solution of 2.77 (21.0 mg, 41 µmol, 1.0 equiv.) in THF (1.5 mL) at –78 °C was added 
LiHMDS solution (77 µL, 1.0 M in THF/toluene, 77 µmol, 1.3 equiv.) and silyl chloride X (13 
µL, 77 µmol, 1.3 equiv.). After 30 minutes the reaction was diluted with saturated NH4Cl 
solution (10 mL) and extracted with EtOAc (3 × 5 mL). The combined organic extracts were 
washed with brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was 
purified by silica gel chromatography (1/0 → 10/1 hexanes/EtOAc) to afford int-19 (19.0 mg, 
66%) as clear oil. 
 
Int-19: [α]23.0D +41.0° (c 0.56, CH2Cl2); Rf = 0.30 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ  0.26 (s, 6H), 0.74 (d, J = 6.0 Hz, 3H), 0.82 (dt, J = 4.4 and 8.0 Hz, 2H), 
1.11-1.32 (m, 4H), 1.43-1.63(m, 4H), 1.72-1.80 (m, 2H), 1.89-1.97 (m, 3H), 2.09-2.13 (m, 1H), 
2.40 (dt, J = 1.2 and 13.2 Hz, 1H), 2.48-2.53 (m, 1H), 3.19 (dd, J = 7.2 and 18.8 Hz, 1H), 3.57 (t, 
J = 8.0 Hz, 2H), 4.03 (d, J = 14.4 Hz, 1H), 4.22 (d, J = 14.4 Hz, 1H), 7.24-7.27 (m, 1H), 7.32-
7.37 (m, 3H), 7.45 (dd, J = 0.8 and 8.0 Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ -1.9, 13.7, 20.8, 22.3, 26.4, 27.0, 27.5, 33.9, 35.4, 38.1, 43.6, 45.7, 47.7, 48.1, 50.7, 
60.5, 91.8, 105.2, 125.7, 126.5, 128.0, 128.2, 134.5, 138.7, 139.7, 142.1, 159.2; IR: v 2920, 1558 
cm-1; HRMS calcd. for C30H40N2SiCl+ [M +H+]: 491.2649. Found: 491.2645. 
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Pyridine int-19 (15.0 mg, 31 µmol, 1.0 equiv.) was dissolved in acetone (1 mL) and NaI (15 mg, 
3.3 mmol, 3.3 equiv.), morpholine (13 mL, 0.15 mmol, 5.0 equiv.), and K2CO3 (10 mg, 2.4 
mmol, 2.4 equiv.) were added. The heterogeneous reaction was heated to reflux. After 48 hours 
the reaction was cooled to 23 °C, diluted with saturated NH4Cl solution (5 mL), and extracted 
with EtOAc (3 × 5 mL). The combined organic extracts were washed with brine (5 mL), dried 
over Na2SO4, filtered, and concentrated. The crude material was purified by silica gel 
chromatography (10/1 hexanes/EtOAc → 10/1 CH2Cl2/MeOH) to afford 2.88 (13.8 mg, 83%) as 
pale yellow oil. 
 
2.88: [α]23.0D +24.4° (c 0.86, CH2Cl2); Rf = 0.35 (silica gel, CH2Cl2/MeOH = 10/1); 1H NMR 
(400 MHz, CDCl3): δ  0.24 (s, 6H), 0.67-0.70 (m, 2H), 0.74 (d, J = 6.4 Hz, 3H), 0.83-0.97 (m, 
1H), 1.11-1.33 (m, 4H), 1.42-1.49 (m, 2H), 1.51-1.68 (m, 3H), 1.72-1.82 (m, 2H), 1.91 (dt, J = 
3.6 and 12.8 Hz, 2H), 2.09-2.11 (m, 1H), 2.37-2.40 (m, 2H), 2.43-2.59 (m, 4H), 2.70 (d, J = 18.8 
Hz, 1H), 3.18 (dd, J = 7.2 and 15.6 Hz, 1H), 3.72 (t, J = 4.8 Hz, 4H), 4.03 (d, J = 15.6 Hz, 1H), 
4.21 (d, J = 15.6 Hz, 1H), 7.25 (t, J = 7.6 Hz, 1H), 7.30 (d, J = 8.0 Hz, 1H), 7.35 (t, J = 7.6 Hz, 
2H), 7.45 (d, J = 7.6 Hz, 2H), 8.08 (d, J = 8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ -1.9, 
13.6, 20.80, 20.83, 22.3, 26.5, 27.1, 33.9, 35.3, 38.2, 43.7, 45.8, 48.1, 50.8, 53.7, 60.5, 62.1, 66.9, 
92.5, 104.9, 125.6, 126.5, 128.0, 128.2, 134.5, 138.6, 139.8, 142.1, 159.2; IR: v 2925, 1450 cm-1; 
HRMS calcd. for C34H48N3OSi+ [M +H+]: 542.35666. Found: 542.35636. 
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In a pressure tube 2.80 (18.5 mg, 43 µmol, 1.0 equiv.) and alkyne-nitrile 2.55 (20.0 mg, 65 µmol, 
1.5 equiv.) were dissolved in degassed THF (4 mL).  Neat CpCo(CO)2 (30 µL, 34 µmol, 0.8 
equiv.) was added and the tube was sealed.  The resulting solution was placed in an oil bath 
heated to 140 °C. After 14 hours the mixture was cooled and the reaction was concentrated. The 
product was purified by silica gel chromatography (20/1 to 10/1 hexanes/EtOAc) to afford 
bipyridyl 2.90 (13.6 mg, 43%) as yellow oil. 
 
2.90: [α]24D +26.3° (c 0.49, CH2Cl2); Rf = 0.65 (silica gel, hexanes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ 0.20 (s, 9H), 0.74 (d, J = 6.4 Hz, 3H), 0.77 (d, J = 6.4 Hz, 3H), 1.10-1.59 
(m, 14H), 1.70-1.83 (m, 4H), 1.90-1.96 (m, 2H), 2.13 (bs, 2H), 2.54 (brs, 4H), 2.73-2.78 (m, 
2H), 3.19-3.28 (m, 2H), 4.11-4.27 (m, 4H), 7.23-7.27 (m, 1H), 7.36 (t, J = 7.6 Hz, 4H), 7.51 (t, J 
= 8.0 Hz, 5H), 7.80 (d, J = 8.4 Hz, 1H), 8.20 (d, J = 8.4 Hz, 1H), 8.43 (s, 1H); 13C NMR (100 
MHz, CDCl3): δ 1.0, 21.4, 21.8, 22.3, 22.4, 26.3, 26.5, 27.1, 27.2, 34.1, 34.2, 35.1, 35.3, 38.8, 
39.5, 43.9, 43.9, 45.9, 45.9, 48.1, 48.1, 51.0, 51.2, 60.3, 60.4, 121.0, 126.4, 126.4, 127.8, 128.0, 
128.2, 128.2, 130.5, 135.2, 135.9, 137.3, 142.3, 142.5, 142.8, 156.9, 157.0, 158.0, 159.9; IR: v 
1453, 1242, 838, 733 cm-1; HRMS calcd. for C49H63N4Si+ [M +H+]: 735.48220. Found: 
735.48176. 
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In a pressure tube alkyne nitrile 2.81 (15 mg, 32 µmol, 1.0 equiv.) and 2.55 (15 mg, 49 µmol, 1.5 
equiv.) were dissolved in degassed THF (2 mL). Neat CpCo(CO)2 (5.0 µL, 41 µmol, 1.3 equiv.) 
was added and the tube was sealed. The resulting solution was placed in an oil bath heated to 140 
°C. After 10 hours the reaction was cooled and concentrated. The crude was purified by silica gel 
chromatography (20/1 → 10/1 hexanes/EtOAc) to afford 2.91 (7.2 mg, 29%) as yellow oil. 
 
2.91: [α]23.0D +26.3° (c 0.38, CH2Cl2); Rf = 0.62 (silica gel, hexanes/EtOAc = 10/1); 1H NMR 
(400 MHz, CDCl3): δ  -0.11 (s, 3H), -0.10 (s, 3H), 0.76 (d, J = 6.0 Hz, 3H), 0.76 (d, J = 6.0 Hz, 
3H), 0.83-1.02 (m, 12H), 1.15-1.19 (m, 2H), 1.26-1.43 (m, 5H), 1.47-1.63 (m, 4H), 1.70-1.84 (m, 
3H), 1.90-1.95 (m, 2H), 2.11-2.14 (m, 2H), 2.51-2.55 (m, 4H), 2.72 (dd, J = 3.6 and 19.2 Hz, 
2H), 3.22 (dd, J = 7.2 and 19.2 Hz, 2H), 4..8-4.14 (m, 2H), 4.23-4.29(m, 2H), 7.23-7.27 (m, 2H), 
7.33-7.40 (m, 5H), 7.49-7.51 (m, 4H), 8.14 (d, J = 8.0 Hz, 2H), 8.45 (s, 1H); 13C NMR (100 
MHz, CDCl3): δ -4.0, -3.8, 14.1, 17.8, 21.3, 22.3, 22.4, 22.6, 26.38, 26.44, 27.1, 27.4, 34.1, 34.2, 
34.7, 35.3, 38.7, 38.8, 43.8, 43.9, 45.6, 46.0, 48.1, 48.3, 50.95, 51.01, 60.2, 60.4, 121.9, 126.4, 
126.4, 127.8, 128.0, 128.1, 128.2, 128.2, 134.6, 135.4, 137.1, 142.4, 142.7, 143.1, 157.0, 157.6, 
158.1, 161.3; IR: v 2925, 2854, 733 cm-1; HRMS calcd. for C52H69N4Si+ [M +H+]: 777.52915. 
Found: 777.52834. 
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To a solution of 2.90 (21 mg, 29 µmol, 1.0 equiv.) in dioxane (1.5 mL) at 23 °C was added 
TBAF solution (0.15 mL, 1.0 M in THF, 75 µmol, 5.2 equiv.). The resulting solution was placed 
in a heated oil bath. After 10 hours the reaction was concentrated and purified by silica gel 
chromatography (1/0 → 10/1 hexanes/EtOAc) to afford compound 2.92 (15.5 mg, 82%) as light 
yellow foam. 
 
2.92: Rf = 0.65 (silica gel, hexanes/EtOAc = 5/1); 1H NMR (500 MHz, CDCl3): δ  0.74 (d, J = 
6.5 Hz, 6H), 0.86-1.03 (m, 2H), 1.14-1.61 (m, 8H), 1.77-1.80 (m, 4H), 1.94 (dt, J = 4.5 and 11.5 
Hz, 2H), 2.14 (brs, 2H), 2.52 (d, J = 9.5 Hz, 4H), 2.80 (d, J = 23.5 Hz, 2H), 3.29 (dd, J = 9.5 and 
23.5 Hz, 2H), 4.12 (d, J = 18.0 Hz, 2H), 4.25 (d, J = 18.0 Hz, 2H), 7.23-7.27 (m, 6H), 7.36 (t, J = 
9.5 Hz, 4H), 7.50 (d, J = 9.5 Hz, 4H), 8.10 (d, J = 10.0 Hz, 2H), 8.21 (d, J = 10.0 Hz, 2H).  13C 
NMR (125 MHz, CDCl3): δ 22.4, 26.5, 27.2, 29.7, 34.2, 35.6, 38.8, 34.8, 45.8, 48.2, 51.0, 60.5, 
119.2, 126.5, 128.0, 128.2, 135.3, 138.0, 142.5, 154.1, 158.2; IR: v 2965, 1601 cm-1; HRMS 
calcd. for C46H55N4Si+ [M +H+]: 663.44267. Found: 663.44200. 
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In a pressure tube 2.63 (14 mg, 33 µmol, 1.0 equiv.) and alkyne-nitrile 2.55 (14 mg, 46 µmol, 1.4 
equiv.) were dissolved in degassed THF (2 mL). Neat CpCo(CO)2 (5 µL, 41 µmol, 1.2 equiv.) 
was added and the tube was sealed. The resulting solution was placed in an oil bath heated to 140 
°C. After 10 hours the mixture was cooled to 23 °C and the reaction was concentrated. The crude 
was purified by silica gel chromatography (20/1 →10/1 hexanes/EtOAc) to afford bipyridyl 2.94 
(6.8 mg, 28%) as yellow oil. 
 
2.94:[α]23.0D +34.2° (c 0.30, CH2Cl2); Rf = 0.2 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (400 
MHz, CDCl3): δ  0.10 (s, 9H), 0.79 (d, J = 5.6 Hz, 3H), 0.82 (d, J = 6.0 Hz, 3H), 0.85-0.91 (m, 
2H), 1.12-1.43 (m, 7H), 1.49-1.66 (m, 6H), 1.75-1.84 (m, 4H), 1.93-2.00 (m, 2H), 2.12-2.18 (m, 
2H), 2.45-2.63 (m, 3H), 2.76 (dd, J = 3.6 and 18.4 Hz, 2H), 3.23 (dt, J = 7.6 and 19.0 Hz, 2H), 
4.04-4.29 (m, 4H), 7.22-7.42 (m, 6H), 7.45 (d, J = 7.6 Hz, 2H), 7.52 (d, J = 7.6 Hz, 2H), 8.18 (d, 
J = 1.6 Hz, 1H), 8.38 (s, 1H), 8.48 (d, J = 1.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 0.6, 14.1, 
20.7, 21.7, 22.3, 22.6, 24.9, 26.3, 26.6, 27.1, 31.8, 34.0, 34.1, 35.3, 38.3, 39.4, 43.8, 45.4, 45.8, 
47.8, 48.0, 50.7, 51.2, 60.2, 60.6, 126.4, 126.5, 127.6, 127.8, 128.1, 128.2, 128.4, 130.8, 134.3, 
135.4, 136.9, 137.5, 141.9, 142.0, 142.7, 147.0, 157.9, 158.5, 159.5; IR: v 3390, 2922, 1559, 732 
cm-1; HRMS calcd. for C49H63N4Si+ [M +H+]: 735.4822. Found: 735.4820. 
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To a solution of 2.94 (8.1 mg, 11 µmol, 1.0 equiv.) in dioxane (1 mL) at 23 °C was added TBAF 
solution (1.0 M in THF, 50 µL, 50 µmol, 4.6 equiv.) and the reaction was placed in a heated oil 
bath. After 10 hours the mixture was cooled to 23 °C, diluted with saturated NH4Cl solution (10 
mL), and extracted with EtOAc (3 × 5 mL). The combined organic extracts were washed with 
brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude material was purified by 
silica gel chromatography (5/1 → 1/1 hexanes/EtOAc) to afford 2.95 (7.3 mg, 99%) as light 
yellow oil. 
 
2.94:[α]23.0D +36.9° (c 0.73, CH2Cl2); Rf = 0.40 (silica gel, hexanes/EtOAc = 1/1); 1H NMR 
(400 MHz, CDCl3): δ  0.76 (d, J = 6.0 Hz, 3H), 0.77 (d, J = 6.0 Hz, 3H), 1.17-1.21 (m, 2H), 
1.23-1.37 (m, 3H), 1.37-1.44 (m, 1H), 1.44-1.55 (m, 2H), 1.55-1.69 (m, 4H), 1.73-1.83 (m, 4H), 
1.92-1.99 (m, 2H), 2.13-2.19 (m, 2H), 2.53-2.57 (m, 4H), 2.79 (dd, J = 18.8 and 34.4 Hz, 2H), 
3.22-3.35 (m, 2H), 4.10-4.32 (m, 4H), 7.24-7.28 (m, 4H), 7.38 (dt, J = 3.6 and 7.2 Hz, 4H), 7.51 
(d, J = 7.2 Hz, 2H), 7.56 (d, J = 7.2 Hz, 2H), 7.61 (d, J = 8.0 Hz, 1H), 8.22 (d, J = 8.0 Hz. 1H), 
8.74 (d, J = 2.4 Hz, 1H), 8.98 (d, J = 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 21.1, 21.7, 
22.3, 22.4, 26.4, 26.6, 27.2, 34.1, 34.2, 35.3, 35.6, 38.7, 39.3, 43.8, 45.9, 46.0,48.0, 48.2, 50.9, 
51.2, 60.4, 60.5, 118.4, 126.4, 126.5, 128.0, 128.2, 132.7, 133.3, 135.3, 137.1, 137.9, 142.4, 
142.6, 145.3, 152.5, 158.7, 158.9; IR: v 3446, 2921, 1447, 732 cm-1; HRMS calcd. for 
C46H55N4+ [M +H+]: 663.4427. Found: 663.4427. 
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To 2.95 (8.0 mg, 12 µmol, 1.0 equiv.) in THF (1 mL) solid 10% palladium on carbon (2.0 mg, 
15.6 μmol, 0.16 equiv.) was added then the heterogeneous solution was rapidly stirred under H2 
(1 atm) at 23 °C. After 20 hours the solution was filtered through a celite pad and concentrated to 
afford the complanadine A (1.2) (5.1 mg, 88%) as pale yellow oil. 
 
Additional purification was achieved as follows: from above complanadine A (12 mg, 25 µmol, 
1.0 equiv.) was dissolved in 5% HCl solution (5 mL) and washed with Et2O (2 × 5 mL), the 
aqueous layer was adjusted to a pH of 13 with 10% aqueous NaOH solution, and the white 
suspension was extracted with EtOAc (3 × 5 mL).  The combined organic extracts were washed 
with brine (5 mL), dried over Na2SO4, filtered, and concentrated to provide complanadine A  
(1.2) (5.1 mg, 88%) as pale yellow oil. 
 
Complanadine A (1.2): [α]24D +14.5° (c 0.30, MeOH); 1H NMR (400 MHz, MeOH): δ 0.85 (d, J 
= 6.4 Hz, 3H), 0.86 (d, J = 6.4 Hz, 3H), 1.21-1.49 (m, 10H), 1.53-1.64 (m, 5H), 1.68-1.72 (m, 
1H), 1.75-1.81 (m, 2H), 1.85-1.89 (m, 2H), 2.18-2.22 (m, 2H), 2.48-2.57 (m, 2H), 2.76-2.85 (m, 
4H), 3.20-3.30 (m, 2H), 7.77 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 8.0 Hz, 1H), 8.48 (s, 1H), 8.93 (s, 
1H); 13C NMR (100 MHz, MeOH): δ 22.4, 27.1, 27.3, 27.7, 34.8, 34.9, 35.7, 36.2, 42.1, 44.7, 
44.8, 44.9, 51.6, 51.7, 57.8, 57.9, 120.4, 133.7, 135.0, 135.9, 136.6, 137.6, 146.1, 153.7, 159.9, 
160.5; IR: v 2913, 1575, 1436 cm-1; HRMS calcd. for C32H43N4+ [M+H+]: 483.34877. Found: 
483.34828.  
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In a pressure tube alkyne int-1a (218 mg, 0.90 mmol, 2.5 equiv.) and alkyne-nitrile 2.55 (110 
mg, 0.36 mmol, 1.0 equiv.) were dissolved in freshly degassed THF (2.0 mL). Neat CpCo(CO)2 
(60 µL, 0.48 mmol, 1.4 equiv.) was added and the tube was sealed. The resulting solution was 
placed in an 140 °C oil bath. After 30 hours the reaction was cooled to 23 °C and concentrated. 
The crude material was purified by silica gel chromatography (1/0 → 5/1 hexanes/EtOAc) to 
afford 2.98 (65 mg, 34%) as a brown oil and unreacted 2.55 (14 mg, 11%) was recovered.  
 
If the reaction was run at 0.05 M, the ratio is 1/3 (2.98/2.97). The undesired product 2.97 was 
subjected to desiylation for characterization. 
 
2.98: [α]23.0D +28.5° (c 0.23, CH2Cl2); Rf = 0.41 (silica gel, hexanes/EtOAc = 5:1); 1H NMR 
(400 MHz, CDCl3): δ 0.13 (d, J = 2.0 Hz, 6H), 0.75 (d, J = 6.0 Hz, 3H), 0.95 (s, 9H), 1.11-1.35 
(m, 4H), 1.43-1.58 (m, 3H), 1.71-1.80 (m, 2H), 1.93 (dt, J = 3.6 and 12.8 Hz, 1H), 2.09-2.12 (m, 
1H), 2.43-2.52 (m, 2H), 3.19 (dd, J = 7.2 and 18.8 Hz, 1H), 4.14 (d, J = 14.4 Hz, 1H), 4.23 (d, J 
= 14.4 Hz, 1H), 4.77 (s, 2H), 7.22-7.26 (m, 1H), 7.32-7.36 (m, 2H), 7.47-7.49 (m, 2H), 8.10 (d, J 
= 2.4 Hz, 1H), 8.31 (d, J = 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ -5.2, -5.1, 18.4, 21.3, 
22.4, 25.9, 26.4, 27.1, 34.0, 35.1, 38.7, 43.8, 45.8, 48.1, 51.1, 60.4, 63.0, 126.4, 127.9, 128.2, 
132.5, 134.4, 137.7, 142.4, 144.9, 157.3; IR: v 2918, 1653, 1094 cm-1; HRMS calcd. for 
C30H45N2OSi+ [M +H+]: 477.33012. Found: 477.32948. 
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To a solution of 2.97 (61 mg, 0.13 mmol, 1.0 equiv.) in THF (5 mL) at 23 °C was added TBAF 
solution (0.15 mL, 1.0 M in THF, 0.15 mmol, 1.2 equiv.). After 30 minutes the mixture was 
diluted with saturated NH4Cl solution (10 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic extracts were washed with brine (5 mL), dried over Na2SO4, filtered, and 
concentrated. The crude material was purified by silica gel chromatography (10/1 → 1/1 
hexanes/EtOAc) to afford int-20 (12 mg, 22%) as light brown foam. 
 
Int-20:[α]23.0D +57.1° (c 0.35, CH2Cl2); Rf = 0.35 (silica gel, Hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ  0.35 (s, 9H), 0.76 (d, J = 6.0 Hz, 3H), 1.14-1.34 (m, 5H), 1.43-1.57 (m, 
3H), 1.71-1.80 (m, 2H), 1.89 (dt, J = 3.6 and 12.8 Hz, 1H), 2.10-2.12 (m, 1H), 2.40-2.53 (m, 
2H), 2.65 (d, J = 19.2 Hz, 1H), 3.16 (dd, J = 7.2 and 19.2 Hz, 1H), 4.09 (d, J = 14.0 Hz, 1H), 
4.22 (d, J = 14.0 Hz, 1H),4.73 (d, J = 1.6 Hz, 2H), 7.24 (t, J = 7.2 Hz, 1H), 7.35 (t, J = 7.2 Hz, 
2H), 7.47 (d, J = 7.2 Hz, 2H), 8.26 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 0.0, 22.0, 23.0, 27.0, 
27.6, 34.6, 35.5, 39.6, 44.3, 46.6, 48.6, 51.6, 60.6, 64.1, 127.0, 128.4, 128.8, 136.2, 142.1, 143.2, 
157.5, 159.4, 163.5; IR: v 2923, 1068, 839 cm-1; HRMS calcd. for C27H39N2OSi+ [M +H+]: 
435.2832. Found: 435.2826. 
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To a solution of 2.98 (200 mg, 0.42 mmol, 1.0 equiv.) in THF (5 mL) at 23 °C was added TBAF 
solution (0.80 mL, 1.0 M in THF, 0.80 mmol, 1.9 equiv.). After 30 minutes the reaction was 
concentrated. The crude material was purified by silica gel chromatography (5/1 → 0/1 
hexanes/EtOAc) to afford 2.99 (119 mg, 78%) as light brown oil. 
 
2.99: [α]23.0D +29.0° (c 0.24, CH2Cl2); Rf = 0.32 (silica gel, EtOAc); 1H NMR (400 MHz, 
CDCl3): δ  0.75 (d, J = 6.0 Hz, 3H), 0.91-0.99 (m, 1H), 1.12-1.33 (m, 4H), 1.45-1.58 (m, 3H), 
1.74-1.80 (m, 2H), 1.92 (dt, J = 4.0 and 13.2 Hz, 1H), 2.08-2.12 (m, 1H), 2.39-2.53 (m, 2H), 
2.69 (d, J = 18.8 Hz, 1H), 3.18 (dd, J = 6.8 and 18.8 Hz, 1H), 4.09 (d, J = 14.4, 1H), 4.22 (d, J = 
14.4 Hz, 1H), 4.73 (s, 2H), 7.23-7.26 (m, 1H), 7.39 (t, J = 7.2 Hz, 2H), 7.47 (d, J = 7.2 Hz, 2H), 
8.11 (d, J = 2.4 Hz, 1H), 8.36 (d, J = 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 21.1, 22.4, 
26.4, 27.0, 33.9, 35.0, 38.5, 43.7, 45.8, 48.1, 51.0, 60.4, 63.1, 126.5, 128.0, 128.2, 133.6, 134.1, 
138.1, 142.2, 145.7, 157.9; IR: v, 2921, 1453, 732 cm-1; HRMS calcd. for C24H31N2O+ [M +H+]: 
363.2436. Found: 363.2433. 
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To a solution of 2.99 (46 mg, 0.13 mmol, 1.0 equiv.) in CH2Cl2 (5 mL) was added solid Dess-
Martin periodiane (215 mg, 0.51 mmol, 4.0 equiv.) at 23 °C. After 30 minutes the heterogeneous 
solution was diluted with saturated NH4Cl solution (10 mL) and extracted with EtOAc (3 × 10 
mL). The combined organic extracts were washed with brine (10 mL), dried over Na2SO4, 
filtered, and concentrated. The crude material was purified by silica gel chromatography (20/1 → 
2/1 Hexanes/EtOAc) to afford 2.100 (44.1 mg, 96%) as pale yellow oil. 
 
2.100: [α]23.0D +28.5° (c 0.23, CH2Cl2); Rf = 0.20 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ  0.77 (d, J = 6.0 Hz, 3H), 1.14-1.37 (m, 4H), 1.53-1.63 (m, 3H), 1.75-1.81 
(m, 2H), 1.99 (dt, J = 3.2 and 12.4 Hz, 1H), 2.11-2.18 (m, 1H), 2.35-2.42 (m, 1H), 2.53-2.58 (m, 
1H), 2.79 (d, J = 19.6 Hz, 1H), 3.27 (dd, J = 7.2 and 19.2 Hz, 1H), 4.18 (dd, J = 14.4 and 64.0 
Hz, 2H), 7.24-7.28 (m, 1H), 7.37 (t, J = 8.0 Hz, 2H), 7.49 (d, J = 8.0 Hz, 2H), 8.57 (d, J = 2.0 
Hz, 1H), 8.47 (d, J = 2.0 Hz, 1H), 10.1 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 21.0, 22.3, 26.4, 
27.1, 33.8, 36.0, 38.2, 43.5, 45.8, 48.1, 51.0, 60.5, 126.7, 128.0, 128.3, 130.3, 134.9, 139.3, 
141.8, 149.0, 165.5, 191.3; IR: v 2919, 1698, 1384 cm-1; HRMS calcd. for C24H29N2O+ [M +H+]: 
361.2280. Found: 361.2278. 
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To a solution of 2.100 (50 mg, 0.14 mmol, 1.0 equiv.) and K2CO3 (47.9 mg, 0.35 mmol, 2.5 
equiv.) in methanol (2 mL) was added dimethyl-1-diazo-2-oxopropylphosphate 2.101 (66.6 mg, 
0.35 mmol, 2.5 equiv.) at 0 °C. After 8 hours the reaction was diluted with saturated aqueous 
NH4Cl solution (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts 
were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated. The crude 
material was purified by silica gel chromatography (20/1 → 5/1 hexanes/EtOAc) to afford 2.102 
(42.3 mg, 86%) as white foam. 
 
2.102:[α]23.0D +27.5° (c 0.29, CH2Cl2); Rf = 0.65 (silica gel, hexanes/EtOAc = 5/1); 1H NMR 
(400 MHz, CDCl3): δ  0.76 (d, J = 6.0 Hz, 3H), 1.14-1.33 (m, 4H), 1.48-1.50 (m, 1H), 1.56-1.64 
(m, 2H), 1.73-1.83 (m, 2H), 1.93 (dt, J = 3.6 and 12.8 Hz, 1H), 2.10-2.13 (m, 1H), 2.40-2.54 (m, 
2H), 2.68 (d, J = 19.2 Hz, 1H), 3.16-3.23 (m, 2H), 4.05 (d, J = 14.0 Hz, 1H), 4.23 (d, J = 14.0 
Hz, 1H), 7.25-7.27 (m, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.47 (d, J = 7.6 Hz, 2H), 8.21 (d, J = 2.0 
Hz, 1H), 8.50 (d, J = 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 20.9, 22.3, 26.4, 27.0, 33.8, 
35.4, 38.2, 43.6, 45.7, 48.1, 50.8, 60.3, 79.2, 81.4, 116.7, 126.6, 128.0, 128.3, 137.5, 137.9, 
142.0, 149.8, 158.9; IR: v 2921, 1450, 1384 cm-1; HRMS calcd. for C25H29N2+ [M +H+]: 
357.2331. Found: 357.2326. 
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Amine 2.56 (600 mg, 1.78 mmol, 1.0 equiv.) was dissolved in acetonitrile/water (6/1, 15 mL).  
Solid CAN (4.0 g, 7.3 mmol, 4.1 equiv.) was added in one portion and the solution was placed in 
a 75 °C oil bath. After 5 hours the mixture was neutralized with aqueous NaOH solution (1.0 M, 
15 mL) and filtered through a celite pad. The mixture was extracted with EtOAc (3 × 15 mL) and 
washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated. The crude material 
was purified by silica gel chromatography (the column was neutralized with 1% Et3N in hexane) 
(5/1 → 0/1 hexanes/EtOAc) to afford the secondary amine 2.119 (260 mg, 67 %, m.p. 153.8- 
154.2 °C) as pale yellow solid.  
 
2.119:[α]24D -24.1° (c 0.27, CH2Cl2); Rf = 0.25 (silica gel, neutralized by Et3N, EtOAc); 1H 
NMR (400 MHz, CDCl3): δ 0.95 (d, J = 6.4 Hz, 3H), 1.13 (t, J = 12.1 Hz, 1H), 1.24-1.32 (m, 
1H), 1.43-1.66 (m, 4H), 1.70-1.80 (m, 2H), 1.91-2.08 (m, 3H), 2.44 (s, 1H), 2.50-2.56 (m, 1H), 
2.81-2.86 (m, 1H), 2.93 (dd, J = 4.0 and 17.2 Hz, 1H), 3.04-3.11 (m, 1H); 13C NMR (100 MHz, 
CDCl3): δ 16.9, 21.8, 24.1, 26.1, 26.4, 36.3, 38.4, 42.3, 45.8, 48.6, 54.1, 75.1, 87.5, 120.5; IR: v 
3285, 1457, 1124, 637 cm-1; HRMS calcd. for C14H21N2+ [M+H+]: 217.17014. Found: 
217.16996.  
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Amine 2.57 (200 mg, 0.55 mmol, 1.0 equiv) was dissolved in acetonitrile/water (6/1, 12 mL) at 
23 °C.  Solid CAN (500 mg, 0.91 mmol, 1.6 equiv.) was added in one portion. After 5 min at 
23 °C the mixture was neutralized with aqueous NaOH solution (1M, 5 mL) and filtered through 
a celite pad.  The mixture was extracted with EtOAc (3 × 10 mL) and the combined organic 
extracts were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated.  The 
crude material was purified by silica gel chromatography (column was neutralized with 1% Et3N 
in hexane) (5/1 → 0/1 hexanes/EtOAc) to afford the secondary amine 2.119 (81 mg, 70 %, m.p. 
153.8- 154.2 °C) as pale yellow solid.  
 
Spectral data the same as above. 
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To a solution of 2.119 (260 mg, 1.2 mmol, 1.0 equiv.) in THF (7 mL) was added neat AcOCHO 
(200 µL, 1.9 mmol, 1.6 equiv.) and Hünig’s base (300 µL, 1.6 mmol, 1.4 equiv.) at 23 °C.  After 
30 minutes the solution was diluted with aqueous saturated NH4Cl solution (10 mL) and 
extracted with EtOAc (3 × 10 mL).  The combined organic extracts were washed with brine (10 
mL), dried over Na2SO4, filtered, and concentrated to afford 2.120 (290 mg, 97%, m.p. 155.0-
155.2 °C) as pale yellow solid.  
 
2.120: [α]24D +81.8° (c 1.0, CH2Cl2); Rf = 0.28 (silica gel, hexanes/EtOAc = 1/1); 1H NMR (400 
MHz, CDCl3): δ 1.07 (d, J = 6.8 Hz, 3H), 1.32 (dt, J = 5.2 and 13.6 Hz, 1H), 1.42-1.67 (m, 4H), 
1.78-1.85 (m, 2H), 1.98-2.19 (m, 3H), 2.34 (d, J = 11.6 Hz, 1H), 2.59-2.64 (m, 2H), 2.87-2.97 
(m, 2H), 4.47-4.51 (m, 1H), 8.36 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 16.9, 21.9, 24.4, 25.1, 
26.5, 36.5, 37.6, 37.7, 44.0, 46.9, 57.4, 76.6, 83.8, 119.8, 158.7; IR: 1659, 1385, 1131, 913 cm-1; 
HRMS calcd. for C15H21N2O+ [M+H+]: 245.16539. Found: 245.16486. 
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To a solution of 2.119 (50 mg, 0.23 mmol, 1.0 equiv.) in CH2Cl2 (3 mL) was added Et3N (0.097 
mL, 0.69 mmol, 3.0 equiv.) and methyl chloroformate (36 µL, 0.46 mmol, 2.0 equiv.) at 23 °C. 
After one hour the resulted solution was diluted with saturated NH4Cl solution (10 mL) and 
extracted with EtOAc (3 × 10 mL). The organic extracts were washed with brine (10 mL), dried 
over Na2SO4, filtered and concentrated. The crude material was purified by silica gel 
chromatography (10/1 → 5/1 hexanes/EtOAc) to afford carbamate 2.121 (55 mg, 87%) as yellow 
oil. 
 
2.121: [α]23.0D +30.0° (c 0.20, CH2Cl2); Rf = 0.70 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ 1.00 (d, J = 6.4 Hz, 3H), 1.30 (dt, J = 5.2 and 13.2 Hz, 1H), 1.40 (t, J = 
13.2 Hz, 1H), 1.51-1.63 (m, 2H), 1.70-1.80 (m, 3H), 1.91-1.99 (m, 2H), 2.14-2.19 (m, 1H), 2.51 
(s, 1H), 2.63 (ddd, J = 0.8, 4.0 and 17.2 Hz, 1H), 2.94 (dd, J = 12.0 and 17.2 Hz, 1H), 3.24-3.31 
(m, 2H), 3.64 (s, 3H), 3.91-3.96 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 17.2, 22.0, 24.7, 24.8, 
25.9, 37.4, 37.9, 43.8, 45.6, 45.7, 52.3, 58.2, 75.3, 84.6, 120.3, 156.7; IR: v 2924, 1713, 1384, 
1268 cm-1; HRMS calcd. for C16H23N2O2+ [M +H+]: 275.1759. Found: 275.1753. 
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To a solution of secondary amine 2.119 (100 mg, 0.46 mmol, 1.0 equiv.) in THF (5 mL) solid 
DMAP (56 mg, 0.46 mmol, 1.0 equiv.) was added following by Et3N (0.30 mL, 2.3 mmol, 5.0 
equiv.) and neat dimethylcarbamoyl chloride (1.0 mL, 10.2 mmol, 22.0 equiv.) at 23 °C. After 12 
minutes the solution was diluted with saturated NH4Cl solution (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated. The crude material was purified by silica gel chromatography 
(5/1 →  1/1 hexanes/EtOAc) to afford urea 2.122 (96 mg, 72%) as yellow oil. 
 
2.122: [α]23.0D +54.5° (c 0.11, CH2Cl2); Rf = 0.50 (silica gel, hexanes/EtOAc = 1/1); 1H NMR 
(400 MHz, CDCl3): δ 0.78 (t, J = 12.4 Hz, 1H), 0.89 (d, J = 6.4 Hz, 3H), 1.18-1.25 (m, 2H), 
1.42-1.73 (m, 5H), 1.86-1.99 (m, 2H), 2.02-2.08 (m, 1H), 2.50 (s, 1H), 2.55 (ddd, J = 0.8, 4.0 
and 17.2 Hz, 1H), 2.73 (td, J = 2.4 and 12.0 Hz, 1H), 2.84 (brs, 6H), 2.88-2.96 (m, 1H), 3.12 (td, 
J = 2.8 and 12.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 17.3, 21.9, 24.1, 25.6, 26.4, 37.2, 
38.4, 44.0, 46.5, 47.0, 56.3, 85.1, 120.5, 139.8, 163.3; IR: v 2924, 1652, 1385 cm-1; HRMS 
calcd. for C17H26N3O+ [M +H+]: 288.2076. Found: 288.2068. 
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To a solution of 2.119 (200 mg, 0.93 mmol, 1.0 equiv.) in CH2Cl2 (10 mL) was added neat acetyl 
chloride (0.20 mL, 0.28 mmol, 3.0 equiv.) and neat triethylamine (0.28 mL, 0.20 mmol, 2.0 
equiv.) at 50 °C. After 2 h the resulted solution was diluted with saturated NH4Cl solution (10 
mL) and extracted with EtOAc (3 × 15 mL). The combined organic extracts were washed with 
brine (10 mL), dried over Na2SO4, filtered and concentrated to amide 2.123 (178 mg, 78%) as 
yellow oil. 
 
2.123: [α]23.0D +22.5° (c 0.80, CH2Cl2); Rf = 0.40 (silica gel, hexanes/EtOAc = 1/1); 1H NMR 
(400 MHz, CDCl3): δ 0.97 (d, J = 6.0 Hz, 3H), 1.24-1.33 (m, 2H), 1.52-1.59 (m, 1H), 1.63-1.71 
(m, 1H), 1.76-1.97 (m, 5H), 2.08 (s, 3H), 2.14-2.20 (m, 1H), 2.50 (s, 1H), 2.65 (ddd, J = 1.2, 4.0 
and 17.2 Hz, 1H), 2.95 (dd, J = 11.6 and 17.2 Hz, 1H), 3.34-3.42 (m, 2H), 3.52-3.58 (m, 1H); 
13C NMR (100 MHz, CDCl3): δ 17.3, 21.8, 24.3, 24.6, 24.6, 25.6, 37.3, 38.0, 43.9, 44.4, 44.8, 
58.1, 75.0, 84.5, 120.2, 172.1; IR: v 3216, 1650, 1390 cm-1; HRMS calcd. for C16H23N2O+ [M 
+H+]:259.1810. Found: 259.1807. 
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To a solution of 2.119 (15 mg, 69 μmol, 1.0 equiv.) in THF (3 mL) was added pyridine (17 μL, 
0.21 mmol, 3.0 equiv.) and acid chloride int-21 (19 μL, 0.14 mmol, 2.0 equiv.) and the solution 
was placed in a 50 °C oil bath. After 3 hours the solution was diluted with saturated NH4Cl 
solution (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were 
washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated to afford amide 2.125 
(11 mg, 49%) as yellow oil. 
 
2.125: [α]23.0D -11.4° (c 0.35, CH2Cl2); Rf = 0.38 (silica gel, hexanes/EtOAc = 1/1); 1H NMR 
(400 MHz, CDCl3): δ 1.00 (d, J = 6.4 Hz, 3H), 1.35 (dt, J = 5.2 and 13.2 Hz, 1H), 1.41 (t, J = 
13.2 Hz, 1H), 1.59-1.63 (m, 1H), 1.70-1.87 (m, 3H), 1.94-2.09 (m, 3H), 2.20-2.24 (m, 1H), 2.59 
(s, 1H), 2.69 (ddd, J = 0.8, 4.0 and 17.2 Hz, 1H), 2.99 (dd, J = 12.0 and 17.2 Hz, 1H), 3.22-3.29 
(m, 1H), 3.50 (dt, J = 2.4 and 12.8 Hz, 1H), 3.61-3.66 (m, 1H), 7.34 (ddd, J = 1.2, 4.8 and 8.8 
Hz, 1H), 7.69 (dt, J = 1.2 and 7.6 Hz, 1H), 7.79 (dt, J = 2.0 and 7.6 Hz, 1H), 8.59 (dq, J = 1.2, 
and 5.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 17.3, 21.9, 24.6, 24.7, 25.7, 37.5, 38.0, 44.1, 
45.2, 46.4, 58.2, 75.7, 84.2, 120.3, 124.1, 124.9, 137.2, 148.6, 155.0, 171.5; IR: v 2926, 1650, 
1384 cm-1; HRMS calcd. for C20H24N3O+ [M +H+]: 322.1919. Found: 322.1915. 
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To a solution of 2.119 (50 mg, 0.23 mmol, 1.0 equiv.) in CH2Cl2 (3 mL) was added trifloroacetic 
anhydride (64 μL, 0.46 mmol, 2.0 equiv.) and triethylamine (0.097 mL, 0.69 mmol, 3.0 equiv.) at 
23 °C. After 30 minutes the solution was diluted with saturated NH4Cl solution (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 
mL), dried over Na2SO4, filtered, and concentrated to afford amide 2.124 (23 mg, 32%) as white 
foam. 
 
2.124: [α]23.0D +58.0° (c 0.50, CH2Cl2); Rf = 0.55 (silica gel, hexanes/EtOAc = 4/1); 1H NMR 
(400 MHz, CDCl3): δ 1.00 (d, J = 6.4 Hz, 3H), 1.28-1.42 (m, 2H), 1.58-1.66 (m, 1H), 1.69-1.77 
(m, 1H), 1.81-2.00 (m, 5H), 2.18-2.24 (m, 1H), 2.61 (s, 1H), 2.67 (ddd, J = 1.2, 4.0 and 16.8 Hz, 
1H), 2.92 (dd, J = 12.0 and 16.8 Hz, 1H), 3.25 (dt, J = 2.8 and 13.2 Hz, 1H), 3.47-3.54 (m, 1H), 
3.65-3.71 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 17.2, 21.8, 24.0, 24.5, 24.7, 37.2, 37.8, 
42.80, 42.84, 43.9, 44.4, 60.1, 82.8, 116.4 (t, J = 288.7 Hz), 119.9, 157.0 (t, J = 34.9 Hz); IR: v 
3265, 2956, 1689, 1184 cm-1; HRMS calcd. for C16H20N2OF3+ [M +H+]:313.1528. Found: 
313.1523. 
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In a pressure tube alkyne-nitrile 2.122 (11 mg, 38 μmol, 1.4 equiv.) and pyridyl-alkyne 2.80 (12 
mg, 28 μmol, 1.0 equiv.) were dissolved in degassed dioxane (2.5 mL). Neat CpCo(CO)2 (5 µL, 
41 μmol, 1.7 equiv.) and triphenylphosphine (44 mg, 0.17 mmol, 6.0 equiv.) were added and the 
tube was sealed. The resulting solution was placed in an oil bath heated to 140 °C for 24 hours. 
The mixture was cooled and the solvent was removed. The product was purified by silica gel 
chromatography (20/1 to 2/1 hexanes/EtOAc) to afford bipyridyl 2.128 (4.5 mg, 22%) and 
bipyridyl 2.129 (4.1 mg, 20%) both yellow oils. 
 
2.128: [α]23.0D +62.2° (c 0.45, CH2Cl2); Rf = 0.50 (silica gel, hexanes/EtOAc = 5/1); 1H NMR 
(400 MHz, CDCl3): δ  0.14 (s, 9H), 0.74 (d, J = 5.6 Hz, 3H), 0.79 (d, J = 5.6 Hz, 3H), 1.15-1.61 
(m, 11 H), 1.72-2.05 (m, 8 H), 2.12 (brs, 2H), 2.21-2.25 (m, 1H), 2.50-2.54 (m, 2H), 2.72-2.88 
(m, 3H), 3.02 (s, 6H), 3.05-3.09 (m ,1H), 3.18-3.27 (m, 2H), 4.12 (d, J = 14.4 Hz, 1H), 4.24 (d, J 
= 14.4 Hz, 1H), 7.24-7.27 (m, 1H), 7.36 (t, J = 7.2 Hz, 2H), 7.50 (d, J = 7.2 Hz, 2H), 7.78 (d, J = 
8.0 Hz, 1H), 8.20 (d, J = 8.0 Hz, 1H), 8.38 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 1.0, 14.7, 
21.4, 22.2, 22.3, 25.0, 26.1, 26.5, 26.6, 27.2, 28.5, 31.6, 33.9, 34.1, 35.1, 37.7, 38.8, 41.2, 43.6, 
43.9, 45.4, 45.9, 46.4, 48.1, 51.1, 60.4, 61.5, 121.1, 126.5, 128.0, 128.2, 130.7, 134.2, 135.2, 
137.4, 142.5, 143.3, 156.9, 157.0, 157.9, 160.2, 164.2; IR: v 2919, 1649, 1384 cm-1; HRMS 
calcd. for C45H62N5OSi+ [M +H+]: 716.4724. Found: 716.4721. 
 
2.129: [α]23.0D +27.4° (c 0.73, CH2Cl2); Rf = 0.40 (silica gel, hexanes/EtOAc = 5/1); 1H NMR 
(400 MHz, CDCl3): δ  0.12 (s, 9H), 0.78 (d, J = 5.6 Hz, 3H), 0.80 (d, J = 5.6 Hz, 3H), 0.83-0.88 
(m, 1H), 0.96 (d, J = 6.4 Hz, 1H), 1.18-1.59 (m, 13H), 1.71-1.79 (m, 2H), 1.92-2.01 (m, 2H), 
2.13 (brs, 2H), 2.39-2.43 (m, 1H), 2.53-2.55 (m, 2H), 2.76 (t, J = 18.8 Hz, 2H), 2.92-3.10 (m, 
8H), 3.16-3.29 (m, 2H), 4.11 (d, J = 14.4 Hz, 1H), 4.25 (d, J = 14.4 Hz, 1H), 7.25-7.27 (m, 1H), 
7..34-7.38 (m, 3H), 7.50 (d, J = 7.2 Hz, 2H), 8.14-8.17 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 
0.26, 14.1, 21.3, 22.3, 22.4, 25.3, 26.0, 26.5, 26.8, 27.2, 31.6, 34.1, 34.2, 34.7, 35.25, 35.30, 38.8, 
43.0, 43.6, 43.9, 45.5, 46.0, 46.2, 48.1, 51.1, 60.3, 61.8, 121.1, 126.5, 128.0, 128.2, 133.6, 133.9, 
135.1, 136.4, 141.2, 142.6, 156.9, 157.4, 157.6, 163.5, 164.0; IR: v 3446, 2918, 1652, 732 cm-1; 
HRMS calcd. for C45H62N4OSi+ [M +H+]: 716.4724. Found: 716.4727 
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In a pressure tube pyridyl alkyne 2.80 (15.6 mg, 36 μmol, 1.0 equiv.), alkyne-nitrile 2.120 (12.9 
mg, 52 μmol, 1.4 equiv.), and triphenylphosphine (79 mg, 0.30 mmol, 8.4 equiv.) were dissolved 
in freshly-degassed dioxane (8 mL).  Neat CpCo(CO)2 (10 μL, 80 μmol, 2.2 equiv.) was added 
and the tube was sealed.  The resulting solution was placed in a 140 °C oil bath. After 24 hours 
the reaction was cooled to 23 °C and concentrated.  The crude material was purified by silica gel 
chromatography (20/1 → 2/1 hexanes/EtOAc) to afford bipyridyls 2.130 (10.2 mg, 42%) and 
2.131 (3.4 mg, 14%) both as yellow oils. 
 
2.182: [α]24D +26.6° (c 0.50, CH2Cl2); Rf = 0.35 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ 0.12 (s, 9H), 0.74 (d, J = 6.0 Hz, 3H), 0.90 (d, J = 6.0 Hz, 3H), 1.15-1.18 
(m, 1H), 1.24-1.32 (m, 4H), 1.35-1.69 (m, 10H), 1.74-1.84 (m, 4H), 1.93-1.96 (m, 2H), 2.05 (s, 
1H), 2.11-2.15 (m, 1H), 2.21-2.32 (m, 1H), 2.52-2.54 (m, 1H), 2.76 (d, J = 40.0 Hz, 1H), 2.82 (d, 
J = 40.4 Hz, 1H), 3.20-3.31 (m, 2H), 4.18 (dd, J = 13.6 and 54.8 Hz, 2H), 4.55-4.59 (m, 1H), 
7.36 (t, J = 7.2 Hz, 2H), 7.46-7.53 (m, 2H), 7.59 (s, 1H), 7.55-7.70 (m, 1H), 7.80 (d, J = 8.0 Hz, 
1H), 8.23 (d, J = 8.0 Hz, 1H), 8.72 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 0.8, 21.2, 22.2, 22.3, 
25.4, 25.8, 26.5, 26.7, 27.2, 33.6, 34.0, 35.0, 35.1, 37.2, 38.6, 42.8, 43.8, 44.2, 45.8, 46.5, 48.1, 
51.0, 60.4, 61.8, 121.0, 126.5, 128.0, 128.2, 128.5, 131.4, 131.9, 135.3, 137.9, 140.6, 142.3, 
156.4, 157.3, 160.5, 161.3; IR: v 1653, 1386, 838 cm-1; HRMS calcd. for C43H57N4OSi+ 
[M+H+]: 673.43016. Found: 673.43002. 
 
2.183: [α]24D +35.2° (c 0.40, CH2Cl2); Rf = 0.28 (silica gel, hexanes/EtOAc = 2/1); 1H NMR 
(400 MHz, CDCl3): δ 0.09 (s, 9H), 0.79 (d, J = 6.4 Hz, 3H), 0.89 (d, J = 6.4 Hz, 3H), 1.18-1.65 
(m, 11H), 1.71-1.87 (m, 5H), 1.93-1.98 (m, 2H), 2.13-2.16 (m, 1H), 2.22-2.24 (m, 1H), 2.29-2.42 
(m, 2H), 2.51-2.55 (m, 2H), 2.73 (d, J = 18.8 Hz, 1H), 2.87 (d, J = 18.8 Hz, 1H), 2.96-3.12 (m, 
1H), 3.21-3.29 (m, 2H), 4.18 (dd, J = 14.4 and 64.8 Hz, 2H), 4.50-4.54 (m, 1H), 7.19 (d, J = 8.0 
Hz, 1H), 7.23-7.27 (m, 1H), 7.34-7.38 (m, 3H), 7.49 (d, J = 7.6 Hz, 2H), 8.18 (d, J = 8.0 Hz, 
1H), 8.66 (s, 1H); 13C NMR (100 MHz, CDCl3): δ -0.1, 0.8, 21.1, 22.2, 22.4, 25.4, 25.8, 26.5, 
26.6, 27.2, 33.7, 34.1, 34.9, 35.3, 37.3, 38.5, 42.8, 43.8, 44.2, 45.9, 46.4, 48.2, 50.9, 60.3, 62.0, 
121.6, 126.5, 128.0, 128.2, 131.0, 131.4, 135.1, 137.2, 142.1, 142.4, 155.9, 156.6, 157.9, 160.6, 
164.8; IR: v 1657, 1652, 1386, 839, 733 cm-1; HRMS calcd. for C43H57N4OSi+ [M+H+]: 
673.43016. Found: 673.43030. 
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To a solution of bipyridyl 2.130 (36 mg, 0.053 mmol, 1.0 equiv.) in dioxane (1 mL) was added 
TBAF solution (1.0 M in THF, 200 µL, 0.20 mmol, 3.8 equiv.) and the mixture was placed in a 
120 ºC oil bath. After 10 hours the solution was cooled to 23 °C, diluted with saturated NH4Cl 
solution (10 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic extracts were 
washed with brine (5 mL), dried over Na2SO4, filtered, and concentrated.  The crude material 
was purified by silica gel chromatography (20/1 → 1/1 hexanes/EtOAc) to afford amine 2.132 
(32.0 mg, 99%) as dark yellow oil. 
 
2.132: [α]24D +35.1° (c 0.40, CH2Cl2); Rf = 0.22 (silica gel, hexanes/EtOAc = 1/1); 1H NMR 
(400 MHz, CDCl3): δ 0.69 (d, J = 6.0 Hz, 3H), 0.82 (d, J = 6.4 Hz, 3H), 1.09-1.38 (m, 6H), 1.43-
1.80 (m, 12H), 1.88 (td, J = 3.6 and 12.8 Hz, 1H), 1.97-2.09 (m, 2H), 2.17-2.27 (m, 2H), 2.41-
2.45 (m, 2H), 2.72 (dd, J = 19.2 and 30.8 Hz, 2H), 3.18-3.27 (m, 2H), 4.11 (dd, J = 14.8 and 68.0 
Hz, 2H), 4.48-4.52 (m, 1H), 7.18-7.20 (m, 1H), 7.27-7.31 (m, 2H), 7.41-7.45 (m, 3H), 7.83 (d, J 
= 2.4 Hz, 1H), 8.15 (d, J = 12.0 Hz, 1H), 8.68 (s, 1H), 8.89 (d, J = 2.4 Hz, 1H); 13C NMR (100 
MHz, CDCl3): δ 21.0, 22.1, 22.4, 25.4, 25.9, 26.5, 26.7, 27.1, 33.5, 34.0, 34.9, 35.5, 37.5, 38.5, 
42.8, 43.7, 44.1, 45.8, 46.3, 48.2, 50.9, 60.4, 61.9, 118.9, 126.5, 128.0, 128.2, 131.5, 133.4, 
134.4, 135.4, 137.7, 142.3, 146.7, 151.7, 157.8, 159.3, 160.5; IR: v 1653, 1443, 1385, 733 cm-1; 
HRMS calcd. for C40H49N4O+ [M+H+]: 601.39064. Found: 601.39037. 
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To a solution of amine 2.132 (35 mg, 0.058 mmol, 1.0 equiv.) in methanol (1 mL) solid 5% 
palladium on carbon (20 mg) was added then rapidly stirred under H2 (1 atm) at 23 °C.  After 8 
hours the solution was filtered through a celite pad and concentrated to afford formamide 2.133 
(22.6 mg, 78 %) as pale brown oil. 
 
2.133: [α]24D +25.2° (c 0.40, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 0.81 (d, J = 6.4 Hz, 3H), 
0.90 (d, J = 6.4 Hz, 3H), 1.24-1.45 (m, 7H), 1.53-1.57 (m, 1H), 1.62-1.70 (m, 6H), 1.78-1.86 (m, 
4H), 2.04-2.09 (m, 2H), 2.24-2.31(m, 3H), 2.66-2.73 (m, 1H), 2.80-2.86 (m, 2H), 3.10-3.34 (m, 
3H), 4.57 (d, J = 5.6 Hz, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.93 (s, 1H), 8.28 (bs, 1H), 8.74 (s, 1H), 
8.93 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 21.5, 22.1, 24.6, 25.4, 25.9 (two peaks very close), 
26.7, 32.9, 33.4, 34.9, 35.0, 37.5, 40.7, 41.4, 42.5, 42.7, 44.1, 44.4, 46.3, 47.4, 60.7, 61.9, 119.3, 
131.6, 133.7, 134.7, 146.6, 153.4, 158.6, 158.8, 160.5, 170.0, 188.6; IR: v 3419, 1652, 1575, 
1262, 910, 731 cm-1; HRMS calcd. for C33H43N4O+ [M+H+]: 511.34369. Found: 511.34377. 
 
 
 117 
 
 
 
Formamide 2.133 (22.6 mg, 0.044 mmol, 1.0 equiv.) was dissolved in MeOH/HCl (conc.) 
solution (12/1, 1mL) and the reaction flask was placed in an oil bath heated to 50 °C.  
After 10 hours the solution was cooled to 23 °C, the acid was quenched with aqueous 
saturated NaHCO3 solution (5 mL), and extracted with EtOAc (3 × 5 mL).  The 
combined organic extracts were washed with brine (5 mL), dried over Na2SO4, filtered, 
and concentrated to afford crude complanadine A (1.2) (21.3 mg) as pale pink oil.   
 
Additional purification was achieved as follows: from above complanadine A (1.2) (12 
mg, 0.025mmol, 1 equiv.) was dissolved in aqueous 5% HCl solution (5 mL) and washed 
with Et2O (2 × 5 mL), the aqueous layer was adjusted to a pH 13 with aqueous 10% 
NaOH solution, and the opaque solution was extracted with EtOAc (3 × 5 mL).  The 
combined organic extracts were washed with brine (5 mL), dried over Na2SO4, filtered, 
and concentrated to provide complanadine A (1.2) (10.8 mg, 90%) as colorless oil. 
 
Complanadine A (1.2): [α]24D +14.5° (c 0.30, MeOH); 1H NMR (400 MHz, MeOH): δ 
0.85 (d, J = 6.4 Hz, 3H), 0.86 (d, J = 6.4 Hz, 3H), 1.21-1.49 (m, 10H), 1.53-1.64 (m, 5H), 
1.68-1.72 (m, 1H), 1.75-1.81 (m, 2H), 1.85-1.89 (m, 2H), 2.18-2.22 (m, 2H), 2.48-2.57 
(m, 2H), 2.76-2.85 (m, 4H), 3.20-3.30 (m, 2H), 7.77 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 8.0 
Hz, 1H), 8.48 (s, 1H), 8.93 (s, 1H); 13C NMR (100 MHz, MeOH): δ 22.4, 27.1, 27.3, 
27.7, 34.8, 34.9, 35.7, 36.2, 42.1, 44.7, 44.8, 44.9, 51.6, 51.7, 57.8, 57.9, 120.4, 133.7, 
135.0, 135.9, 136.6, 137.6, 146.1, 153.7, 159.9, 160.5; IR: v 2913, 1575, 1436 cm-1; 
HRMS calcd. for C32H43N4+ [M+H+]: 483.34877. Found: 483.34828. 
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We have found the optical rotation of complanadine A changes as the molecule 
transitions from the free base form to protonated forms. 
Effects of acid addition on rotation: 
–19.0° complanadine A free base 
–9.5°   complanadine A free base with 2 equiv TFA 
–4.7°   complanadine A free base with 4 equiv TFA 
+2.4°  complanadine A free base with 6 equiv TFA 
and +10.5° complanadine A free base with 6 equiv HCl
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Acid comparison: 
 
Full acid added: 
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4ul acid added  
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Synthetic complanadine A: 
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Isolated complanadine A: 
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Spectra overlay (synthetic over isolated):
 
 196 
 
 
 197 
 
CHAPTER 3 Dihydroxylation of Alkenes Using Phthaloyl Peroxide 
 198 
 
3.1 Introduction 
 
The large-scale preparation of diols from alkenes is one of the major transformations 
used in industrial chemistry. The production levels of the two major glycols, ethylene glycol (14 
million tons/ year) and propylene glycol (1.4 million tons/year), highlight their importance.1,2 
Currently, the industrial production of diols occurs through a two-stage process;3 oxidation of the 
parent alkene to the corresponding epoxide followed by a subsequent hydration step. Although 
the epoxidation step has been optimized, a significant amount of waste (>10%) is routinely 
generated during the epoxide hydrolysis reaction. Besides ethylene and propylene glycol a 
variety of other vicinal diols are used as solvents and starting materials for polymers, fine 
chemicals, pharmaceuticals, cosmetics, and cleaners. To date, the direct dihydroxylation of 
alkenes for the large-scale production of diols has not been feasible.  
Phthaloyl peroxide 3.2 had previously been examined as a reagent for the 
dihydroxylation of alkenes (Figure 3.1). The reaction of phthaloyl peroxide 3.2 with alkenes, 
primarily stilbenes and styrenes, was studied by Greene and coworkers generating the 
corresponding five and eight membered lactones.3,4 These can be readily hydrolyzed to generate 
diol products. Recently a related derivative, cyclopropylmalonyl peroxide, was found to have 
similar reactivity, generating diol products from stilbenes and styrenes.5 We sought to investigate 
the ability of the intermediate lactones to undergo reaction a reaction with hydrogen peroxide in 
the presence of base to regenerate the starting phthaloyl peroxide and thus allow a catalytic 
cycle. 
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Figure 3.1. Proposed catalytic phthaloyl peroxide 3.2 mediated dihydroxylation. 
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3.2 Optimized Phthaloyl Peroxide Synthesis 
 
Use of the existing methods for the synthesis of phthaloyl peroxide 3.2 were unreliable 
and frequently generated explosive by-products.6 After screening numerous hydrogen peroxide 
sources we found the used of sodium percarbonate Na2CO3•H2O2 in dichloromethane proved 
optimal.7 (Scheme 3.1). These conditions allowed the synthesis phthaloyl peroxide 3.2 and 
related derivatives on the gram scale. Recrystallization was possible yielding high purity 
phthaloyl peroxide 3.2 using pentane-benzene mixtures. A series of phthaloyl peroxide 
derivatives were prepared and found to have variable stabilities declining from 3.6 to 3.16. 
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Scheme 3.1: The synthesis of phthaloyl peroxide 3.2 and related derivatives. 
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3.3 Scope and Generality of Phthaloyl Peroxide Derivatives in the 
Dihydroxylation of alkenes 
With access to phthaloyl peroxide 3.7 we examined its reactivity with stilbene 3.17 
(Table 3.1). From the study 3,4-dichloro phthaloyl peroxide 3.7 was selected for additional 
investigations as it possesses a good combination of reactivity, availability, and, interestingly, 
stability. We found, in general, the unsymmetric peroxides had lower stability, possibly as result 
of polarizing the molecule. 
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Table 3.1. Reaction of phthaloyl peroxide derivatives with stilbene 3.17. 
 
 204 
 
The scope and generality of the reaction, to date, is shown in Table 3.2. The phthaloyl 
peroxide 3.7 can react with stilbene, indene and styrene derivatives in efficient yield and good 
stereoselectivities. The reaction was also extended to cycloalkenes to give diol product such as 
3.52, 3.53, 3.54 in variable yield. This was the first instance of isolated olefins (without 
conjugation to an arene) undergoing reaction with a phthaloyl peroxide. 
Table 3.2. Dichlorophthaloyl peroxide 3.7 mediated dihydroxylation of alkenes. 
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As the synthesis of phthaloyl peroxide 3.2 seemed to be inconsistent we examined the 
effects that water has on the reaction. We found the used of dichloromethane that was “wet” 
provided the most consistent results. This “wet” solvent can be easily prepared by combining 
dichloromethane and water, shaking, and separating the dichloromethane layer. Use of this 
pretreated solvent provided the most consistent results. 
Scheme 3.2.  Role of water in phthaloyl peroxide 3.2 synthesis and failed efforts for 
dihydroxylation. 
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3.4 Conclusion 
The development of a new, general synthesis of phthaloyl peroxide and related 
derivatives allowed the testing of several new reagents for their ability to oxidatively 
functionalize alkenes. For the first time the reaction of phthaloyl peroxide and isolated olefins 
was possible. With a better understanding of the reactivity of phthaloyl peroxide additional 
studies focused on the hydroxylation of arenes was made possible.  
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3.6 Experimental Section 
 
Representative procedure for phthaloyl peroxide synthesis: 
 
 
To a solution of phthaloyl chloride 3.6 (0.40 g, 1.5 mmol, 1.0 equiv) in CH2Cl2 (25 mL), 
solid sodium percarbonate (Aldrich available H2O2: 20-30%) (0.34 g, 2.2 mmol, 1.5 
equiv) was added in one portion. The heterogeneous reaction mixture was stirred 
vigorously for 3 hours (rapid stirring is required).  The reaction mixture was filtered 
through celite and concentrated to provide the phthaloyl peroxide 3.2 as white solid (0.27 
g, 78%) matching existing characterization data.1 
 
m-Chlorophthaloyl Peroxide 3.14 
 
Following the representative procedure peroxide 3.14 was prepared as a white solid 
(69%). This compound will slowly decompose. If necessary, recrystallization from 
benzene/hexanes can be performed. 
m.p. 63.5-64.5 oC decomposition. 1H NMR (400 MHz, CDCl3): δ 8.26 (m, 1H), 8.22 (d, 
J = 8.0 Hz, 1H), 7.97 (dd, J = 1.5 and 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 
161.2, 161.0, 143.9, 136.8, 131.7, 130.0, 125.0, 121.8;IR v 3447, 1749, 1635 cm-1; 
HRMS calcd. for C8H3O4Cl+ [M]+: 197.9720. Found:197.9719.  
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o-Fluorophthaloyl Peroxide 3.12 
 
 
Following the representative procedure the peroxide 3.12 was synthesized as a white 
solid (67%).  This compound will slowly decompose. If necessary, recrystallization from 
benzene/hexanes can be performed. 
m.p. 57.5-58.5 oC. 1H NMR (400 MHz, CDCl3): δ 8.40 (dd, J = 2.4 and 8.8 Hz, 1H), 
7.94 (dd, J = 2.4 and 7.8 Hz, 1H), 7.70 (dt, J = 2.4 and 8.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 161,1, 161.0, 133.7, 133.6, 124.5, 124.3, 117.1, 116.9; IR v 3083, 1761, 1607 
cm-1; HRMS calcd. for C8H3O4F+ [M]+: 182.0015. Found:182.0014.  
 
m-Nitrophthaloyl Peroxide 3.16 
 
Following the representative procedure peroxide 3.16 was prepared as pale yellow oil 
(68%). This compound quickly decompose at 23 °C and must be used directly.  
1H NMR (400 MHz, CDCl3): δ 9.08 (d, J = 2.4 Hz, 1H), 8.80 (dd, J = 2.4 and 8.4 Hz, 
1H), 8.52 (d, J = 8.4 Hz, 1H); IR v 3111, 1784, 1757, 1541 cm-1. 
 
o-Fluorophthaloyl Peroxide 3.10 
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Following the representative procedure peroxide 3.10 was prepared as a white solid 
(76%). This compound will slowly decompose.  If necessary, recrystallization from 
benzene/hexanes can be performed. 
m.p. 133.2-134.5 oC, decomposition. 1H NMR (400 MHz, CDCl3): δ 8.13 (d, J = 8.4 Hz, 
1H), 8.03 (dt, J = 4.8 and 8.4 Hz, 1H), 7.14 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 
163.3, 160.6, 138.7, 138.6, 126.6, 125.2, 124.9, 124.7; IR v 1786, 1748, 1291, 906 cm-1; 
HRMS calcd. for C8H3O4F+ [M]+: 182.0015. Found:182.0014.  
 
3,4-Dichlorophthaloyl Peroxide 3.8 
 
Following the general procedure, the peroxide 3.8 (0.5 g, 1.83 mmol) was synthesized as 
a white solid (333 mg, 78%).  This compound displayed improved stability relative to the 
other peroxides. If necessary, recrystallization from benzene/hexanes can be performed. 
 
m.p. 89-91 oC, decomposition. 1H NMR (400 MHz, CDCl3): δ 8.38 (s, 2H); 13C NMR 
(100 MHz, CDCl3): δ 160.4, 142.4, 131.8, 122.6; IR v 1748, 906 cm-1; HRMS calcd. for 
C8H4O4Cl2+ [M]+: 231.9330. Found:231.9331 .  
 
Representative dihydroxylation procedure: 
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Procedure 1 (synthesis of lactones): Solid trans-stilbene (40.0 mg, 0.22 mmol, 1.0 eq) 
and 3, 4-dichlorophthaloyl peroxide 3.7 (80 mg, 0.34 mmol, 1.5 eq) were dissolved in 
dichloroethane (4 mL) and placed in an oil bath at 80 °C under nitrogen.  After stirring 
for 8 hours the reaction mixture was cooled to 23 °C, diluted with sat. Na2CO3 (aq., 10 
mL) and sat. Na2S2O3 (aq., 10 mL), and extracted with EtOAc (3 × 10 mL).  The organic 
extracts were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated. 
The crude material was purified by silica gel chromatography (hexanes:EtOAc 20:1 to 
5:1) to afford the eight-membered ring product 3.23 (20 mg, 22%) as light yellow oil and 
five-membered ring product 3.24 as a white solid (42 mg, 46%).  
 
Lactone 3.23: 
Rf  Hexanes:EtOAc = 5:1, 0.85. 1H NMR (400 MHz, CDCl3): δ 7.90 (s, 2H), 7.31-7.43 
(m, 10H), 6.16 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 168.8, 137.1, 134.1, 133.6, 
130.5, 129.3, 128.8, 127.4, 89.8; IR v 3034, 1740, 1259 cm-1; HRMS calcd. for 
C23H18O5Cl2Na+ [M+Na]+: 435.0167. Found:435.0161.  
Lactone 3.24: 
Rf  (Hexanes:EtOAc = 5:1) 0.79; m.p. 89.5-90.5 °C; 1H NMR (400 MHz, CDCl3): δ 8.00 
(s, 2H), 7.31-7.43 (m, 10H), 5.41 (d, J = 11.2 Hz, 1H), 5.24 (d, J = 11.2 Hz, 1H); 13C 
NMR (100 MHz, CDCl3): δ 175.3, 163.8, 140.9, 139.9, 137.2, 135.2, 133.9, 129.4, 
129.2, 128.9, 128.2, 127.0, 126.9, 126.5, 125.4, 123.3, 88.4, 86.5; IR v 3384, 1789, 1304  
cm-1;  HRMS calcd. for C23H18O5Cl2Na+ [M+Na]+: 435.0167. Found:435.0161. 
 
 
Procedure 2 (synthesis of diols): Solid trans-stilbene (40.0 mg, 0.22 mmol, 1.0 eq) and 
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3,4-dichlorophthaloyl peroxide (80 mg, 0.34 mmol, 1.5 eq) were dissolved in DCE (4 
mL) and placed in an oil bath at 80 °C under nitrogen. After stirring for 8 hours the 
reaction mixture was cooled to 23 °C and the solvent was removed under reduced 
pressure.  The residue was dissolved in MeOH (3 ml) and H2O (0.15 mL) and K2CO3 
(123 mg, 0.89 mmol, 4 eq) were added resulting in a heterogeneous mixture that was 
vigorously stirred for 10 hours. The reaction was diluted with EtOAc (10 mL).  The 
organic layer was collected and dried over Na2SO4.  After filtration, the solvent was 
removed under reduced pressure.  The resulting residue was purified by column 
chromatography on silica (hexanes:EtOAc 10:1 to 1:1) to afford (±)-hydrobenzoin 3.34 
(34.2 mg, 72%, syn:anti = 19:1).  
 
 (±)-Hydrobenzoin 3.35 
 
Dihydroxylation was performed according to procedure 2 (yield 72%).  The 
diastereoselectivity ratio was syn:anti = 20:1.  Analytical data matched literature.2 
 
(±)-1,2-Di-4-bromophenylethane-1,2-diol 3.36 
 
Dihydroxylation was performed according to procedure 2 (yield 74%).  The 
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diastereoselectivity ratio was syn:anti = 20:1.  Analytical data matched literature.2 
 
meso-Hydrobenzoin 3.37 
 
Dihydroxylation was performed according to procedure 2 (yield 72%).  The 
diastereoselectivity ratio was syn:anti = 3:1.  Analytical data matched literature.2 
 
1-Phenylpropane-1,2-diol 3.48 
 
Dihydroxylation was performed according to procedure 2 (yield 40%).  The 
diastereoselectivity ratio was syn:anti = 7.5:1. Analytical data matched literature.2 
 
1-Phenylethane-1,2-diol 3.39 
 
Dihydroxylation was performed according to procedure 2 (yield 46%). Analytical data 
matched literature.2 
 
1-(4-Methoxyphthyl)ethane-1,2-diol 3.40 
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Dihydroxylation was performed according to procedure 2 (yield 56%). Analytical data 
matched literature.2 
 
 
 
1-(4-Chlorophenyl)ethane-1,2-diol 3.44 
 
Dihydroxylation was carried out according to general procedure 2 (yield 51%). All the 
experimental data matched with literature.2 
 
 
1-(3-Chlorophenyl)ethane-1,2-diol 3.39 
HO OH
3.39
Cl
 
Dihydroxylation was performed according to procedure 2 (yield 40%). Analytical data 
matched literature.3 
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1-(2-Chlorophenyl)ethane-1,2-diol 3.42 
 
Dihydroxylation was performed according to procedure 2 (yield 39 %). Analytical data 
matched literature.2 
1-(4-Methylphenyl)ethane-1,2-diol 3.47 
 
Dihydroxylation was performed according to procedure 2 (yield 65 %). Analytical data 
matched literature.2 
 
1-(3-Methylphenyl)ethane-1,2-diol 3.46 
 
Dihydroxylation was performed according to procedure 2 (yield 44 %). Analytical data 
matched literature.2 
1-(2-Methylphenyl)ethane-1,2-diol 3.45 
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Dihydroxylation was performed according to procedure 2 (yield 33 %). Analytical data 
matched literature.2 
 
1-(4-Chlorophenyl)ethane-1,2-diol 3.38 
 
Dihydroxylation was performed according to procedure 2 (yield 32 %). Analytical data 
matched literature.2 
 
 
1-(4-tert-Butylphenyl)ethane-1,2-diol 3.41 
 
Dihydroxylation was performed according to procedure 2 (yield 66%).   
Rf   (Hexanes:EtOAc = 1:1) 0.30;  m.p. 126.5-128.0 °C; 1H NMR (400 MHz, CDCl3): δ 
7.39 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.81 (dd, J = 4.0 and 8.0 Hz, 1H), 3.67-
3.79 (m, 2H), 1.32 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 151.0, 137.5, 125.8, 125.5, 
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74.5, 68.0, 34.5, 31.3; IR v 3409, 2958, 1384  cm-1; HRMS .[M+Na+]+: 217.1204, 
found: 217.1200.  
 
 
Tetrahydro naphthalene 1,2-cis-diol 3.49 
 
Dihydroxylation was performed according to procedure 2 (yield 71%). The 
diastereoselectivity ratio was syn:anti = 4:1. Analytical data matched literature.4 
 
Indane-1,2 –diol 3.50 
 
Dihydroxylation was performed according to procedure 2 (yield 45%). The 
diastereoselectivity ratio was syn:anti = >25:1. Analytical data matched literature.2 
 
 
 
 
 
2-Phenyl-cyclohexane-1,2-diol 3.52 
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Dihydroxylation was performed according to procedure 2 (yield 35%). The 
diastereoselectivity ratio was syn:anti = 25:1. Analytical data matched literature.5 
 
1,2-Cyclooctanediol 3.53 
 
Dihydroxylation was performed according to procedure 2 (yield 74%). The 
diastereoselectivity ratio was syn:anti = 25:1. Analytical data matched literature.6  
 
1,2-Cycloheptanediol 3.54 
 
Dihydroxylation was performed according to procedure 2 (yield 44%). The 
diastereoselectivity ratio was syn:anti = 25:1. Analytical data matched literature.6 
 
1-(1-Hydroxyethyl)cyclohexanol 3.51 
 
Dihydroxylation was performed according to procedure 2 (yield 67%). The 
diastereoselectivity ratio was syn:anti = 25:1. Analytical data matched literature.2 
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3.7 Spectrum: 
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CHAPTER 4 Phthaloyl Peroxide-Mediated Hydroxylation of Arenes.  
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4.1 Introduction 
 
Since the discovery of phenol in 1834 by Runge from coal tar advances have been made 
in synthesizing substituted phenols which are fundamental components in industrial, 
pharmaceutical, and natural occurring compounds.1 Historically, the methods for the synthesis of 
phenols focused on Lewis acid assisted electrophilic aromatic substitutions, radical reactions and 
metal mediated CH functionalization to directly hydroxylate the arene of interest.2 However, 
direct hydroxylation of arenes without pre-functionalized precursors still remains a challenge. 
The methods using Lewis acids or Brønsted acid combined with excess oxidants are limited in 
their substate scope due to the strongly acidic and oxidizing nature of the reaction.3 Transition 
metal catalyzed CH oxidation of arenes with or without a directing group has been developed, 
and the reaction can be accomplished at both sp2- and sp3-CH bonds.4 We have found phthaloyl 
peroxide functions remarkably well converting arenes to phenols, as only the aromatic CH 
bonds are oxidized in the presence of active CH bonds, such as tertiary and benzylic CH 
bonds. In addition the reaction has a high degree of tolerance for a wide array of functional 
groups. This mild, metal-free, and operationally simple method for the aryl-specific 
hydroxylation is also suitable for transformations of complex natural products and late-stage 
synthetic intermediates. In addition to synthetic studies, density functional theory (DFT) 
calculations show that this new reaction proceeds through a diradical mechanism identifying the 
origins of the exclusive selectivity for aromatic CH bonds. 
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4.2 Background of Phenolic Compound Synthesis 
 
In nature, oxidase P450 oxidizes a variety of small molecules to enhance their excretion 
and clearance.  This included the conversion of arenes 4.1 to hydroxyl containing compounds 
including phenols 4.2.5 The reaction of alkanes proceeds through a oxidative process dubbed the 
rebound mechanism (Scheme 4.1). The oxidation processed through Fe (III) coordinated to 
porphyrin and cysteine. In the oxidation sequence, 4.4 is reduced to 4.5 which facilitates oxygen 
approaching to form intermediate 4.6. As the iron-oxygen complex 4.6 is further reduced to 4.7, 
the intermediate will be oxidized to 4.8 with an Fe (V) core. As the substrate is positioned within 
the enzyme it will oxidize it to form 4.3 for the next catalytic cycle in a related process. The 
oxidation of arenes to phenols by P450 enzyme proceeds through the NIH shift, generating the 
phenolic products 4.2 from arenes 4.1 through a 1,2-hydride shift mechanism of the epoxide 
precursor 4.09.6  
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Scheme 4.1. P450 hydroxylation of arenes. 
 
 
An overview of synthetic approaches for the direct synthesis of phenols is shown in 
Scheme 4.2.  In almost all of the examples the oxidant is the limiting reagent, limiting the utility 
of this approach when the substrate is valuable. The reason for this less than ideal stoichiometery 
is that the products of the reactions, phenols, are more reactive than the starting arenes to the 
reaction conditions. Fenton’s reagent has been studied for the hydroxylation of arenes, however, 
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its primary use, waste water purification highlights the challenges using this reagent, namely it is 
an indiscriminate oxidant.7, 8 In addition to problems of over oxidation there are severe 
limitations on the functional group compatibility using these methods.  
Scheme 4.2. Lewis acid mediated hydroxylation of arenes. 
 
Transition metal-catalyzed hydroxylation of arenes have been developed (Scheme 4.3). 
Notable achievements have been accomplished by Crabtree,2e Sanford,4f, g Yu,4h Ritter,4k 
Gevorgyan,4i, j Dong,9 and Rao10.2d In general the hydroxylation reactions use directing groups 
and the hydroxylation occurs at the expected position in good to excellent yields.  
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Scheme 4.3. Transitional metal-catalyzed hydroxylation of arenes. 
 
In industry phenol is prepared through two major processes the cumene process and the 
toluene process (Scheme 4.4).11 In the first flow chart of the cumene oxidation process there are 
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four major steps including oxidation, concentration, cleavage and distillation. In Dow’s 
improved process, toluene is used as the feedstock to reduce cost. 
Scheme 4.4. Cumene and toluene oxidation processes. 
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Additional oxidative approaches have been developed as shown in Scheme 4.5 where a 
Mo complex was used to hydroxylate nitrobenzene 4.33 under heterogeneous condition to give 
the desired product 4.34.12 Wang and coworkers were able to hydroxylate benzene using light 
and oxygen as well.13  
Scheme 4.5. Additional methods for the synthesis of phenols. 
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4.3 Hydroxylation of Arenes to Phenols Using Phthaloyl Peroxide 
 
Following from our studies centered on the dihydroxylation of alkenes the reactions of 
arenes14 with phthaloyl peroxide was examined. The initial substates for the reaction were 
mesitylene and 1,3,5-triisopropyl benzene. Initial success was achieved using dichloroethane as a 
solvent, providing the phthaloylated adduct 4.37 in 35% yield (Figure 4.1). 
 
Figure 4.1. Crystal structure of compound 4.37. 
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Subsequently solvents were systematically investigated to provide optimal conditions for 
the hydroxylation of 4.38. While standard solvents gave low yields of 4.40. Fluorinated solvent 
including trifluoroethanol (TFE) and hexafluoroisopropanol (HFIP) at ambient temperatures 
increased the yield to 97%. The cyclic malonyl peroxide 4.41 was similarly effective (93% yield)  
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Table 4.1. Optimization of the hydroxylation of 4.18 by phthaloyl peroxide 3.2. 
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The new protocol allowed the direct incorporation of hydroxyl groups into a broad range 
of arenes as summarized in Table 4.2. Toluene 4.47 was hydroxylated to give a 1:1 ratio of o-
cresol and p-cresol in 46% yield. Interestingly we did not observe any over oxidized product. 
Compounds 4.48-4.53 reacted well providing the corresponding phenols in 49-99% yield.  
Oxidation of polycyclic aromatic hydrocarbons generated the expected phenolic products 4.54-
4.59 in yields of 63-75%. 
Table 4.2. Hydroxylation of aliphatic substituted arenes 4.45 by phthaloyl peroxide 3.2. 
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We studied the decomposition of phthaloyl peroxide by thermogravimetric analysis 
(Figure 4.2). The therogravimetric data for 3.2 is shown as the red line showed that below 100 ºC 
peroxide 3.2 is stable however above 110 ºC the solid decomposed rapidly. In comparison, the 
peroxide 4.41 was also subjected to TGA (black line). This peroxide was less thermally stable 
but had a gradual decomposition. 
 
 
Figure 4.2. TGA data of peroxides 3.2 and 4.41.  
The oxidation of functionalized arenes is presented in Table 4.2. Aryl halides 4.62 and 
4.63 showed good reactivity providing the desired products in 73% and 63% yield respectively. 
Oxidation of bromide 4.64 or boronate 4.65 showed selectivity favoring hydroxylation on phenyl 
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ring without effecting bromine or boron. Oxidations of anisole and its derivatives also gave 
corresponding products 4.66-4.69 in medium yield (45-62%). Aldehydes and ketones underwent 
oxidation with no evidence of Bayer-Villager oxidation with the products 4.70 or 4.71 formed in 
good yields.15 Even alkenes were inert under the reaction conditions as 4.76 was generated in 
51% yield with 16% recovered starting material.  
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Table 4.3. Hydroxylation of functionalized arenes by phthaloyl peroxide 3.2. 
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A series of functionalized vanillate derivatives 4.80-4.90 were successfully synthesized to 
showcase the functional group compatibility of peroxide 3.2 (Table 4.4). Alkyl silane 4.82, azide 
4.94, pinacol boronate 4.96 and allene 4.99, were all tolerated under the reaction conditions.  
Table 4.4. Hydroxylation of vanillate derivatives by phthaloyl peroxide 3.2. 
 
Based on the compatibility of functional groups late stage oxidative modification a 
number of complex molecules was investigated. The natural product (+)-γ-tocopherol 4.104 was 
selected based on its biological activity acting as a chemopreventative agent (Scheme 4.6).16 
Reaction of dehydroxy-(+)-γ-tocopherol 4.107 with peroxide 3.2 formed 4.109, 4.110, and 4.111 
in 47% combined yield and returned 23% of the starting material. Reaction of triflate 4.106 
 264 
 
under the same condition generated 4.108 as the sole produced in 54% yield along with 12% of 
4.106 recovered.  
Scheme 4.6. Phthaloyl peroxide 3.2 mediated hydroxylation of tocopherol derivatives. 
 
   Hydroxylation of dehydroabietylamine derivatives is shown in Scheme 4.7. 
Dehydroabietylamine 4.112 and its derivatives possess antiinflammatory activities.17 The 
dehydroabietylamine phenolic derivatives 4.117 was previously synthesized in a three step 
sequences in 69% yield using standard Friedel Crafts/Bayer-Villager chemistry. In comparison, 
substrate 4.115 was reacted under our standard conditions to form phenol 4.117 in 57% yield. 
Comparing the to the original reported protocol,18 the phthaloyl peroxide oxidation avoided the 
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use of excess aluminum reagents and oxidants. The step economy19 was dramatically improved. 
The sulfonyl dehydroabietylamine derivative 4.112 gave products 4.119 and 4.120 in 53% yield. 
The Cbz dehydroabietylamine phenol 4.121 was also prepared in similar yield. 
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Scheme 4.7. Phthaloyl peroxide 3.2 mediated hydroxylation of dehydroabietylamine derivatives. 
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Clovanemagnolol 4.122, isolated from the bark of the bigleaf Magnolina tree, was shown 
to have neuronal growth promoting effects (Scheme 4.8).20 Followed the literature synthesis 850 
mg of precursor 4.124 was prepared and subjected to the phthaloyl peroxide 3.2 mediated 
oxidation and the the hydroxylated product 4.124 was isolated in 42% yield with 37% recovered 
starting material. 
Scheme 4.8. Phthaloyl peroxide 3.2 mediated hydroxylation clovanemagnolol derivative 4.123. 
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While the reaction worked with a variety of functionality the reaction failed with the 
substartes shown in Scheme 4.9. We found that thioether 4.125 was oxidized at sulfur. The acetal 
4.126 was hydrolyzed under the acidic reaction condition. Acid 4.127 has significant purification 
problem. It should also be noted that the iodobenzenes similar to 4.128 or 4.129 are not 
substrates as there is likely oxidation at iodine providing iodoso compounds. Only the electron 
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rich or neutral aromatic compounds were found to be suitable substrates under these reaction 
conditions. Very electron rich compounds such as natural products brucine 4.130 or rotenone 
4.132 provided none of the desired products possibly due to rapid oxidation of the resulting 
phenolic compounds, more a limitation of the compounds themselves. Solubility under the 
reaction conditions was also important as the estrone 4.131, insoluble in the fluorinated alcoholic 
solvent, was recovered from the reaction unchanged (Scheme 4.10). 
Scheme 4.9. Incompatible functional groups for the phthaloyl peroxide-mediated hydroxylation. 
 
Scheme 4.10. Unsuccessful hydroxylation at selected natural product derivatives. 
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4.4 Mechanistic Study of the Hydroxylation of Reaction  
 
It is great honor to collaborate with Yong Liang and K. N. Houk in UCLA, we were able 
to evaluate the reaction mechanism through three different processes. The first process was the 
direct attack of mesitylene 4.16 onto the peroxide through the transition state 4.134. The 
transitional state for 4.134 showed an energy of 35.7 kcal/mol (Scheme 4.11).   
Scheme 4.11. DFT for an ionic mechanism. 
 
In Scheme 4.12 the energy for the direct abstraction of a hydrogen from mesitylene was 
found to be 47.0 kcal/mol, a significant barrier. Being even higher (Scheme 4.13) the mechanism 
going through a single electron transfer was ruled out as 4.141 was computed to lead to an 
energy barrier of 52.9 kcal/mol. 
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Scheme 4.12. DFT analysis of Csp2-H activation mechanism. 
 
Scheme 4.13. DFT analysis of SET mechanism. 
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On the basis of quantum mechanical calculations, this metal-free aromatic C–H oxidation 
most likely occurs through a reverse rebound diradical mechanism (Scheme 4.14). Multiple 
computational tests using density functional theory (DFT) and ab initio methods were 
investigated. The energy required from diradical 4.135 was found to be 8.6 kal/mol with a 21.1 
kcal/mol barrier for the homolysis of the peroxide bond.  
Scheme 4.14. DFT analysis of the reversed rebounded mechanism. 
 
The reaction’s selectivity for aryl C-H bonds relative to benzlic C-H bonds was also 
investigated. The free energy surfaces for reactions of the aromatic and benzylic C–H bonds of 
mesitylene 4.16 with diradical 4.135 from phthaloyl peroxide 3.2 or benzoyloxy radical 4.150 
are shown in Scheme 4.15. As illustrated, the addition of one radical center in 4.135 to the 
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aromatic ring of mesitylene requires a free energy of only 10.0 kcal mol-1. The subsequent 
intramolecular hydrogen transfer is very facile with a barrier of less than 4 kcal mol-1.  
Scheme 4.15. Experimental results and CPCM-(U)B3LYP/6-31+G(d) computed free energy 
surfaces for the functionalization of aromatic and benzylic C–H bonds of 
mesitylene, reaction pathways involving diradical A generated from the thermal  
decomposition of phthaloyl peroxide. 
 
 
The direct hydrogen abstraction to form benzylic radical 4.151 is disfavored, 5.5 kcal 
mol-1 higher than for the aromatic C–H functionalization. This difference accounts for the 
exclusive aryl-selectivity under experimental conditions. By contrast, benzoyloxy radical 4.150, 
formed from benzoyl peroxide, reacts with mesitylene 4.16 to give only the benzylic C–H 
functionalized product under similar conditions. The computed activation energy for the benzylic 
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hydrogen abstraction by benzoyloxy radical (4.150) is 18.9 kcal mol-1.22 In this case, the two-step 
aromatic C–H functionalization is disfavored as the intermolecular hydrogen abstraction in 4.155 
from radical intermediate 4.37 becomes rate-determining with a much higher overall barrier of 
25.8 kcal mol-1. This is in agreement with the experimental fact that benzoyloxy radical mediated 
aromatic C–H oxidation is not observed. 
Scheme 4.16. Experimental results and CPCM-(U)B3LYP/6-31+G(d) computed free energy 
surfaces for the functionalization of aromatic and benzylic C–H bonds of 
mesitylene, reaction pathways involving benzoyloxy radical 4.150 generated 
from benzoyl peroxide under irradiation with 313 nm light. 
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At last, as summarized in Scheme 4.17, we successfully discovered, developed a useful 
method to hydroxylate arenes by phthaloyl peroxide 3.2 on a broad range of electron rich and 
neutral substrates.22 What is more, we gained insights into the reverse rebound diradical 
mechanism for this transformation which would guide the application of this new mechanism in 
other research fields. 
Scheme 4.17. Phthaloyl peroxide 3.2 mediated reverse rebound diradical activation. 
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4.5 Conclusion  
In summary, the phthaloyl peroxide 3.2 mediated hydroxylation of arenes provides a 
new, selective method for the conversions of arenes to phenols. The hydroxylation procedure is 
performed under mild conditions without the utilization of metallic reagents or strong acids, 
saving time, cost, and purification steps. Moreover, this methodology possesses broad functional 
group compatibility, has excellent selectivity for aromatic C–H bonds, and does not lead to over-
oxidation. The tolerance of the reaction toward a variety of functional groups permits the 
modification of advanced synthetic intermediates. Mechanistic insights into the reverse rebound 
process provides a novel strategy for selective C–H functionalization and lays the foundation for 
the discovery of new chemical transformations using diradical. 
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4.7 Experimental section 
Safety information 
 
All the peroxides are very dangerous, particularly for phthaloyl peroxide 3.2 and malonoyl 
peroxide 4.41. These procedures should be carried out by knowledgeable laboratory workers. 
And all the reaction conditions should be conducted behind shield. Thermogravimetric analysis 
(TGA) data showed that phthaloyl peroxide 3.2 was stable below 110 ºC, and which would 
uncontrollable decompose at above temperature. And the structure related malonoyl peroxide 
4.41 decomposed quickly at temperature above 60 ºC. Therefore, all the peroxides should be 
stored around cool area. The NMR study on the phthaloyl peroxide 3.2, stored at 0 ºC for half a 
year, showed no observed decomposition. In order to repeat the reaction result, it is VERY 
important to follow the reaction procedure: after the substrates were fully dissolved in 
HFIP or any given solvent, the peroxide was added in small portions at room temperature. 
Neat electro-rich aromatic compounds (e.x.: anisole) reacted uncontrollably with both phthaloyl 
peroxide 3.2 and malonoyl peroxide 4.41 without solvent. The impure phthaloyl peroxide 3.2 
will affect the yield of the reaction significantly. Author recommends recrystallizing 3.2 by 
benzene/pentane system(the crude was dissolved with benzene at minimum volume at room 
temperature, then 3-5 equivalent volume of pentane was slowly added to precipitate the solid 
which was filtered on filtrate funnel to give the white crystal). The best purity of the peroxide 
should be white needle-like powder. Phthaloyl peroxide 3.2 was not sensitive to the metal 
spatulas. But author still recommends precaution of metals. 
 
Other necessary safety information can be obtained from the references.  
 
 
Optimization for phthaloyl peroxide (3.2) mediated hydroxylation of arenes 
 
       A borosilicate vial was equipped with a magnetic stir bar and 1,3,5-triisopropylbenzene 4.38 
(20 mg, 0.098 mmol). Selected solvent (1.5 mL, 0.026 M) was added by syringe to make 
homogeneous or heterogeneous solution. To the resulting solution, peroxides (1.3-10 equiv.) 
were added in one portion and the vial was sealed with a septa screw cap and placed in an oil 
bath (40 °C). After 18 hours, the reaction crude was cooled and the solvent was evaporated by a 
steam of N2 flow. The crude was upon for further NMR analysis. The final optimized condition 
is entry 20. 
 
Reason of this choice:  
 
       Based on our observation on the common solvents entry 1-10, we found only the chlorinated 
solvent delivered the product in low yield (<40%). Expanded investigation showed 
hexafluoroisopropanol (HFIP) promoted the yield to 97%.  In order to understand the generality 
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of the hydroxylation process with different peroxides, a screen of other peroxides showed that 
only the malonyl peroxide 4.41 had comparable reactivity. There are three reasons that determine 
the choice of phthaloyl peroxide 3.2. First, after thermogravimetric analysis (TGA) of the two 
unique peroxides, we found the phthaloyl peroxide 3.2 was stable at relative low temperature (< 
100 °C) in contrast to the decomposing file (50% weight loss at 60 °C)  of malonyl peroxide 4.41 
(details in TGA data). Second we also observed diminished reactivity of malonyl peroxide 4.41 
with substrates in the paper. Moreover, it is easy to synthesize 3.2 with cheap materials (Aldrich: 
phthaloyl chloride: 28.2 $/100g, sodium percarbonate: 5 $/100g) at reasonable scale (1-5 g 
phthaloyl peroxide 3.2 after recrystallization) in one single step. Further optimization using 
phthaloyl peroxide 3.2 showed the best result can be obtained by using a slight excess of 3.2 (1.3 
equiv.).  
 
Synthesis of substrates:  
 
General procedure for functionalization of methyl vinillate: 
 
 
 
 
A 100 mL flask with a Teflon-coated stir bar was charged with methyl vinillate SI-1 (1.0 equiv.), 
K2CO3 (2.5 equiv.) and bromo/iodo compound RCH2X (2.0 equiv.). To the mixture, acetone (10-
20 mL) was added to generate a suspension. A cold-water cooled condenser was connected to the 
flask and which was immersed into a 70 ºC oil bath. Upon complete consumption of the methyl 
vinillate (as determined by TLC, 12-36 h), the reaction mixtures was diluted with 50 mL Et2O, 
and filtered through a glass filtrate. The crude material was concentrated and purified by silica 
gel column chromatography to afford the desired product. 
 
 
 
  
Substrate scope-characterization: 
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6c: Prepared from the general procedure using methyl vinillate SI-1 (0.50 g, 2.7 mmol) in 
acetone (10 mL). After 10 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (10/1 → 5/1 hexanes/EtOAc, v/v) to give 6c (0.73 
g, 99%) as white solid.  m.p.: 54.5-55.3 °C; TLC (hexanes/EtOAc, 10/1 v/v): RF = 0.65; 1H-
NMR (400 MHz, CDCl3): δ 7.65 p.p.m. (dd, J = 2.0 and 8.8 Hz, 1H), 7.51 (d, J = 2.0 Hz, 1H), 
6.97 (d, J = 8.8 Hz, 1H), 3.88 (s, 6H), 3.71 (s, 2H), 0.16 (s, 9 H); 13C-NMR (100 MHz, CDCl3): δ 
167.0, 155.3, 149.0, 123.6, 122.0, 112.8, 111.1, 62.2, 56.2, 51.9, -2.9; IR (KBr): 2955, 1717, 
1293, 1261 cm−1; HRMS (m/z): [M+H]+ calcd for C13H21O4Si, 269.12091; found, 269.12043. 
 
 
 
 
6d: Prepared from the general procedure using methyl vinillate SI-1 (1.0 g, 1.6 mmol) in acetone 
(17.5 mL). After 36 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (20/1 → 10/1 hexanes/EtOAc, v/v) to give 6d 
(1.22 g, 85%) as white crystalline solid.  m.p.: 51.5-52.3 °C; TLC (hexanes/EtOAc, 10/1 v/v): 
RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 7.67 p.p.m. (dd, J = 2.0 and 8.0 Hz, 1H), 7.54 (d, J = 
2.0 Hz, 1H), 6.88 (d, J = 8.0 Hz, 1H), 5.16 (penta, J = 6.4 Hz, 1H), 4.69 (penta, J = 3.2 Hz, 2H), 
4.11 (t, J = 6.4 Hz, 2H) 3.91 (s, 3H), 3.89 (s, 3H), 2.23-2.17 (m, 2H), 2.00 (penta, J = 6.4 Hz, 
2H); 13C-NMR (100 MHz, CDCl3): δ 208.5, 166.8, 152.4, 148.8, 123.4, 122.4, 112.2, 111.4, 
89.0, 75.4, 68.1, 56.0, 51.9, 28.1, 24.4; IR (KBr): 2950, 1955, 1716, 1600 cm−1; HRMS (m/z): 
[M+H]+ calcd for C15H19O4, 263.1283; found, 263.1284. 
 
 
 284 
 
 
 
6h: Prepared from the general procedure using methyl vinillate SI-1 (0.47 g, 2.6 mmol) in 
acetone (10 mL). After 24 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (10/1 → 5/1 hexanes/EtOAc, v/v) to give 6h (0.58 
g, 90%) as white crystalline solid. m.p.: 60.0-62.0 °C; TLC (hexanes/EtOAc, 5/1 v/v): RF = 
0.55; 1H-NMR (400 MHz, CDCl3): δ 7.65 p.p.m. (dd, J = 2.0 and 8.4 Hz, 1H), 7.55 (d, J = 2.0 
Hz, 1H), 6.88 (J = 8.4 Hz, 1H), 4.17 (t, J = 6.0 Hz, 2H), 3.90 (s, 3H), 3.89 (s, 3H), 2.64 (t, J = 
7.2 Hz, 2H), 2.20 (penta, J = 6.0 Hz, 2H); 13C-NMR (100 MHz, CDCl3): δ 166.7, 151.7, 149.0, 
123.4, 119.1, 112.4, 112.1, 66.4, 55.9, 52.0, 25.3, 14.1; IR (KBr): 2953, 2246, 1710, 1273 cm−1; 
HRMS (m/z): [M+Na]+ calcd for C13H15NNaO4, 272.08933; found, 272.08940. 
 
 
 
 
6j: Prepared from the general procedure using methyl vinillate SI-1 (0.50 g, 2.7 mmol) in 
acetone (15 mL). After 12 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (10/1 → 5/1 hexanes/EtOAc, v/v) to give 6j (0.68 
g, 99%) as white crystalline solid.  m.p.: 58.5-60.5 °C; TLC (hexanes/EtOAc, 5/1 v/v): RF = 
0.45; 1H-NMR (400 MHz, CDCl3): δ 7.64 p.p.m. (dd, J = 1.6 and 8.4 Hz, 1H), 7.53 (d, J = 1.6 
Hz, 1H), 6.87 (d, J = 8.4 Hz, 1H), 4.04 (d,  J = 6.8 Hz, 2H), 3.90 (s, 3H), 3.89 (s, 3H), 2.86 
(hepta, J = 3.6 Hz, 1H), 2.13-2.20 (m, 2H), 1.82-2.04 (m, 4H); 13C-NMR (100 MHz, CDCl3): δ 
166.9, 152.8, 148.9, 123.5, 122.4, 112.5, 111.7, 73.2, 56.1, 51.9, 34.4, 25.1, 18.6; IR (KBr): 
2949, 1716, 1271 cm−1; HRMS (m/z): [M+H]+ calcd for C14H19O4, 251.1283; found, 251.1283. 
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6l: Prepared from the general procedure using methyl vinillate SI-1 (0.50 g, 2.7 mmol) in 
acetone (10 mL). After 24 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (20/1 → 10/1 hexanes/EtOAc, v/v) to give 6l (0.78 
g, 96%) as colorless oil. TLC (hexanes/EtOAc, 4/1 v/v): RF = 0.70; 1H-NMR (400 MHz, 
CDCl3): δ 7.64 p.p.m. (dd, J = 2.0 and 8.4 Hz, 1H), 7.53 (d, J = 2.0 Hz, 1H), 6.88 (J = 8.4 Hz, 
1H), 4.09-4.16 (m, 4H), 3.90 (s, 3H), 3.89 (s, 3H), 2.53 (t, J = 6.4 Hz, 2H), 2.17 (penta, J = 6.4 
Hz, 2H), 1.24 (t, J = 7.2 Hz, 3H); 13C-NMR (100 MHz, CDCl3): δ 173.0, 166.9, 152.2, 148.9, 
123.5, 122.7, 112.3, 111.5, 67.7, 60.5, 56.0, 52.0, 30.6, 24.3, 14.2; IR (KBr): 2954, 1724, 1672, 
1284 cm−1; HRMS (m/z): [M+Na]+ calcd for C15H20NaO6, 319.11521; found, 319.11505.  
 
 
 
 
6m: Prepared from the general procedure using methyl vinillate SI-1 (1.5 g, 8.2 mmol) in 
acetone (20 mL). After 24 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (10/1 → 5/1 hexanes/EtOAc, v/v) to give 6m (2.8 
g, 96%) as colorless oil. TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.43; 1H-NMR (400 MHz, 
CDCl3): δ 7.64 p.p.m. (ddd, J = 0.8, 2.0 and 7.6 Hz, 1H), 7.53 (d, J = 2.0 Hz, 1H), 6.90 (J = 7.6 
Hz, 1H), 4.17 (t, J = 6.0 Hz, 2H), 3.89 (s, 3H), 3.87 (s, 3H), 3.80 (t, J = 6.0 Hz, 2H), 2.02 
(dpenta, J = 0.8 and 6.0 Hz, 2H), 0.86 (s, 9H), 0.02 (s, 6H); 13C-NMR (100 MHz, CDCl3): δ 
166.9, 152.6, 148.8, 123.5, 122.3, 112.2, 111.3, 65.6, 59.3, 55.9, 51.9, 32.0, 25.8, 18.2, -5.5; IR 
(KBr): 2953, 1720, 1106 cm−1; HRMS (m/z): [M+H]+ calcd for C18H31O5Si, 355.1941; found, 
355.1942. 
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6n: SI-9 (0.27 g, 0.93 mmol, 1.0 equiv.) was dissolved in DMF (5 mL), added solid NaI (0.28 g, 
1.9 mmol, 2.0 equiv.) and NaN3 (0.12 g, 1.9 mmol, 2.0 equiv.) in sequence. The flask was 
immersed in a 66 °C oil bath for  24 hours. The reaction was cooled and quenched with aqueous 
saturated NH4Cl solution (20 mL). The crude was extracted with EtOAc (3 × 10 mL). The 
organic extracts were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated. 
The crude product was purified by silica gel column chromatography (10/1 → 5/1 
hexanes/EtOAc, v/v) to afford off-white solid 6n (0.22 g, 94%). m.p.: 47.0-48.5 °C; TLC 
(hexanes/EtOAc, 5/1 v/v): RF = 0.40; 1H-NMR (400 MHz, CDCl3): δ 7.64 p.p.m. (dd, J = 2.0 
and 8.4 Hz, 1H), 7.56 (d, J = 2.0 Hz, 1H), 6.88 (J = 8.4 Hz, 1H), 4.22 (t, J = 4.2 Hz, 2H), 3.91 (s, 
3H), 3.89 (s, 3H), 3.67 (t, J = 4.2 Hz, 2H); 13C-NMR (100 MHz, CDCl3): δ 166.7, 151.6, 149.1, 
123.6, 123.3, 112.6, 112.2, 67.7, 56.0, 52.0, 50.0; IR (KBr): 2951, 2111, 1715, 1272 cm−1; 
HRMS (m/z): [M+H]+ calcd for C11H14N3O4, 252.0984; found, 252.0987. 
 
 
 
 
6p: Prepared from the general procedure using methyl vinillate SI-1 (0.30 g, 1.6 mmol) in 
acetone (7.5 mL). After 36 hours, followed the workup procedure, the reaction crude mixture 
was purified by silica gel column chromatography (10/1 → 5/1 hexanes/EtOAc, v/v) to give 6p 
(0.43 g, 75%) as white amorphous solid.  m.p.: 64.5-65.1 °C; TLC (hexanes/EtOAc, 5/1 v/v): RF 
= 0.45; 1H-NMR (400 MHz, CDCl3): δ 7.63 p.p.m. (dd, J = 2.0 and 8.4 Hz, 1H), 7.52 (d, J = 2.0 
Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 4.05 (t, J = 3.2 Hz, 2H), 3.89 (s, 3H), 3.88 (s, 3H), 1.96 (penta, 
J = 7.6 Hz, 2H), 1.23 (s, 12H), 0.87-0.96 (m, 2H); 13C-NMR (100 MHz, CDCl3): δ 166.9, 152.6, 
148.8, 123.5, 122.2, 112.2, 111.4, 83.1, 70.4, 56.0, 51.9, 24.8, 23.3; IR (KBr): 2977, 1716, 1600, 
1514 cm−1; HRMS (m/z): [M]+ calcd for C18H27O611B, 350.1901; found, 350.1901. 
 
Procedure for synthesis of 4-Bpin-4’-methoxy-biphenyl 4i: 
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4i: To the solution of SI-11 (0.58 g, 1.96 mmol, 1.0 equiv.) in acetone (10 mL), potassium 
carbonate (0.81 g, 5.9 mmol, 3.0 equiv) and methyl iodine (0.24 mL, 3.9 mmol, 2.0 equiv) were 
added. The flask was immersed into a 70 °C oil bath for 36 hours. The flask was cooled to 23 °C 
and poured into Et2O (50 mL). The crude was filtered and concentrated to pale yellow paste 
which was purified by silica gel column chromatography (100/1 → 10/1 hexanes/EtOAc, v/v) to 
give 4i (0.50 g, 86%) as white solid. m.p. 140-142 ºC; TLC (hexanes/EtOAc, 20/1 v/v): RF = 
0.25; 1H-NMR (400 MHz, CDCl3): δ 7.87 p.p.m. (dd, J = 2.0 and 8.4 Hz, 2H), 7.59-7.56 (m, 
4H), 6.99 (dd, J = 2.0 and 6.8 Hz, 2H), 3.86 (s, 3H), 1.37 (s, 12H); 13C-NMR (100 MHz, 
CDCl3): δ 159.4, 143.4, 135.2, 133.4, 128.2, 126.0, 114.2, 83.7, 55.3, 24.9; IR (KBr): 3408, 
1975, 1607 cm−1; HRMS (m/z): [M+H]+ calcd for C19H2311BO3, 310.1740; found, 310.1754. 
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Phthaloyl peroxide 3.2 mediated oxidation of arenes to phenols: 
General procedure A- Hydroxylation of arenes on small scale: 
 
 
 
A borosilicate vial was equipped with a magnetic stir bar and corresponding arenes 4.60 (0.2-0.8 
mmol). HFIP or TFE (2-5 mL, 0.1-0.3 M) was added by syringe to make homogeneous solution. 
In some cases, to assist dissolving the arenes, certain volume of DCCl3 was added. To the 
resulting solution, phthaloyl peroxide 3.2 (1.3 equiv.) was added in small portions and the vial 
was sealed with a septa screw cap and placed in an oil bath (23-50 °C). After 3-24 hours, the 
reaction crude was cooled and the solvent was evaporated by a steam of N2 flow or by vacuum. 
Under a stream of N2, MeOH (3 mL) and saturated NaHCO3 solution (0.2 mL) was added and 
the vial was swiftly sealed with septa screw cap and parafilm. After a certain period of time, the 
reaction crude was either (i) quenched with pH 7 buffer (5 mL) and extracted with EtOAc or 
Et2O (10 mL × 3), and the combined organic layer was washed with brine (5 mL) and dried over 
Na2SO4, filtered and concentrated or (ii) concentrated directly onto silica in vacuo. The crude 
material was then purified by silica gel column chromatography using the noted mixed solvent to 
gain the desired phenolic product 4.61. 
 
 
 
General procedure B- Hydroxylation of arenes on large scale: 
 
Precaution: The reaction should be presented by experienced research assistant under full 
protective equipment. A 250 mL flask was equipped with a magnetic stir bar and corresponding 
arenes 4.60 (10-30 mmol). HFIP or TFE (50-200 mL, 0.2-0.4 M) was added by syringe to make 
homogeneous solution. To the resulting solution, phthaloyl peroxide 3.2 (1.3 equiv.) was added 
in small portions in 10 min and the flask was capped with a septa and placed in an oil bath (23-
55 °C). After a certain period of time, the reaction crude was cooled and 0.05 mL of the crude 
was taken and concentrated for NMR analysis to assure the fully consumption of phthaloyl 
peroxide 3.2. Bulb to bulb distillation was setup to distill off the solvent in a 90 °C oil bath.  
After the distillation, the flask is cooled, MeOH (100-200 mL) and saturated NaHCO3 soution 
(10-20 mL) were added and the flask was sealed with a septum with a N2 balloon and the flask 
was immersed in an oil bath under certain temperature. After a certain period of time, the 
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reaction crude was quenched with pH 7 buffer (150 mL) and extracted with EtOAc (50 mL × 3), 
and the combined organic layer was washed with brine (30 mL) and dried over Na2SO4, filtered 
and concentrated. The crude material was purified by silica gel column chromatography using 
the noted mixed solvent to gain the desired phenolic product 4.61. 
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Substrate scope-characterization (Table 2): 
 
 
 
 
2,4,6-Trimethylphenol 4.16a: Prepared from general procedure A using mesitylene 2a (50 mg, 
0.42 mmol) and HFIP (2.5 mL) at 40 °C. After 12 hours, followed the workup procedure, the 
reaction crude mixture was directly purified by silica gel column chromatography (20/1 → 10/1 
pentane/Et2O, v/v) to afford the title compound 4.16a(55.0 mg, 97%). The spectrums match the 
commercial sources. 
 
 
 
 
o-Cresol 4.47-1 and p-cresol 4.47-2: Prepared from general procedure A using toluene 2b (50 
mg, 0.54 mmol) and HFIP (2.5 mL) at 50 °C. After 24 hours, followed the workup procedure, 
the reaction crude mixture was purified by silica gel column chromatography (15/1 → 10/1 
pentane/Et2O, v/v) to afford the title compounds 4.47-1 and 4.47-2 (26.9 mg, 46%, 4.47-1 : 4.47-
2 = 1:1). The spectrums match the commercial sources. 
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2-Butylphenol 4.48-1 and 4-butylphenol 4.48-2: Prepared from general procedure A using n-
butyl benzene 2c (70 mg, 0.52 mmol) and HFIP (2.5 mL) at 50 °C. After 24 hours, followed the 
workup procedure, the reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 pentane/Et2O, v/v) to afford the title compounds 4.48-1 and 4.48-2 (38.0 mg, 49%, 
4.48-1 : 4.48-2 = 1:1). The spectrums match the commercial sources. 
 
 
 
 
2,3-Dimethylphenol 4.49-1 and 3,4-dimethylphenol 4.49-2: Prepared from general procedure A 
using o-xylene 2d (50 mg, 0.47 mmol) and HFIP (2 mL) at 50 °C. After 24 hours, followed the 
workup procedure, the reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 pentane/Et2O, v/v) to afford the title compounds 4.49-1 and 4.49-2 (35.5 mg, 62%, 
4.49-1 : 4.49-2 = 2.1:1). The spectrums match the commercial sources. 
 
 
 
 
2,4-Dimethylphenol 4.50-1 and 2,6-dimethylphenol 4.50-2: Prepared from general procedure A 
using m-xylene 2e (50 mg, 0.47 mmol) and HFIP (2.5 mL) at 50 °C. After 24 hours, followed the 
workup procedure, the reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 pentane/Et2O, v/v) to afford the title compounds 4.50-1 and 4.50-2 (53.9 mg, 94%, 
4.50-1 : 4.50-2 = 6.1:1). The spectrums match the commercial sources. 
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2,5-Dimethylphenol 4.51: Prepared from general procedure A using p-xylene 2f (50 mg, 0.47 
mmol) and HFIP (2 mL) at 40 °C. After 24 hours, followed the workup procedure, the reaction 
crude mixture was purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, 
v/v) to afford the title compound 4.51 (49.2 mg, 86%). The spectrums match the commercial 
sources. 
 
 
 
 
2,3,5,6-Tetramethylphenol 4.52: Prepared from general procedure A using 1,2,4,5-
tetramethylbenzene 2g (70 mg, 0.52 mmol) and HFIP (2.5 mL) at °C. After 10 hours, followed 
the workup procedure, the reaction crude mixture was purified by silica gel column 
chromatography (20/1 → 10/1 pentane/Et2O, v/v) to afford the title compound 4.52 (70.0 mg, 
89%). The spectrums match the commercial sources. 
 
 
 
 
2,3,4,5,6-Pentamethylphenol 4.53: Prepared from general procedure A using 1,2,3,4,5-
pentamethylbenzene 2h (80 mg, 0.54 mmol) and HFIP (2.5 mL) at 40 °C. After 8 hours, 
followed the workup procedure, the reaction crude mixture was purified by silica gel column 
chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the title compound 4.53 (85 mg, 
96%). The spectrums match the commercial sources. 
 293 
 
 
 
 
 
2,4,6-Triisopropylphenol 4.40: Prepared from general procedure A using 1,3,5-
triisopropylbenzene 4.38 (50 mg, 0.25 mmol) and HFIP (2 mL) at 40 °C. After 12 hours, 
followed the workup procedure, the reaction crude mixture was purified by silica gel column 
chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the title compound 4.40 (52.5 mg, 
97%). The spectrums match the commercial sources. 
 
Large scale: 
 
2,4,6-Triisopropylphenol 4.40: Prepared from general procedure B using 4.38 (5.0 g, 24.4 mmol) 
and HFIP (100 mL) at 40 °C. After 36 hours, HFIP (92 mL) was recovered after bulb to bulb 
distillation.  It should be notice that to hydrolyze the crude, MeOH (200 mL) and saturated 
K2CO3 solution (10 mL) was added and flask was immersed in a 70 °C oil bath for 48 hours. The 
reaction crude was quenched with pH 7 buffer (150 mL) and extracted with EtOAc (50 mL × 3), 
and the combined organic layer was washed with brine (30 mL) and dried over Na2SO4, filtered 
and concentrated. The reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.40 (5.05 g, 94%) as yellow oil. 
 
 
 
 
 
5,6,7,8-Tetrahydro-1-naphthol 4.54-1 and 5,6,7,8-tetrahydro-2-naphthol 4.54-2: Prepared from 
general procedure A using 1,2,3,4-tetrahydronaphthalene 2k (70 mg, 0.53 mmol) and HFIP (2.5 
mL) at 40 °C. After 12 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the title 
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compounds 4.54-1 and 4.54-2 (55.2 mg, 70%, 4.54-1 : 4.54-2 = 1.5:1). The spectrums match the 
commercial sources. 
 
 
 
 
2-Hydroxybiphenyl 4.55-1 and 4-hydroxybiphenyl 4.55-2: Prepared from general procedure A 
using biphenyl 2l (70 mg, 0.45 mmol) and HFIP (2.5 mL) at 40 °C. After 12 hours, followed the 
workup procedure, the reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 pentane/Et2O, v/v) to afford biphenyl 2l (17.1 mg, 24%) and the title compounds 
4.55-1 and 4.55-2 (49.9 mg, 65%, 4.55-1 : 4.55-2 = 2.5:1). The spectrums match the commercial 
sources. 
 
 
 
 
1-Naphthol 4.56-1 and 2-naphthol 4.56-2: Prepared from general procedure A using naphthalene 
2m (70 mg, 0.55 mmol) and HFIP (3 mL) at 23 °C. After 6 hours, followed the workup 
procedure, the reaction crude mixture was purified by silica gel column chromatography (15/1 → 
10/1 pentane/Et2O, v/v) to afford the title compounds 4.56-1 and 4.56-2 (49.3 mg, 63%, 4.56-1 : 
4.56-2 = 5.8:1). The spectrums match the commercial sources. 
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1-Methyl-2-naphthol 4.57-1, 4-methyl-1-naphthol 4.57-2 and 5-methyl-1-naphthol 4.57-3: 
Prepared from general procedure A using 1-methylnaphthlene 2n (70 mg, 0.49 mmol) and HFIP 
(3 mL) at 23 °C. After 6 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the title 
compounds 4.57-1, 4.57-2 and 4.57-3 (45.9 mg, 66%, 4.57-1 : 4.57-2 : 4.57-3 = 1.4:2:1). The 
spectrums match the commercial sources and reported spectrum. 
 
 
 
 
3,8-Dimethyl-1-naphthol 4.58-1 and 4,8-dimethyl-1-naphthol 4.58-2: Prepared from general 
procedure A using 1,5-dimethylnaphthlene 2o (80 mg, 0.51 mmol) and HFIP (3 mL) at 23 °C. 
After 8 hours, followed the workup procedure, the reaction crude mixture was purified by silica 
gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the title compound 4.58-1 
(30.9 mg, 35%) and 4.58-2 (20.8 mg, 33%).  
 
3,8-Dimethyl-1-naphthol 4.58-1: m.p.: 154.0-157.0 °C; TLC (hexanes/EtOAc, 10/1 v/v): RF = 
0.49; 1H-NMR (400 MHz, CDCl3): δ 7.81 p.p.m. (d, J = 8.8 Hz, 2H), 7.39 (t, J = 8.8 Hz, 1H), 
7.19 (d, J = 6.0 Hz, 1H), 7.10 (d, J = 6.0 Hz, 1H), 4.90 (s, 1H), 2.67 (s, 3H), 2.55 (s, 3H); 13C-
NMR (100 MHz, CDCl3): δ 150.2, 134.8, 134.0, 128.2, 126.1, 124.1, 123.4, 121.6, 117.0, 115.7, 
19.7, 10.7; IR (KBr): 3270, 1384 cm−1; HRMS (m/z): [M]+ calcd for C12H12O, 172.0888; found, 
172.0888. 
 
4,8-Dimethyl-1-naphthol 4.58-2: m.p.: 87.0-89.6 °C; TLC (hexanes/EtOAc, 10/1 v/v): RF = 
0.55; 1H-NMR (400 MHz, CDCl3): δ 7.77 p.p.m. (dd, J = 0.8 and 8.4 Hz, 1H), 7.38 (dt, J = 0.8 
and 8.4 Hz, 1H), 7.23 (dt, J = 0.8 and 7.2 Hz, 1H), 7.10 (dd, J = 0.8 and 7.2 Hz, 1H), 6.63 (d, J = 
8.4 Hz, 1H), 5.25 (brs, 1H), 2.97 (s, 3H), 2.59 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 152.4, 
135.4, 134.9, 128.0, 126.8, 126.1, 125.8, 123.9, 122.4, 109.6, 25.0, 19.7; IR (KBr): 3255, 1591, 
1384 cm−1; HRMS (m/z): [M+H]+ calcd for C12H13O, 173.0966; found, 173.0966. 
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2,6-Dimethyl-1-naphthalenol 4.59-1 and 3,7-dimethyl-1-naphthalenol 4.59-2: Prepared from 
general procedure A using 2,6-dimethylnaphthlene 2p (80 mg, 0.51 mmol) and HFIP (3 mL) at 
23 °C. After 6 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford 4.59-1 (66.1 mg, 
68%) and 4.59-2 (6.1 mg, 8%).  
 
2,6-Dimethyl-1-naphthalenol 4.59-1: m.p.: 105.9-108.9 °C; TLC (hexanes/EtOAc, 10/1 v/v): RF 
= 0.59; 1H-NMR (400 MHz, CDCl3): δ 8.01 p.p.m. (d, J = 8.4 Hz, 1H), 7.54 (s, 1H), 7.30 (dd, J 
= 1.6 and 8.4 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 7.20 (d, J = 8.4 Hz, 1H), 5.13 (s, 1H), 2.50 (s, 
3H), 2.40 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 148.5, 134.9, 133.7, 129.0, 127.5, 126.6, 
122.4, 120.7, 119.5, 115.3, 21.6, 15.6; IR (KBr): 3424, 1277,1250 cm−1; HRMS (m/z): [M+H]+ 
calcd for C12H13O, 173.0966; found, 173.0967. 
 
 
 
4.59-3: To 3,7-dimethyl-1-naphthalenol 4.59-2 (6.1 mg, 0.040 mmol), pyridine (0.4 mL) and 
acetic anhydride (0.5 mL) were added at 23 ºC. After 14 hours, the volatile was removed under 
reduced pressure. The reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.59-3 (7.6 mg, 90%). The total two-steps yield is 
7%. 
 
4.59-3: TLC (hexanes/EtOAc, 15/1 v/v): RF = 0.45; 1H-NMR (400 MHz, CDCl3): δ 7.66 p.p.m. 
(d, J = 8.4 Hz, 1H), 7.57-7.50 (m, 1H), 4.46 (s, 1H), 7.27 (dd, J = 1.6 and 8.4 Hz, 1H), 7.04 (d, J 
= 1.6 Hz, 1H), 2.48 (s, 3H), 2.47 (s, 3H), 2.45 (s. 3H); 13C-NMR (100 MHz, CDCl3): δ 169.7, 
145.9, 135.3, 134.4, 133.1, 128.8, 127.3, 125.1, 124.9, 120.2, 119.8, 21.9, 21.6, 21.1; IR (KBr): 
3390, 1768, 1203 cm−1; HRMS (m/z): [M]+ calcd for C14H14O, 214.0994; found, 214.0995. 
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4.62-1 and 4.62-2: Prepared from general procedure A using 5-bromo-m-xylene 4a (100 mg, 
0.54 mmol) and HFIP (3 mL) at 50 °C. After 24 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (15/1 → 10/1 
hexanes/EtOAc, v/v) to afford the title compounds 4.62-1 (68.3 mg, 63%) and 4.62-2 (11.1 mg, 
10%). The spectrums match commercial sources. 
 
 
 
 
4.63: Prepared from general procedure A using mesityl bromide 4b (100 mg, 0.50 mmol) and 
HFIP (3 mL) at 50 °C. After 24 hours, followed the workup procedure, the reaction crude 
mixture was purified by silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to 
afford 4.63 (68.1 mg, 63%) as pale yellow solid. The spectrums match commercial sources. 
 
 
 
 
4.64-1, 4.64-2 and 4.64-3: Prepared from general procedure A using 4c (110 mg, 0.47 mmol) and 
HFIP (3 mL) at 23 °C. After 12 hours, followed the workup procedure, the reaction crude 
mixture was purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to 
afford the 4c (33.2 mg, 30%) and mixtures of 4.64-1 and 4.64-2 (42.5 mg, 36%, 4.64-1 : 4.64-2 
=1:1), and 4.64-3 (19.8mg, 17%). The spectrum of 4.64-3 matches the commercial sources. 
Preparation scale TLC separated 4.64-1 (16.6 mg, 15%) and 4.64-2 (16.5 mg, 15%). 
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4.64-1: m.p.: 190-192 °C, TLC (pentane/Et2O, 10/1 v/v): RF = 0.50; 1H-NMR (400 MHz, 
CDCl3): δ 7.63-7.59  p.p.m. (m, 2H), 7.39-7.36 (m, 2H), 7.29-7.21 (m, 2H), 7.0 (dt, J = 1.2 and 
8.0 Hz, 1H), 6.96 (dd, J = 1.2 and 8.0 Hz, 1H), 5.01 (s, 1H); 13C-NMR (100 MHz, CDCl3): δ 
152.2, 136.1, 132.2, 130.8, 130.2, 129.4, 127.0, 122.0, 121.1, 116.0; IR (KBr): 3433, 1384 cm−1; 
HRMS (m/z): [M+H]+ calcd for C12H10O81Br, 250.9895; found, 250.9899. 
 
4.64-2: m.p.: 180-183 °C, TLC (pentane/Et2O, 10/1 v/v): RF = 0.55; 1H-NMR (400 MHz, 
CDCl3): δ 7.52-7.47  p.p.m. (m, 2H), 7.44-7.40 (m, 3H), 7.17 (d, J = 1.6 Hz, 1H), 7.13 (dd, J = 
1.6 and 8.0 Hz, 1H), 7.09 (d, J = 8.0 Hz, 1H), 5.27 (s, 1H); 13C-NMR (100 MHz, CDCl3): δ 
153.2, 136.0, 131.3, 129.5, 128.9, 128.3, 127.1, 124.0, 122.1, 119.1; IR (KBr): 3411, 1632 cm−1; 
HRMS (m/z): [M+H]+ calcd for C12H10O81Br, 250.9895; found, 250.9898. 
 
 
 
 
 
 
4.66-1 and 4.66-2: Prepared from general procedure A using anisole 4d (60 mg, 0.55 mmol) and 
TFE (3 mL) at 23 °C. After 14 hours, followed the workup procedure, the reaction crude mixture 
was purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, v/v) to afford the 
title compounds (31.2 mg, 45%, 4.66-1 : 4.66-2 =1.4:1). The spectrums match the commercial 
sources. 
 
 
 
 
4.67-1 and 4.67-2: Prepared from general procedure A using 4-methyl anisole 4e (65 mg, 0.53 
mmol) and TFE (3 mL) at 23 °C. After 16 hours, followed the workup procedure, the reaction 
crude mixture was purified by silica gel column chromatography (15/1 → 10/1 pentane/Et2O, 
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v/v) to afford 4e (12.1 mg, 19%) and title compounds (45.8 mg, 62%, 4.67-1 : 4.67-2 =1.1:1). 
The spectrums match the commercial sources. 
 
 
 
 
4.68-1 and 4.68-2: Prepared from general procedure A using 2,2-dimethyl-propanoic acid 4-
methoxyphenyl ester 4f (100 mg, 0.48 mmol) and TFE (3 mL) at 23 °C. After 6 hours, followed 
the workup procedure, the reaction crude mixture was purified by silica gel column 
chromatography (15/1 → 2/1 pentane/Et2O, v/v) to afford 4f (10.0 mg, 10%), 4.68-1 (43 mg, 
40%) and 4.68-2 (16.4 mg, 15%).  
 
4.68-1: TLC (pentane/Et2O, 2/1 v/v): RF = 0.45; 1H-NMR (400 MHz, CDCl3): δ 6.81  p.p.m. (d, 
J = 8.8 Hz, 1H), 6.64 (d, J = 2.4 Hz, 1H), 6.54 (dd, J = 2.4 and 8.8 Hz, 1H), 5.69 (s, 1H), 3.89 (s, 
3H), 1.33 (s, 9H); 13C-NMR (100 MHz, CDCl3): δ 177.3, 146.1, 145.1, 144.3, 112.4, 110.5, 
108.5, 56.2, 39.0, 27.1; IR (KBr): 3436, 2971, 1749, 1508 cm−1; HRMS (m/z): [M+H]+ calcd for 
C12H17O4, 225.1127; found, 225.1125. 
 
 
 
4.68-3: To 4.68-2 (16.4 mg, 0.073 mmol), pyridine (0.4 mL) and acetic anhydride (0.5 mL) were 
added. After 14 hours, the volatile was removed under reduced pressure. The reaction crude 
mixture was purified by silica gel column chromatography (15/1 → 4/1 hexanes/EtOAc, v/v) to 
afford 4.68-3 (18.0 mg, 92%). The total two-steps yield is 14%. 
 
4.46-3: TLC (hexanes/EtOAc, 4/1 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 7.04 p.p.m. 
(d, J = 9.2 Hz, 1H), 6.77 (dd, J = 2.8 and 9.2 Hz, 1H), 6.72 (d, J = 2.8 Hz, 1H), 3.79 (s, 3H), 2.26 
(s, 3H), 1.34(s, 9H); 13C-NMR (100 MHz, CDCl3): δ 176.3, 168.1, 157.5, 142.5, 135.9, 123.6, 
111.9, 109.0, 55.7, 39.1, 27.1, 20.7; IR (KBr): 3498, 1751, 1740 cm−1; HRMS (m/z): [M+Na]+ 
calcd for C12H18NaO5, 289.10464; found, 289.10454. 
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4.69-1 and 4.69-2: Prepared from general procedure A using tert-butyl(4-
methoxyphenoxy)dimethylsilane 4g (120 mg, 0.50 mmol) and TFE (3 mL) at 23 °C. After 4 
hours, followed the workup procedure, the reaction crude mixture was purified by silica gel 
column chromatography (15/1 → 4/1 hexanes/EtOAc, v/v) to afford 4.69-1 (52.2 mg, 41%) and 
4.69-2 (22.9 mg, 18%).  
 
4.69-1: TLC (hexanes/EtOAc, 2/1 v/v): RF = 0.75; 1H-NMR (400 MHz, CDCl3): δ 6.69  p.p.m. 
(d, J = 8.8 Hz, 1H), 6.47 (d, J = 2.8 Hz, 1H), 6.31 (dd, J = 2.8 and 8.8 Hz, 1H), 5.57 (s, 1H), 3.84 
(s, 3H), 0.97 (s, 9H), 0.17 (s, 6H); 13C-NMR (100 MHz, CDCl3): δ 150.1, 146.0, 141.3, 111.1, 
110.7, 107.2, 56.4, 25.7, 18.2, -4.5; IR (KBr): 3447, 1627, 1507 cm−1; HRMS (m/z): [M-H]- calcd 
for C13H21O3Si, 253.12654; found, 253.12642. 
 
Procedure for characterization of 4.69-2: To 4.69-2 (22.9 mg, 0.09 mmol, 1.0 equiv.) in THF (1 
mL), TBAF (0.10 mL, 1 mol/L, 1.1 equiv.) was slowly added at room temperature. After 1 hour, 
saturated NH4Cl solution (5 mL) was added into the solution. The crude was extracted with Et2O 
(10 mL × 3) and the combined organic solution was washed with brine, then dried on Na2SO4. 
The crude was filtered and concentrated to afford 4-methoxycatechol and the spectrum matches 
the commercial source. 
 
 
 
 
 
Pinacol phenol 4.65-1 and pinacol phenol 4.65-2: Prepared from general procedure A using 4i 
(100 mg, 0.32 mmol) and HFIP (3 mL) at 23 °C. After 8 hours, followed the workup procedure, 
the reaction crude mixture was purified by silica gel column chromatography (15/1 → 5/1 
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hexanes/EtOAc, v/v) to afford the title compounds 4.65-1 and 4.65-2 (81.1 mg, 77%, 4.65-1 : 
4.65-2 =2:1).  
 
4.65-1: m.p.: 117-119 °C, TLC (CH2Cl2/MeOH, 100/1 v/v): RF = 0.65; 1H-NMR (400 MHz, 
CDCl3): δ 7.85 p.p.m. (d, J = 8.4 Hz, 2H), 7.60 (dd, J = 2.0 and 8.4 Hz, 2H), 7.22 (d, J = 2.0 Hz, 
1H), 7.12 (dd, J = 2.0 and 8.4 Hz, 1H), 6.92 (d, J = 8.4 Hz, 1H), 5.64 (s, 1H), 3.93 (s, 3H), 1.36 
(s, 12H); 13C-NMR (100 MHz, CDCl3): δ 146.4, 145.8, 143.4, 135.2, 134.5, 126.0, 118.9, 113.4, 
110.8, 83.8, 56.0, 24.9; IR (KBr): 3408, 1361 cm−1; HRMS (m/z): [M+H]+ calcd for C19H2411BO4, 
328.17983; found, 328.17931. 
 
 
 
 
4.65-3: To the compound 4.65-2 (13.0 mg, 0.040 mmol), pyridine (0.4 mL) and acetic anhydride 
(0.5 mL) were added at 23 ºC. After 10 hours, the volatile was removed under reduced pressure. 
The reaction crude mixture was purified by silica gel column chromatography (15/1 → 5/1 
hexanes/EtOAc, v/v) to afford 4.65-3 (13.2 mg, 90%).  
 
4.43-3: TLC (CH2Cl2/MeOH, 100/1 v/v): RF = 0.49; 1H-NMR (500 MHz, CDCl3): δ 7.83 p.p.m. 
(d, J = 8.2 Hz, 2H), 7.39 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.5 Hz, 1H), 6.87 (dd, J = 2.5 and 8.5 
Hz, 1H), 6.69 (d, J = 2.5 Hz, 1H), 3.84 (s, 3H), 2.09 (s, 3H), 1.36 (s, 12H); 13C-NMR (125 MHz, 
CDCl3): δ 169.2, 159.9, 148.5, 140.4, 134.7, 131.3, 128.1, 112.4, 108.5, 83.8, 55.6, 29.7, 24.9, 
20.9; IR (KBr): 3427, 1764, 1360 cm−1; HRMS (m/z): [M+Na]+ calcd for C19H23BNaO4, 
349.15857; found, 349.15869. 
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4.70: Prepared from general procedure A using 3,4-dimethoxyacetophenone 4k (90 mg, 0.50 
mmol) and TFE (3 mL) at 23 °C. After 8 hours, followed the workup procedure, the reaction 
crude mixture was purified by silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, 
v/v) to afford 4.70 (73.2 mg, 75%).  
 
Large scale: 
 
4.70: Prepared from general procedure B using 4k (2.5 g, 13.8 mmol) and TFE (50 mL) at 23 °C. 
After 24 hours, followed the workup procedure, TFE (41 mL) was recovered.  The reaction crude 
mixture was purified by silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to 
afford 4.70 (2.04 g, 74%) as yellow solid. 
 
4.70: m.p.: 67.0-68.5 °C, TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.35; 1H-NMR (400 MHz, 
CDCl3): δ 12.6  p.p.m. (s, 1H), 7.49 (d, J = 8.8 Hz, 1H), 6.48 (d, J = 8.8 Hz, 1H), 3.92 (s, 3H), 
3.88 (s, 3H), 2.57 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 203.1, 158.5, 157.0, 136.4, 127.0, 
115.3, 102.8, 60.6, 56.1, 26.4; IR (KBr): 2937, 1718 cm−1; HRMS (m/z): [M+H]+ calcd for 
C10H13O4, 197.0814; found, 197.0812. 
 
 
 
 
4.71: Prepared from general procedure A using 3,5-dimethoxybenzaldehyde 4l (50 mg, 0.30 
mmol) and TFE (3 mL) at 23 °C. After 6 hours, followed the workup procedure, the reaction 
crude mixture was purified by silica gel column chromatography (15/1 → 4/1 hexanes/EtOAc, 
v/v) to afford 4l (17.9 mg, 36%) and 4.71 (26.2 mg, 48%). The spectrums match the commercial 
sources. 
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4.72: Prepared from general procedure A using 3-benzyloxy-4-methoxybenzaldehyde 4m (120 
mg, 0.50 mmol) and TFE (3 mL) at 23 °C. After 24 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (15/1 → 4/1 
hexanes/EtOAc, v/v) to afford 4m and 4.50 (100.5 mg, 4m : 4.72= 1:2.6). For characterization, 
the mixed compounds were dissolved in Et2O (15 mL), which was extracted with aqueous NaOH 
solution (1.5 M, 3 × 5 mL), the combined aqueous layer was neutralized with aqueous HCl 
solution (1 M) to pH 7. Then the aqueous layer was extracted with EtOAc (3 × 5 mL) and the 
combined organic layer was washed with brine (15 mL) and dried on over Na2SO4. Filtered and 
concentrated the mixtures, 4.72 (72.6 mg, 57%) was pure enough for analysis. 
 
4.72: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.40; 1H-NMR (400 MHz, CDCl3): δ 11.2 p.p.m. (s, 
1H), 9.74 (s, 1H), 7.51-7.49 (m, 1H), 7.37-7.26 (s, 5H), 6.58 (d, J = 8.8 Hz, 1H), 5.09 (s, 2H), 
3.90 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 194.9, 159.6, 156.0, 137.3, 134.9, 130.3, 128.5, 
128.2, 128.0, 116.5, 130.9, 74.8, 56.2; IR (KBr): 3401, 1701, 1641, 1291 cm−1; HRMS (m/z): 
[M+Na]+ calcd for C15H14NaO4, 283.07843; found, 283.07841. 
 
 
 
 
4.73-1 and 4.73-2: Prepared from general procedure A using 4n (110 mg, 0.48 mmol) and TFE 
(3 mL) at 23 °C. After 12 hours, followed the workup procedure, the reaction crude mixture was 
purified by silica gel column chromatography (15/1 → 2/1 hexanes/EtOAc, v/v) to afford 4n 
(11.9 mg, 11%) and the mixed products (89.7 mg, 76%, 4.73-1 : 4.73-2 =1:1.4). And the 
resulting phenolic products 4.73-1 and 4.73-2 (20 mg) was further purified by preparative HPLC 
(10-90% MeCN in H2O, 0.1% TFA, 25 minute ramp, 1mL/min, 30 mm diameter column) to 
afford 4.73-1 and 4.73-2 (17.9 mg, 90%) as pure material for analysis purpose. And the final 
yield is 68%. 
 
4.73-1 : 4.73-2 = 1: 1.4: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.45; 1H-NMR (400 MHz, 
CDCl3): δ 9.95 p.p.m. (s, 1H), 9.94 (s, 1.4 H (1HB))*, 7.62-7.54 (m, 2.8 H (1H + 1HB)), 7.51-
7.45 (m, 2.4 H (1H + 1HB)), 7.42 (dd, J = 1.2 and 2.4 Hz, 1.4 H (1HB)), 7.40 (dd, J = 1.2 and 
2.4 Hz, 1H), 7.28-7.24 (m, 9.6 H (2H+2HB)), 6.89 (d, J = 9.2 Hz, 1.4 H (1HB)), 6.83 (d, J = 8.8 
Hz, 1H), 6.67 (d, J = 3.6 Hz, 1H), 6.65 (d, J = 3.6 Hz, 1.4 H (1HB)), 6.55 (dd, J = 3.2 and 8.8 
Hz, 1H), 6.46 (dd, J = 3.6 and 8.8 Hz, 1.4 H (1HB)), 5.73 (s, 1H), 5.42 (s, 1.4 H (1HB)), 3.91 (s, 
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3H), 3.81 (s, 4.2 H (3HB)); 13C-NMR (100 MHz, CDCl3): δ 191.9, 191.7, 159.1, 158.7, 157.6, 
149.8, 148.7, 146.6, 143.6, 137.9, 137.8, 135.6, 130.4, 130.2, 124.6, 124.3, 123.8, 122.7, 121.2, 
117.1, 116.1, 111.3, 111.0, 107.3, 106.3, 102.5, 56.3, 55.7; IR (KBr): 3419, 2839, 1699, 1695, 
1504, 1233 cm−1; HRMS (m/z): [M+H]+ calcd for C14H13O4, 245.0813; found, 245.0813. 
*1.4 H = one proton (1HB) for 4.73-2  
 
 
 
 
4.76: Prepared from general procedure A using 4-(allyloxy)-3-methoxybenzaldehyde 4o (90 mg, 
0.47 mmol) and HFIP (3 mL) at 23 °C. After 6 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (15/1 → 4/1 
hexanes/EtOAc, v/v) to afford 4o and 4.76 (66.1 mg, 4o : 4.76=16% : 51%). For 
characterization, the mixed compounds were dissolved in Et2O (15 mL), which was extracted 
with aq. NaOH (1.5 M, 3 × 5 mL), the combined aqueous layer was neutralized with aq. HCl (1 
M) to pH 7. Then the aqueous layer was extracted with EtOAc (3 × 5 mL) and the combined 
organic layer was washed with brine (15 mL) and dried over Na2SO4. Filtered and concentrated 
the mixtures, 4.76 was pure enough for analysis. 
 
4.76: TLC (pentane/Et2O, 2/1 v/v): RF = 0.59; 1H-NMR (400 MHz, CDCl3): δ 11.20 p.p.m. (s, 
1H), 9.75 (s, 1H), 7.26 (d, J = 8.8 Hz, 1H), 6.58 (d, J = 8.8 Hz, 1H), 6.11-6.01 (m, 1H), 5.43 (dq, 
J = 1.6 and 17.2 Hz, 1H), 5.33 (dq, J = 1.6 and 17.2 Hz, 1H), 4.70 (dt, J = 1.6 and 5.2 Hz, 2H), 
3.91 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 194.8, 158.4, 155.9, 136.4, 132.1, 130.0, 118.3, 
116.5, 105.3, 69.6, 60.9; IR (KBr): 3421, 1647, 1501 cm−1; HRMS (m/z): [M]+ calcd for 
C11H12O4, 208.0736; found, 208.0735. 
 
 
 
 
4.75-1 and 4.75-2: Prepared from general procedure A using methyl 4-methoxyphenylacetate 4k 
(90 mg, 0.50 mmol) and TFE (3 mL) at 23 °C. After 8 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (15/1 → 4/1 
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hexanes/EtOAc, v/v) to afford 4k (13.9mg, 15%), 4.75-1, 4.75-2 (50.0 mg, 51%, 4.75-1 : 4.75-2 
= 3:1). And the resulting residue was further purified by preparative HPLC (10-90% MeCN in 
H2O, 0.1% TFA, 25 minute ramp, 1mL/min, 30 mm diameter column) to afford two titled 
compounds as pure material for analysis. 
 
4.75-1: TLC (hexanes/EtOAc, 4/1 v/v): RF = 0.55; 1H-NMR (400 MHz, CDCl3): δ 6.86 p.p.m. 
(d, J = 2.0 Hz, 1H), 6.80 (d, J = 8.4 Hz, 1H), 6.74 (dd, J = 2.0 and 8.4 Hz, 1H), 5.59 (s, 1H), 3.87 
(s, 3H), 3.68 (s, 3H), 3.53 (s, 2H); 13C-NMR (100 MHz, CDCl3): δ 172.2, 145.7, 145.6, 127.1, 
120.8, 115.5, 110.6, 55.9, 52.0, 40.6; IR (KBr): 3343, 1725 cm−1; HRMS (m/z): [M+Na]+ calcd 
for C10H12NaO4, 219.06278; found, 219.06254. 
 
4.75-2: TLC (hexanes/EtOAc, 4/1 v/v): RF = 0.55; 1H-NMR (400 MHz, CDCl3): δ 7.60 p.p.m. 
(brs, 1H), 6.97 (d, J = 8.4 Hz, 1H), 6.53 (d, J = 2.8 Hz, 1H), 6.44 (dd, J = 2.8 and 8.4 Hz, 1H), 
3.77 (s, 3H), 3.75 (s, 3H), 3.62 (s, 2H); 13C-NMR (125 MHz, CDCl3): δ 174.8, 160.7, 156.3, 
131.4, 112.6, 106.8, 103.5, 52.7, 37.2, 27.2; IR (KBr): 3390, 1719, 1621 cm−1; HRMS (m/z): 
[M+Na]+ calcd for C10H12NaO4, 219.06278; found, 219.06283. 
 
 
 
 
 
4.74-1 and 4.74-2: Prepared from general procedure A using methyl 3-methoxy-2-
methylbenzoate 4m (80 mg, 0.45 mmol) and TFE (3 mL) at 23 °C. After 6 hours, followed the 
workup procedure, the reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 2/1 pentane/Et2O, v/v) to afford 4m (17.1 mg, 19%), 4.74-1 (33.2 mg, 34%) and 4.74-2 
(17.5 mg, 18%).  
 
4.74-1: m.p.: 62.5-64.0 °C, TLC (pentane/Et2O, 10/1 v/v): RF = 0.65; 1H-NMR (400 MHz, 
CDCl3): δ 10.4 p.p.m. (s, 1H), 7.04 (d, J = 9.2 Hz, 1H), 6.82 (dd, J = 0.8 and 9.2 Hz, 1H), 3.97 
(s, 3H), 3.78 (s, 3H), 2.42 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 171.8, 155.8, 150.8, 129.1, 
119.3, 114.9, 113.7, 57.1, 52.2, 14.4; IR (KBr): 3368, 1718, 1384 cm−1; HRMS (m/z): [M+H]+ 
calcd for C10H13O4, 197.0814; found, 197.0814. 
 
4.74-2: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.45; 1H-NMR (400 MHz, CDCl3): δ 7.69 p.p.m. 
(d, J = 8.4 Hz, 1H), 6.83 (dd, J = 0.8 and 8.4 Hz, 1H), 6.04 (s, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 
2.55 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 167.5, 152.2, 145.7, 134.3, 128.2, 122.5, 112.4, 
61.0, 51.6, 13.7; IR (KBr): 3393, 1716, 1057 cm−1; HRMS (m/z): [M+H]+ calcd for C10H13O4, 
197.0814; found, 197.0814. 
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4.80: Prepared from general procedure A using methyl 3-methoxy-2-methylbenzoate 6a (100 
mg, 0.51 mmol) and TFE (3 mL) at 23 °C. After 3 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (15/1 → 5/1 
hexanes/EtOAc, v/v) to afford 4.80 (87.9 mg, 81%).  
 
4.80: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.50; 1H-NMR (400 MHz, CDCl3): δ 10.90 p.p.m. (s, 
1H), 7.59 (d, J = 9.2 Hz, 1H), 6.48 (d, J = 9.2 Hz, 1H), 3.92 (s, 3H), 3.91 (s, 3H), 3.89 (s, 3H); 
13C-NMR (100 MHz, CDCl3): δ 170.4, 158.0, 155.9, 136.5, 125.7, 107.0, 103.1, 60.7, 56.0, 52.1; 
IR (KBr): 2954, 1679, 1088 cm−1; HRMS (m/z): [M+Na]+ calcd for C10H12NaO5, 235.05769; 
found, 235.05775. 
 
 
 
 
4.81: Prepared from general procedure A using 6b (100 mg, 0.34 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.81 (67.0 mg, 
64%).  
 
4.81: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.79; 1H-NMR (400 MHz, CDCl3): δ 10.95 p.p.m. (s, 
1H), 7.47 (d, J = 8.8 Hz, 1H), 6.39 (d, J = 8.8 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 1.00 (s, 9H), 
0.21 (s, 6H); 13C-NMR (100 MHz, CDCl3): δ 170.5, 156.9, 154.9, 139.2, 125.0, 112.5, 107.3, 
60.2, 52.1, 25.6, 18.3, -4.6; IR (KBr): 2955, 2931, 1674 cm−1; HRMS (m/z): [M+H]+ calcd for 
C15H25O5Si, 313.1471; found, 313.1471. 
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4.82: Prepared from general procedure A using 6c (100 mg, 0.37 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.82 (88.9 mg, 
84%).  
 
 
 
4.82-1: To compound 4.82 (88.9 mg, 0.31 mmol), pyridine (0.8 mL) and acetic anhydride (1 mL) 
were added. The reaction mixture was stirred for 18 hours. The volatile was removed under 
reduced pressure. The reaction crude mixture was purified by silica gel column chromatography 
(15/1 → 4/1 hexanes/EtOAc, v/v) to afford 4.82-1 (97.1 mg, 95%). The total yield in two steps is 
80%, 
 
4.82-1: TLC (hexanes/EtOAc, 10/1 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 7.75 p.p.m. 
(d, J = 8.8 Hz, 1H), 6.93 (d, J = 8.8 Hz, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.66 (s, 2H), 2.38 (s, 3H), 
0.17 (s, 9H); 13C-NMR (100 MHz, CDCl3): δ 169.3, 164.7, 159.2, 144.9, 141.7, 127.0, 115.6, 
109.1, 62.1, 60.8, 51.9, 20.7, -3.1; IR (KBr): 2954, 1769, 1720 cm−1; HRMS (m/z): [M]+ calcd for 
C15H22O6Si, 326.1186; found, 326.1187. 
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4.99: Prepared from general procedure A using 6d (130 mg, 0.50 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.99 (91.2 mg, 
66%).  
 
4.99: TLC (hexanes/EtOAc, 10/1 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 10.88 p.p.m. 
(s, 1H), 7.56 (d, J = 8.8 Hz, 1H), 6.47 (d, J = 8.8 Hz, 1H), 5.19-5.12 (m, 1H), 4.69 (penta, J = 3.2 
Hz, 2H), 4.10 (t, J = 6.8 Hz, 2H), 3.92 (s, 3H), 3.87 (s, 3H), 2.25-2.18 (m, 2H), 1.97 (penta, J = 
6.8 Hz, 2H); 13C-NMR (100 MHz, CDCl3): δ 208.6, 170.4, 157.6, 156.0, 136.7, 125.5, 106.8, 
104.2, 89.0, 75.4, 68.0, 60.7, 52.1, 28.3, 24.5; IR (KBr): 2953, 1955, 1673, 1507 cm−1; HRMS 
(m/z): [M]+ calcd for C15H19O5, 279.1232; found, 279.1231. 
 
 
 
 
4.93-1: Prepared from general procedure A using 6e (110 mg, 0.46 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 2/1 hexanes/EtOAc, v/v) to afford 4.93-1 (108.9 mg, 
93%).  
 
 
 
4.93-2: To 4.93-1 (110 mg, 0.43 mmol), pyridine (0.8 mL) and acetic anhydride (1 mL) were 
added. The reaction mixture was stirred overnight. The volatile was removed under reduced 
pressure. The reaction crude mixture was purified by silica gel column chromatography (15/1 → 
4/1 hexanes/EtOAc, v/v) to afford 4.93-2 (119 mg, 93%). The total yield in two steps is 89%. 
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4.69-2: TLC (hexanes/EtOAc, 2/1 v/v): RF = 0.55; 1H-NMR (400 MHz, CDCl3): δ 7.73 p.p.m. 
(d, J = 8.8 Hz, 1H), 6.83 (d, J = 8.8 Hz, 1H), 4.35 (dd, J = 3.2 and 11.2 Hz, 1H), 4.03 (ddd, J = 
0.4, 5.6 and 11.2 Hz, 1H), 3.85 (s, 3H), 3.83 (s, 3H), 3.41-3.37 (m, 1H), 2.92 (dt, J = 0.4 and 4.4 
Hz, 1H), 2.78 (ddd, J = 0.4, 2.8 and 4.4 Hz, 1H), 2.38 (s, 3H); 13C-NMR (100 MHz, CDCl3): δ 
169.2, 164.5, 156.1, 145.3, 142.1, 127.0, 116.9, 110.3, 69.7, 61.0, 52.0, 49.8, 44.5, 20.7; IR 
(KBr): 3433, 2951, 1769, 1720, 12.8 cm−1; HRMS (m/z): [M+Na]+ calcd for C14H16NaO7, 
319.07882; found, 319.07918. 
 
 
 
 
4.92: Prepared from general procedure A using 6f (100 mg, 0.42 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.92 (90.1 mg, 
84%).  
 
4.92: m.p.: 58.5-59.5 °C, TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.65; 1H-NMR (400 MHz, 
CDCl3): δ 10.89 p.p.m. (s, 1H), 7.54 (d, J = 8.8 Hz, 1H), 6.44 (d, J = 8.8 Hz, 1H), 3.92-3.90 (m, 
8H), 1.35-1.26 (m, 1H), 0.67-0.62 (m, 2H), 0.38-0.35 (m, 2H); 13C-NMR (100 MHz, CDCl3): δ 
170.4, 157.6, 156.0, 136.8, 125.5, 106.8, 104.5, 73.6, 60.6, 52.1, 10.2, 3.3; IR (KBr): 3084, 3003, 
1672, 1284 cm−1; HRMS (m/z): [M]+ calcd for C13H16O5, 252.0998; found, 252.0999. 
 
 
 
 
4.86: Prepared from general procedure A using 6g (100 mg, 0.45 mmol) and TFE (2.5 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
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silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.62 (68.9 mg, 
64%).  
 
4.86: m.p.: 99.9-101.4 °C, TLC (hexanes/EtOAc, 2/1 v/v): RF = 0.75; 1H-NMR (400 MHz, 
CDCl3): δ 10.92 p.p.m. (s, 1H), 7.58 (d, J = 9.2 Hz, 1H), 6.59 (d, J = 9.2 Hz, 1H), 4.80 (d, J = 2.4 
Hz, 2H), 3.91 (s, 3H), 3.89 (s, 3H), 2.53 (t, J = 2.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3): δ 
170.3, 156.1, 157.8, 137.6, 125.8, 107.9, 105.0, 77.9, 76.2, 60.7, 56.5, 52.1; IR (KBr): 3266, 
1677 cm−1; HRMS (m/z): [M]+ calcd for C12H12O5, 236.0685; found, 236.0682. 
 
 
 
 
4.98: Prepared from general procedure A using 6h (120 mg, 0.48 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 2/1 hexanes/EtOAc, v/v) to afford 4.98 (110.8 mg, 
87%).  
 
4.98: TLC (hexanes/EtOAc, 2/1 v/v): RF = 0.40; 1H-NMR (400 MHz, CDCl3): δ 10.93 p.p.m. (s, 
1H), 7.58 (d, J = 9.2 Hz, 1H), 6.46 (d, J = 9.2 Hz, 1H), 4.19 (t, J = 5.6 Hz, 2H), 3.93 (s, 3H), 
3.87 (s, 3H), 2.64 (t, J = 5.6 Hz, 2H), 2.20 (penta, J = 5.6 Hz, 2H); 13C-NMR (100 MHz, CDCl3): 
δ 170.4, 156.8, 156.2, 136.9, 125.7, 118.9, 107.6, 104.4, 66.3, 60.8, 52.2, 25.4, 10.1; IR (KBr): 
2955, 1718, 1674, 1439 cm−1; HRMS (m/z): [M+H]+ calcd for C13H16NO5, 266.10230; found, 
266.10243. 
 
 
 
 
4.85: Prepared from general procedure A using 6i (120 mg, 0.46 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
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silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.85 (104.1 mg, 
82%).  
 
4.85: m.p.: 99.9-101.4 °C, TLC (hexanes/EtOAc, 4/1 v/v): RF = 0.75; 1H-NMR (400 MHz, 
CDCl3): δ 10.91 p.p.m. (s, 1H), 7.57 (d, J = 9.2 Hz, 1H), 6.49 (d, J = 9.2 Hz, 1H), 4.21 (t, J = 5.6 
Hz, 2H), 3.92 (s, 3H), 3.86 (s, 3H), 3.79 (t, J = 5.6 Hz, 2H), 2.29 (penta, J = 5.6 Hz, 2H); 13C-
NMR (100 MHz, CDCl3): δ 170.4, 157.2, 156.1, 136.7, 125.7, 107.1, 104.2, 65.2, 60.7, 52.2, 
41.3, 32.0; IR (KBr): 3140, 2955, 1674, 1286 cm−1; HRMS (m/z): [M]+ calcd for C12H15O535Cl, 
274.0608; found, 274.0610. 
 
 
 
 
4.88: Prepared from general procedure A using 6j (100 mg, 0.40 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.88 (90.5 mg, 
85%).  
 
4.88: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.50; 1H-NMR (400 MHz, CDCl3): δ 10.87 p.p.m. (s, 
1H), 7.55 (d, J = 9.2 Hz, 1H), 6.45 (d, J = 9.2 Hz, 1H), 4.02 (d, J = 6.8 Hz, 2H), 3.91 (s, 3H), 
3.86 (s, 3H), 2.88-2.80 (m, 1H), 2.20-2.10 (m, 2H), 2.04-1.83 (m, 4H); 13C-NMR (100 MHz, 
CDCl3): δ 170.4, 157.9, 156.0, 136.7, 125.5, 106.7, 104.3, 72.8, 60.6, 52.1, 34.4, 24.8, 18.5; IR 
(KBr): 2937, 1673 cm−1; HRMS (m/z): [M+H]+ calcd for C14H19O5, 267.1232; found, 267.1229. 
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4.89: Prepared from general procedure A using 6k (110 mg, 0.50 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.89 (87.5 mg, 
74%).  
 
4.89: m.p.: 56.5-57.9 °C, TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.55; 1H-NMR (400 MHz, 
CDCl3): δ 10.90 p.p.m. (s, 1H), 7.53 (d, J = 9.2 Hz, 1H), 6.45 (d, J = 9.2 Hz, 1H), 6.09-5.99 (m, 
1H), 5.43-5.38 (m, 1H), 5.31-5.27 (m, 1H), 4.65-4.63 (m, 2H), 3.90 (s, 3H), 3.88 (s, 3H); 13C-
NMR (100 MHz, CDCl3): δ 170.3, 157.0, 156.0, 136.7, 132.5, 125.4, 117.9, 106.9, 104.5, 69.4, 
60.6, 52.1; IR (KBr): 3019, 1670, 1384 cm−1; HRMS (m/z): [M+H]+ calcd for C14H12O5, 
238.0841; found, 238.0841. 
 
 
 
 
4.97: Prepared from general procedure A using 6l (140 mg, 0.47 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.97 (126.6 mg, 
86%).  
 
4.97: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.55; 1H-NMR (400 MHz, CDCl3): δ 10.89 p.p.m. (s, 
1H), 7.55 (d, J = 8.8 Hz, 1H), 6.46 (d, J = 8.8 Hz, 1H), 4.17-4.08 (m, 4H), 3.91 (s, 3H), 3.88 (s, 
3H), 2.54 (t, J = 7.2 Hz, 2H), 2.16 (dpenta, J = 0.8 and 7.2 Hz, 2H), 2.51 (t, J = 7.2 Hz, 3H); 13C-
NMR (100 MHz, CDCl3): δ 173.0, 170.4, 157.4, 156.1, 136.7, 125.6, 107.0, 104.2, 67.7, 60.7, 
60.5, 52.1, 30.6, 24.5, 14.2; IR (KBr): 3139, 2956, 1733, 1674, 1285 cm−1; HRMS (m/z): 
[M+Na]+ calcd for C15H20NaO7, 335.11012; found, 335.11035. 
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4.84: Prepared from general procedure A using 6m (160 mg, 0.45 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 1/1 hexanes/EtOAc, v/v) to afford 4.84 (110.1 mg, 
95%). From the crude NMR, no silyl group was deprotected. After column chromatography, the 
TBS group was deprotected cleanly on silica gel. 
 
4.84: TLC (hexanes/EtOAc, 1/1 v/v): RF = 0.42; 1H-NMR (400 MHz, CDCl3): δ 10.90 p.p.m. (s, 
1H), 7.56 (d, J = 8.8 Hz, 1H), 6.48 (d, J = 8.8 Hz, 1H), 4.23-4.18 (m, 2H), 3.91-3.84 (m, 8H), 
2.11-2.03 (m, 2H); 13C-NMR (100 MHz, CDCl3): δ 170.4, 157.3, 156.0, 136.6, 125.7, 107.1, 
104.1, 67.0, 60.6, 60.3, 52.1, 31.8; IR (KBr): 3391, 1673 cm−1; HRMS (m/z): [M]+ calcd for 
C12H16O6, 256.0947; found, 256.0945. 
 
 
 
 
4.94: Prepared from general procedure A using 6n (150 mg, 0.60 mmol) and TFE (4 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.94 (135.5 mg, 
85%).  
 
4.94: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.50; 1H-NMR (400 MHz, CDCl3): δ 10.93 p.p.m. (s, 
1H), 7.58 (d, J = 8.8 Hz, 1H), 6.46 (d, J = 8.8 Hz, 1H), 4.23 (t, J = 4.8 Hz, 2H), 3.93 (s, 3H), 
3.90 (s, 3H), 3.66 (t, J = 4.8 Hz, 2H); 13C-NMR (100 MHz, CDCl3): δ 170.3, 156.7, 156.3, 137.1, 
125.6, 107.7, 104.5, 67.9, 60.8, 52.2, 50.2; IR (KBr): 2955, 2108, 1673, 1289 cm−1; HRMS (m/z): 
[M+H]+ calcd for C11H14N3O5, 268.0933; found, 268.0935. 
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4.95: Prepared from general procedure A using 6o (95 mg, 0.35 mmol) and TFE (3 mL) at 23 °C. 
After 3 hours, followed the workup procedure, the reaction crude mixture was purified by silica 
gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford 4.95 (84.1 mg, 84%).  
 
4.95: m.p.: 63.0-64.5 °C, TLC (hexanes/EtOAc, 10/1 v/v): RF = 0.60; 1H-NMR (400 MHz, 
CDCl3): δ 10.91 p.p.m. (s, 1H), 7.53 (d, J = 8.8 Hz, 1H), 7.43-7.24 (m, 5H), 6.48 (d, J = 8.8 Hz, 
1H), 5.18 (s, 2H), 3.90 (s, 3H), 3.88 (s, 3H), 3.66 (t, J = 4.8 Hz, 2H); 13C-NMR (100 MHz, 
CDCl3): δ 170.4, 157.1, 156.1, 137.1, 136.3, 128.6, 128.0, 127.1, 125.5, 107.1, 104.9, 70.6, 60.7, 
52.1; IR (KBr): 3030, 1673, 1618 cm−1; HRMS (m/z): [M]+ calcd for C16H16O5, 288.0998; found, 
288.0998. 
 
 
 
 
4.96: Prepared from general procedure A using 6p (80 mg, 0.23 mmol) and TFE (3 mL) at 23 
°C. After 3 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 5/1 hexanes/EtOAc, v/v) to afford 4.96 (47.9 mg, 
57%).  
 
4.96: TLC (hexanes/EtOAc, 5/1 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 10.87 p.p.m. (s, 
1H), 7.55 (d, J = 8.8 Hz, 1H), 6.48 (d, J = 8.8 Hz, 1H), 4.05 (t, J = 6.8 Hz, 2H), 3.91 (s, 3H), 
3.87 (s, 3H), 1.95 (penta, J = 6.8 Hz, 2H), 1.24 (s, 12H), 0.93 (t, J = 6.8 Hz, 2H); 13C-NMR (100 
MHz, CDCl3): δ 170.5, 157.7, 156.0, 136.7, 125.5, 106.6, 104.3, 83.2, 70.5, 60.7, 52.1, 24.8, 
23.6; IR (KBr): 2978, 1673, 1439 cm−1; HRMS (m/z): [M]+ calcd for C18H2711BO7, 367.1928; 
found, 367.1935. 
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4.109, 4.110 and 4.111: Prepared from general procedure A using 4.107 (100 mg, 0.26 mmol), 
TFE (2 mL) and DCCl3 (4 mL) at 23 °C. After 12 hours, followed the workup procedure, the 
reaction crude mixture was purified by silica gel column chromatography (10/1 → 1/3 
hexanes/CH2Cl2, v/v) to afford 4.107 (25.5 mg, 26%), tocopherol 4.110 (19.9 mg, 19%), 4.109 
and 4.111 (29.1 mg, 28%, 4.109 : 4.111 = 1.5:1) as yellow oil. The spectrums of tocopherol 
4.110 match the commercial sources. 
 
4.109 : 4.111 = 1.5:1: TLC (hexanes/CH2Cl2, 1:3 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): 
δ 6.81 p.p.m. (d, J = 8.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1.5 H’ (1HA))*, 6.32 (d, J = 8.0 Hz, 1.5 H’ 
(HA)), 6.24 (d, J = 8.0 Hz, 1H), 4.55 (s, 1H), 4.54 (s, 1.5 H’ (HA)), 2.70-2.62 (m, 
2H+3H’(2HA)), 2.09 (s, 3H), 2.97 (s, 4.5 H’ (3HA)), 2.05-1.58 (m, 2H+3H’(2HA)), 1.58-1.03 
(m, 24H + 36 H’ (24HA)), 1.01-1.83 (m, 12H + 18H’ (12 HA)); 13C-NMR (100 MHz, CDCl3): δ 
152.6, 152.5, 151.7, 127.6, 126.4, 118.4, 113.2, 111.4, 108.0, 106.4, 104.8, 76.1, 75.6, 40.1, 39.8, 
39.4, 37.4, 37.3, 32.8, 32.7, 31.2, 30.4, 28.0, 24.8, 24.4, 24.2, 24.0, 22.7, 22.6, 21.8, 21.0, 20.9, 
19.7, 19.6, 16.8, 15.5, 7.9; IR (KBr): 3431, 2925, 1612, 1462 cm−1; HRMS (m/z): [M-H]- calcd 
for C27H45O2, 401.34256; found, 401.34266. 
*1.5 H’ = one proton (1HA) for 4.109 
 
 
 
 
4.108: Prepared from general procedure A using 4.106 (100 mg, 0.19 mmol), HFIP (2.5 mL) at 
23 °C. After 12 hours, followed the workup procedure, the reaction crude mixture was purified 
by silica gel column chromatography (10/1 → 1/1 hexanes/CH2Cl2, v/v) to afford 4.106 (11.9 
mg, 12%) and 4.108 (55.1 mg, 54%) as yellow oil. 
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Large scale: 
 
Prepared from general procedure B using 4.106 (12 g, 22.4 mmol) and HFIP (200 mL) at 23 °C 
for 24 hours. HFIP (190 mL) was recovered. Followed the workup procedure, the reaction crude 
mixture was purified by2silica gel column chromatography (10/1 → 1/1 hexanes/CH2Cl2, v/v) to 
afford 4.106 (1.7 g, 14%) and 4.108 (5.5 g, 45%) as deep yellow oil. 
 
 
4.108: TLC (hexanes/CH2Cl2, 1/1 v/v): RF = 0.35; 1H-NMR (400 MHz, CDCl3): δ 6.96 p.p.m. (s, 
1H), 4.95 (brs, 1H), 2.72-2.58 (m, 2H), 2.09 (s, 3H), 1.82-1.69 (m, 2H), 1.64-1.05 (m, 24H), 
0.90-0.81 (m, 12 H); 13C-NMR (100 MHz, CDCl3): δ 151.9, 144.0, 130.5, 118.7, 118.6 (q, J = 
303 Hz) 114.6, 113.5, 76.9, 40.1, 39.4, 37.43, 37.37, 37.3, 32.8, 32.7, 30.8, 28.0, 24.8, 24.4, 24.1, 
22.7, 22.6, 21.8, 20.9, 19.7, 19.6, 8.5; IR (KBr): 3555, 2927, 1421, 1213 cm−1; HRMS (m/z): 
[M+Na]+ calcd for C28H45F3NaO5S, 573.28320; found, 573.28307. 
 
 
 
 
4.117: Prepared from general procedure A using 4.115 (141 mg, 0.34 mmol), HFIP (3 mL) at 40 
°C. After 24 hours, followed the workup procedure, the reaction crude mixture was purified by 
silica gel column chromatography (15/1 → 1/1 hexanes/EtOAc, v/v) to afford the 4.117 (10.1 
mg, 7%) and 13 (92.5 mg, 63%) as pale yellow oil. The spectrum data matched the literature 
data7. 
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4.124: Prepared from general procedure A using 4.123 (850 mg, 1.96 mmol), HFIP (10 mL) at 
23 °C. After 24 hours, followed the workup procedure, the reaction crude mixture was purified 
by silica gel column chromatography (15/1 → 10/1 hexanes/EtOAc, v/v) to afford the 4.123 (315 
mg, 37%) and 4.124 (400 mg, 43%) as pale yellow oil. 
 
 
4.124: TLC (hexanes/EtOAc, 10/1 v/v): RF = 0.55; 1H-NMR (400 MHz, C6D6): δ 7.07 p.p.m. (d, 
J = 2.4 Hz, 1H), 6.93 (dd, J = 2.4 and 8.4 Hz, 1H), 6.73 (d, J = 8.4 Hz, 1H), 5.64 (s, 1H), 4.58 
(dd, J = 1.6 and 8.0 Hz, 1H), 2.04-1.97 (m, 4H), 1.90 (dd, J = 6.4 and 8.8 Hz, 1H), 1.76-1.53 (m, 
4H), 1.53-1.36 (m, 4H), 1.29-1.22 (m, 2H), 1.13 (d, J = 12.4 Hz, 1H), 1.07 (s, 3H), 0.95 (s, 3H), 
0.87 (s, 3H); 13C-NMR (150 MHz, C6D6): δ 170.8, 147.4, 144.9, 122.7, 117.9, 114.5, 113.2, 87.8, 
76.5, 50.3, 45.1, 44.2, 38.2, 37.0, 33.7, 32.7, 31.6, 28.0, 27.9, 25.5, 23.9, 21.3, 20.6; IR (KBr): 
3531, 2952, 1719, 1494 cm−1; HRMS (m/z): [M+NH4]+ calcd for C23H3181BrNaO4, 475.12807; 
found, 475.12797. 
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Procedure to isolate the mono-phthalic acid ester 4.37, 4.39 and spectrum data: 
 
General Procedure C: A borosilicate vial was equipped with a magnetic stir bar and 
corresponding arenes (1.0 mmol, 1.0 equiv.) and HFIP (5 mL, ~0.3 M) was added by syringe to 
make homogeneous solution. To the resulting solution, phthaloyl peroxide (1.3 equiv.) was 
added in small portions and the vial was sealed with a septa screw cap and placed in a 40 °C oil 
bath. After 24 hours, the reaction crude was cooled and the solvent was evaporated slowly by a 
steam of N2 flow, at one time, some yellow brown crystalline solid was precipitated. The solid 
was either (i) carefully picked up by tweezers and washed with pentane and dried, or (ii) quickly 
purified by silica gel column chromatography (5/1 → 1/1 hexanes/EtOAc, v/v) to afford the 
adduct. 
 
 
 
4.19: Prepared from general procedure C using mesitylene 4.16 (50 mg, 0.42 mmol), HFIP (2 
mL). After 24 hours, followed the workup procedure (ii), the pale yellow solid 4.37 (117 mg, 
99%) was isolated and the crystal was further grown in ether solution. 
 
4.37: m.p. 140.5-142.5 °C; TLC (hexanes/EtOAc, 1/1 v/v): RF = 0.28; 1H-NMR (400 MHz, 
CDCl3): δ 8.05-8.03 p.p.m. (m, 1H), 7.90-7.88 (m, 1H), 7.69-7.65 (m, 2H), 6.91 (s, 2H), 2.29 (s, 
3H), 2.24 (s, 6H); 13C-NMR (100 MHz, CDCl3): δ 172.1, 165.1, 145.8, 136.0, 135.6, 131.73, 
131.68, 131.4, 130.0, 129.7, 129.5, 129.4, 128.3, 125.7, 20.8, 16.4; IR (KBr): 2920, 1753, 1702, 
1384cm−1; HRMS (m/z): [M+Na]+ calcd for C17H16NaO4, 307.09463; found, 307.09476. 
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4.39: Prepared from general procedure C using 1,3,5-triisopropylbezene 4.38 (1.0 g, 4.9 mmol), 
HFIP (20 mL). After 24 hours, followed the workup procedure (i), the brown solid was good for 
characterization. 
 
4.39: m.p. shrink above 130 °C ; TLC (hexanes/EtOAc, 1/1 v/v): RF = 0.25; 1H-NMR (400 
MHz, CDCl3): δ 8.15-8.12 p.p.m. (m, 1H), 7.89-7.86 (m, 1H), 7.69-7.67 (m, 2H), 7.04 (s, 2H), 
3.06 (hepta, J = 6.8 Hz, 2H), 2.91 (hepta, J = 6.8 Hz, 1H), 1.26 (d, J = 7.2 Hz, 6H), 1.22 (d, J = 
7.2 Hz, 12H); 13C-NMR (100 MHz, CDCl3): δ 172.1, 165.8, 147.0, 143.3, 140.0, 132.9, 132.3, 
131.5, 130.2, 129.9, 129.8, 122.0, 34.1, 27.4, 24.1; IR (KBr): 2963, 1740, 1705, 1260 cm−1; 
HRMS (m/z): [M+Na]+ calcd for C23H28NaO4, 391.18798; found, 391.18804. 
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III. Crystal data 
 
Crystal data of 4.37: 
 
 
 
 
 
 
 
 
 
 
View of 4.37 showing the atom labeling scheme. Displacement ellipsoids are scaled to 
the 50% probability level. 
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